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ABSTRACT
This works explores the use of rhodium-catalyzed intramolecular C–H insertion
on diazosulfones and sulfonates as a tool to simplify the synthesis of organic molecules.
Dirhodium-induced intramolecular C–H insertion on diazo carbonyl compounds is a
relatively well-studied reaction. It occurs with an overwhelming bias for the formation of
five-membered carbocycles or heterocycles, with the order of reactivity of C–H bonds
being methine > methylene >> methyl. This intrinsic preference can be overridden by
dissimilar factors such as substrate conformation, insertion site electronic effects and the
reactivity of the dirhodium catalyst.
This study has disclosed that when diazo- sulfones and sulfonates are employed,
dirhodium-induced intramolecular C–H insertion preferentially forms six-membered
heterocycles. Apparently, the difference in bond lengths and bond angles around the SO2
fragment incorporated into the newly forming ring allows more distant C–H bonds to be
targeted for insertion. The preference for formation of six- versus five-membered
heterocyclic sulfones, however, is tenuous in nature, and is dependent on the substrate
structure and the nature of the dirhodium catalyst used. Dirhodium catalysts bearing
electron poor ligands shift the preference back to formation of five-membered rings,
presumably due to forming more reactive carbenoid intermediates. The presence of
methyl substituents on the carbon atom adjacent to the sulfone fragment also favors the
formation of five-membered sulfones, likely due to the steric compression of the bond
angle. Rh2(S-pttl)4 [dirhodium(II)tetrakis(N-phthaloyl-(S)-tert-leucinate)] catalyst has
xxviii

been identified as the current best lead to the development of chiral catalysts for this
reaction. Selectivity of 3:1 (50% ee) was achieved with its use, and 20:1 (91% de) when
combined with the use of a (-)-menthol-based chiral auxiliary.
The synthetic utility of these novel six-membered heterocycles has also been
explored. To which end, the enantioselective synthesis of bakuchiol has been achieved in
14 linear steps by employing intramolecular C–H insertion on a diazo sulfonate to install
the quaternary center in its structure. The alkylation of these substrates with active
electrophiles under relatively mild conditions and with excellent yields has been attained
with high diastereoselectivity. Novel methodologies have been originated to transform
the obtained δ-sultones into γ-butyrolactones and δ-valerolactones using TBHP/t-BuOK
and SmI2/DMPU, respectively. The conversion of carbethoxythiane-1,1-dioxides to
cyclic α-sulfonyl oximes has also been demonstrated under relatively mild conditions
(NaH, isoamyl nitrite, rt, 8 h). Currently, the versatility of these new transformations is
being pursued in the synthesis of the natural products quebrachamine and mesembrine.
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CHAPTER 1
GENERAL INTRODUCTION AND BACKGROUND
1.1 C–H Bond Functionalization via Carbon–Carbon Bond Formation
In 2011, the FDA approved thirty five new drugs that offered significant advances
in the treatment of hepatitis C, lupus, late-stage prostate cancer, pneumonia and other
life-threatening diseases.1 Most of these drugs were small molecule (molecular weight
less than 1000) organic compounds. Increased knowledge about the in vivo activity of
these drugs will lead to the development of analogs and other new drugs, which at times
is associated with increase in molecular complexity. The development of these drugs
entails complex and lengthy multi-step syntheses, which are often reflected in the cost of
production, availability, marketing price, and overall success of the drug. This increases
the need to develop efficient synthetic strategies that would allow the synthesis of
bioactive molecules in an economical fashion.
Over the years, the synthesis of organic molecules has been achieved by
modifying precursors and intermediates at preexisting functional groups.2-5 This
conventional approach neglects sp3 carbon–hydrogen (C–H) bonds, which are ubiquitous
in organic molecules and are usually the most prevalent “functional group”.6-9 The sp3 C–
H bond has a bond length of 1.09 Å, bond energy of 413 kJ/mol, and it is non-polar
because of a small difference in electronegativity between carbon and hydrogen.9, 10 In
general, the sp3 C–H bond is inert. The inertness arises from the fact it possesses no
1

empty orbitals of low energy or filled orbitals of high energy that can readily participate
in a chemical reaction.6, 11 The inertness and ubiquitous nature of sp3 C–H bonds makes
the development of synthetically useful reactions daunting. However, the advent of
efficient selective C–H bond functionalization strategies, especially in the context of
carbon–carbon (C–C) bond formation, could greatly improve the available methods for
making organic molecules.12-14 A major challenge to the development of such strategies
has been the need for reagents that are reactive enough to cleave the relatively stable C–H
bonds but still sufficiently selective to distinguish between the different types of C–H
bonds in organic molecules.15-22
In organic substrates, the functional groups present dictate the reactivity of
proximal C–H bonds. This notion has been used to classify C–H bonds on organic
substrates into three groups: sp2 hybridized C–H bonds, activated sp3 hybridized C–H
bonds, and unactivated sp3 hybridized C–H bonds (Figure 1).5 C–H bonds which are sp2
hybidized are found in arenes and alkenes, while activated sp3 C–H bonds refer to sp3 C–
H bonds adjacent to heteroatoms or functional groups. Unactivated sp3 C–H bonds, on
the other hand, are not adjacent to a heteroatom or functional group. Activated sp3
hybridized C–H bonds are weaker (and thus more reactive) than their unactivated
counterparts and can be selectively functionalized.5, 6, 8, 23-28 The selective activation of
sp3 hybridized C–H bonds is known to be both kinetically and thermodynamically
unfavorable. Nevertheless, huge strides have been made in recent years to selectively
activate these bonds thanks to the works of Smoliakova,29, 30 Sames,5 and Murai.31

2

Figure 1. Different types of C–H bonds in organic substrates; FG represents other
functional groups in the substrates.5

Historically, the functionalization of C–H bonds via C–C bond formation heavily
depended on radical reactions.32, 33 However, the ubiquity of C–H bonds in organic
substrates and the difficulties associated with controlling radical reactions significantly
retarded the development of efficient and synthetically meaningful transformations. Over
the past three decades, considerable progress has been made in the area of C–H bond
functionalization.5, 6, 14, 34 Two cutting edge transition-metal-based transformations have
been originated for C–H bond functionalization, specifically with respect to new C–C
bond formation.
The first of these transformations is direct C–H activation, which entails adding a
reactive transition metal complex (Ru, Ir, Rh or Pd) across a relatively strong C–H bond
(90-105 kcal/mol) to form a weaker carbon–metal bond (50-80 kcal/mol), followed by a
subsequent transformation to generate a new C–C bond (Scheme 1).29, 35-37 Direct C–H
activation owes its roots to the pioneering work of Shilov,38 Bercaw,6 Bergman,25
Crabtree,39, 40 Murai31 and Goldman,41 and dates back to the 1970s and 1980s.

3

Scheme 1. Direct C–H activation mechanism; “R” represents a nucleophile and MLn
represents reactive transition metal complex.34

Direct C–H activation generally involves harsh reaction conditions (high
temperatures), which may not be tolerated by other functional groups on the substrate.
This, alongside the fact that the reactive transition metal complex may bind too tightly
with the C–H bond, has limited the use of this transformation for synthetic purposes.6, 37,
42

An attempted solution to this problem has been the use of neighboring functional

groups to direct less reactive metal complexes to the target C–H bond activation site.11, 25,
43

Less reactive metal complexes tend to bind loosely and generate activated C–H bonds,

which are more reactive and, thereby, creating more avenues for subsequent
transformations.
For some time, direct C–H activation has been restricted to sp2 hybridized C–H
bonds (aryl and vinyl), since the activation of sp3 hybridized C–H bonds is known to be
unfavorable, both kinetically and thermodynamically. In recent years, Murai and coworkers have taken advantage of the fact sp3 hybridized C–H bonds adjacent to
heteroatoms are weaker (more reactive) to show that pyrrolidine and piperidine C–H
bonds can be activated by Ru3(CO)12 and further coupled to unactivated alkenes.44 In the
aforementioned transformation, the 2-pyridyl nitrogen atom on compound 4 is needed to
4

direct the ruthenium complex to the desired C–H bond resulting in the formation of
ruthenium hydride complex 6, which reacts with the unactivated alkene 7 to form alkyl
ruthenium complex 8, from which reductive elimination gives the final product 9
(Scheme 2).

Scheme 2. Proposed mechanism for direct C–H bond activation of activated sp3 C–H
bonds using ruthenium complexes by Murai et al.44

Expanding on Murai’s work, Sames and co-workers have developed the arylation
of sp3 hybridized C–H bonds without the aid of a directing group.28, 43 They demonstrated
that N-phenylpyrrolidine can be arylated with iodobenzene in the presence of Cs2CO3 and
t-BuOH (Table 1). Mechanistic investigations revealed an oxidative pathway for the
reaction. Even though these results reveal that sp3 hybridized C–H bonds can be directly
activated, the yields for the products remain relatively low, considerably limiting the
synthetic utility of this transformation.

5

Table 1. Studies on non-directed sp3 C–H bond activation using ruthenium complexes
reported by Sames et al.28

The other type of transition-metal-based transformations for functionalizing C–H
bonds is metal-carbenoid C–H insertion. In this case, the reactive transition metal
complex inserts into a C–H bond to generate a three-centered cyclic transition state,
which leads directly to the functionalized products (Scheme 3).3, 45-51 Unlike C–H
activation, metal carbenoid C–H insertion is highly selective. The metal complexes,
which initiate the reaction, are readily regenerated rendering the process highly catalytic.
The metal carbenoids are masked carbenes, and require an appropriate level of
electrophilicity to proficiently effect C–H insertion. If the metal carbenoid is extensively
electrophilic, competing side reactions become an issue.4, 34 On the other hand, if the

6

electrophilicity is insufficient, the metal carbenoid lacks the reactivity to insert into an
unactivated C–H bond.

Scheme 3. Catalytic cycle for C–H functionalization by metal carbenoid insertion from
diazo compounds.34

Free carbenes are overly reactive and tend to react with organic substrates in
ways, which are unselective and uncontrollable.52-54 The binding of the metal complex to
the carbene serves to modulate its reactivity, thereby allowing more control over the
outcome of the reaction. The metal complex binds to the carbene through strong σacceptor interactions and weak Π-back donation interactions, which stabilize the carbine,
but still ensure that it remains active enough to insert into a C–H bond.14, 55 Overall, the
reactivity of the carbenoid is determined by the nature of the ligands on the metal
complex as well as the substituents adjacent to the carbene moiety.

7

1.2 Classes of Metal Carbenoid
In general, metal carbenoids are conveniently obtained by the extrusion of
nitrogen from diazo compounds.56 Depending on the substituents adjacent to the diazo
moiety, three classes of metal carbenoids have been distinguished: acceptor carbenoids,
acceptor/acceptor carbenoids, and donor/acceptor carbenoids (Figure 2).3 In this context,
acceptor refers to an electron-withdrawing group (EWG) while donor refers to an
electron-donating group (EDG). Typical acceptor groups are carbonyl, nitro, cyano,
phosphonyl and sulfonyl, while typical donor groups are vinyl, aryl and heteroaryl. The
presence of an EWG increases the electrophilicity and reactivity of the resulting
carbenoid, while that of an EDG stabilizes the carbenoid and enhances its selectivity.15, 5759

Figure 2. Classes of diazo-based metal carbenoids.34

Acceptor carbenoids are highly reactive but exhibit limited selectivity since they
do not bear an EDG. The high reactivity makes them susceptible to competing reactions
like carbene dimerization. Acceptor carbenoids are commonly used in intramolecular and
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cyclopropanation reactions, in which their reactivity can be modulated by steric effects.17,
60

Acceptor/acceptor carbenoids are obtained from diazo compounds bearing two
EWGs. The presence of the second EWG stabilizes the diazo compounds, and highly
reactive metal catalysts are needed for the extrusion of nitrogen to form the carbenoids.
Once formed, the resulting carbenoids are highly reactive and are liable to carbene
dimerization. Acceptor/acceptor carbenoids can also be used for intramolecular and
cyclopropanation reactions, even though they will be less selective than their acceptor
counterparts.17, 61
Donor/acceptor carbenoids are derived from diazo compounds that possess an
EWG and a donor substituent like a vinyl or aryl group, capable of stabilizing the
resulting carbenoid through resonance.49, 60 Again, because the diazo precursor is
stabilized, very reactive metal catalysts are needed to generate the carbenoid. This class
of carbenoids exhibits high chemoselectivity and is widely used for intermolecular
reactions.

1.3 Use of Rhodium(II) Complexes in Carbenoid C–H Insertion
Rhodium(II) complexes are the most effective and versatile catalysts for metal
carbenoid-mediated C–H insertion.20, 62-67 Prior to the introduction of rhodium(II)
complexes by Teyssie and co-workers in the 1980s, mostly copper complexes were
employed with varying levels of success.63, 68, 69 The superiority of rhodium(II)
complexes lies in its inherent ability to form Rh–Rh bonds. This intrinsic property
9

permits the formation of a dirhodium-bridge, caged within a ‘lantern’ structure, which is
thought to be the essential feature of these complexes.57, 70, 71 Only one of the two
rhodium atoms actually binds to the carbene; the other atom serves as an electron sink to
increase the electrophilicity of the carbenoid moiety, and also facilitates the cleavage of
the rhodium–carbon bond upon completion of the reaction.15, 55 To date, four main classes
of rhodium(II) complexes have been established for metal carbenoid insertion reactions.
They are rhodium(II) carboxylates, rhodium(II) carboxamidates, rhodium(II) phosphates,
and ortho-metalated arylphosphine rhodium(II) complexes. More recently, rhodium(II)
carboxylates and carboxamidates have emerged at the forefront as the most effective and
versatile catalysts for carbenoid C–H insertion.46, 47, 72 Representative examples include:
Rh2(OAc)4 (rhodium acetate) 14, Rh2(S-DOSP)4 (tetrakis[(S)-(+)-N-(pdodecylphenylsulfonyl)prolinato]dirhodium(II) 15, Rh2(S-pttl)4 (dirhodium(II) tetrakis[Nphthaloyl-(S)-tert-leucinate]) 16, Rh2(S-MEPY)4 (dirhodium(I1) tetrakis[methyl-2pyrrolidone-5(S)-carboxylate]) 17 among others. The reactivity of these rhodium(II)
complexes is governed by the nature of the ligands on the dirhodium bridge.55, 57 In
general, electron-withdrawing ligands tend to increase the electrophilicity and reactivity
of the catalyst, while electron-donating groups tend to enhance the selectivity.
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Figure 3. Common rhodium catalysts used for carbenoid C–H insertion of diazo
compounds.14

1.4 Rhodium-Catalyzed C–H Insertion Mechanism
The catalytic cycle of rhodium-catalyzed C–H insertion reactions involves three
main steps: (1) rhodium-assisted nitrogen extrusion from the diazo compound, (2)
activation of the C–H bond and (3) C–C bond formation.55, 61, 73 The sequence of
occurrence of the C–H activation and C–C bond formation steps has been a subject of
considerable speculation and various models of the C–H activation transition state (TS)
have been proposed. Doyle and co-workers based on experimental results put forth a
model, in which after nitrogen extrusion, there is overlap of the carbenoid’s p-orbital with
the σ-orbital of the reacting C–H bond to form a three-centered concerted transition state
where C–C and C–H bond formation with the carbene carbon occurs at the same time as
the ligated metal dissociates but not to the same extent (Scheme 4).15 They further
emphasized that the presence of electron-withdrawing ligands on the dirhodium bridge
increases the elcetrophilicity of the carbene and forces bond formation to occur at a
greater distance, resulting in an early transition state, which leads to lower selectivity. On
the other hand, the presence of electron-donating ligands favors a late transition state and
leads to higher selectivity.
11

Scheme 4. Proposed mechanistic pathway by Doyle et al. for rhodium-catalyzed C–H
insertion from diazo precursors.15

Taber and co-workers suggested a four-centered transition state whereby there is
an interaction between the hydrogen of the C–H bond and one of the rhodium atoms
(Scheme 5).21, 74 According to this model, after nitrogen extrusion, the resulting carbenoid
20 can be depicted as an inverted ylide 21, which rapidly forms a reversible threecentered two electron intermediate complex 22. For bond formation to proceed, a fourcentered TS 23 is needed, in which the Rh–C bond is aligned with the target C–H bond.
Provided sufficient overlap exists, the electron pair of the C–H bond moves to form a
new C–C bond, and synchronously, the electron pair of the Rh–C bond moves to form a
new C–H bond. This affords product 24 and releases initial rhodium complex 14.
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Scheme 5. Proposed mechanism by Taber et al. for rhodium-catalyzed C–H insertion
from diazo precursors.21

A recent demonstration by Nakamura and co-workers confirmed the model
advanced by Doyle and co-workers.55 Using B3LYP density functional studies on
dirhodium tetracarboxylate-catalyzed C–H bond activation, they disclosed the energetics
and geometry of important intermediates and TS in the catalytic cycle. They proposed
that the reaction is initiated by the formation of a complex between the rhodium catalyst
and the diazo compound. This is followed by back donation of electrons from the
rhodium 4dxz orbital to the C–N σ*-orbital, which provides the driving force for nitrogen
extrusion to form the rhodium carbenoid.
The rhodium carbenoid is highly electrophilic because of its vacant 2p orbital. As
such, the C–H activation and formation of the C–C bond proceed in a single step via a
three-centered hydride transfer-like TS with small activation energy. Throughout the
reaction, only one of the two rhodium atoms serves as a carbene binding site; the other
13

assists the C–H insertion reaction by enhancing the electrophilicity of the carbene bound
rhodium and facilitating the cleavage of the rhodium–carbon bond. Neither of the
rhodium atoms interacts directly with the target C–H bond undergoing insertion.

Scheme 6. Proposed mechanism by Nakamura et al. for rhodium-catalyzed C–H insertion
from diazo precursors.55

1.5 Synthetic Utility of Rhodium-Induced C–H Insertion
Rhodium-induced C–H insertion can either be intermolecular or intramolecular.58,
75-78

For some time, regioselectivity challenges associated with intermolecular substrates

and competing side reactions, like carbene dimerization, limited rhodium carbeonid C–H
14

insertion to substrates capable of intramolecular reactions; whereby the target C–H bond
and the rhodium carbenoid are connected by a suitable tether, which provides close
proximity leading to favorable regioselectivities.42 However, vigorous research in the
area of intermolecular rhodium-catalyzed C–H insertion has shown that this
transformation is just as strategic and meaningful synthetically as the intramolecular
version.19, 49, 75, 76, 79

1.5.1 Intermolecular Rhodium-Induced C–H Insertion
The disclosure by Davies and co-workers that donor/acceptor carbenoids are
capable of undergoing highly regio- and stereoselective intermolecular C–H insertion
reactions has evolved intermolecular C–H insertion from a synthetically limited reaction
to a broadly useful transformation.19, 49, 75 This is highlighted by a number of impressive
examples, in which intermolecular C–H insertion has been employed as a strategic
reaction to install stereogenic centers in natural product targets.3, 49, 77
Intermolecular C–H insertion is best catalyzed by Rh2(S-DOSP)4 and is highly
favored at sites that stabilize positive charge.19, 80 It can occur at primary, secondary and
tertiary C–H bonds, controlled by a tenuous balance of steric and electronic factors.
Based on the ability of the substrate to stabilize positive charge, the trend of reactivity is
as follows: tertiary > secondary > primary. However, because the rhodium(II) catalyst
bears bulky ligands, from a steric stand point, the order of reactivity becomes primary >
secondary > tertiary. Overall, secondary C–H bonds are most favored because they
stabilize positive charge without being too sterically crowded. 67, 81
15

Intermolecular C–H insertion reactions can be separated into cyclopropanation,82
[4 +3] cycloaddition50 and C–H functionalization.83 Intermolecular cyclopropanation
routinely occurs with high diasteroselectivity (>20 : 1 dr), and the obtained
cyclopropanes can be rearranged or ring-opened to allow the synthesis of other organic
compounds. An illustrative example is the reaction of styryldiazoacetate 32 with styrene
33 catalyzed by Rh2(S-DOSP)4 to afford vinylcyclopropane 34 in 79% yield, > 20 : 1 dr
and 98% ee.84 The resulting vinylcyclopropane 34 has been converted to amino acids 35
and 36, and cyclopropanedicarboxylate 37, which can be ring-expanded when subjected
to Lewis acid-catalyzed conditions in the presence of an aldehyde or ring-opened by a
cuprate reagent, as illustrated in the synthesis of the antidepressant (+)-sertraline 38 by
Corey and coworkers.82

Scheme 7. Rhodium-catalyzed intermolecular cyclopropanation in the synthesis of the
antidepressant (+)-sertraline by Corey et al.82
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A representative example of an intermolecular [4+3] cycloaddition is that between
vinyldiazoacetate 39 and the (E,Z)-diene 40 catalyzed by Rh2(OOct)4 to generate
cycloheptadiene 42 as a single regioisomer and diastereomer in 49%.85 Selective
intermolecular cyclopropanation of the (Z) double bond occurs to generate the
divinylcyclopropane 41, which undergoes a Cope rearrangement to provide 42 as a single
diastereomer. The cis double bond of 42 is reduced by Wilkinson’s catalyst to form 43.
Base hydrolysis of the acetyl group followed by in situ lactonization results in the
synthesis of (±)-tremulenolide A 44. Also, DIBAL reduction of the two esters on 43
completes the synthesis of (±)-tremulenediol 45.
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Scheme 8. Rhodium-catalyzed intermolecular [4 + 3] cycloaddition in the synthesis of
(±)-tremulenolide A and (±)-tremulenediol by Davies and co-workers.85

When some chiral catalysts are used in intermolecular [4 + 3] cycloaddition, the
directing ability of a chiral substrate can be overridden. This has been demonstrated by
Sarpong and co-workers86 in a parallel kinetic resolution approach used to synthesize
cyathane and cyanthiwigin diterpenes. The Rh2(S-DOSP)4-catalyzed reaction of (+)-46
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preferentially favors the formation of 48, while that of (-)-46 leads to 50. Compound 48 is
a precursor to (-)-cyanthiwigin G 49, while 50 is a precursor to (+)-cyanthin A3 51.

Scheme 9. Synthesis of cyathane and cyanthiwigin diterpenes via intermolecular
rhodium-catalyzed C–H insertion.86

Intermolecular C–H insertion reactions can also provide complementary
approaches to conventional synthetic strategies to help streamline the preparation of
target natural products. For instance, intermolecular C–H insertion adjacent to oxygen
forms β-hydroxy esters, which are products routinely derived from aldol reactions,87
similarly, the same reaction on analogous leads to β-amino esters, products of a Mannich
reaction (Scheme 10).88 In Scheme 10a, intermolecular insertion is preferentially favored
at the C–H bond adjacent to the siloxy group of compound 52 rather than the acetoxy
group. This stems from the fact that the electron-withdrawing acetoxy group deactivates
the adjacent C–H bonds towards insertion, while the electron-donating siloxy group
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activates the adjacent C–H bonds towards insertion. In Scheme 10b, the benzylic C–H
bonds in compound 57, which are electronically most activated, are sterically
inaccessible so the insertion occurs at the methyl C–H bonds.

Scheme 10. Intermolecular rhodium-catalyzed insertion applied to the synthesis of
products classically obtained by aldol and Mannich reactions.87, 88

The synthesis of the antidepressant (S)-venlafaxine by Davies and co-workers is
an impressive example where this chemistry has been put to use.89 In the synthesis,
Rh2(S-DOSP)4-catalyzed reaction of aryldiazoacetate 62 with N-methyl-1-aza-2,520

disilacyclopentane 63, generated β-amino ester 64 in 68% yield and 93% ee, which was
further converted in two steps to (S)-venlafaxine 65 (Scheme 11). The disilyl protecting
group in 63 serves to protect the amino group from the electrophilic carbenoid, so that
just its adjacent C–H bonds can react in an intermolecular fashion with the carbenoid.
Also, the disilyl group is very labile, and the β-amino ester is readily released and
isolated as its hydrochloride salt.

Scheme 11. Intermolecular rhodium-catalyzed C–H insertion applied to the synthesis of a
β-amino ester en route to the synthesis of (S)-venlafaxine.89

Intermolecular C–H insertion reactions are also capable of initiating cascade
reactions.90-92 An elegant example of this class of reactions has been termed the combined
C–H activation/Cope rearrangement.92 The reaction occurs in a concerted fashion through
a six-membered transition state to form products that are normally obtained from
intermolecular C–H insertion followed by a Cope rearrangement. However, the
intermolecular C–H insertion product was reported not to be an intermediate in this
reaction because it is the most stable thermodynamic product. The pathway is thought to
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be initiated by intermolecular insertion, but is interrupted by Cope rearrangement leading
to the formation of product 69 (Scheme 11).

Scheme 12. Mechanistic pathway for the combined C–H activation/Cope
rearrangement.92

The combined C–H activation/Cope rearrangement has been employed as as the
key step in the synthesis of the diterpenes (-)-colombiasin A and (-)-elisapterosin B, both
isolated from Pseudopterogorgia elisabethae (Scheme 13).93 In the synthesis,
dihydronapthalene 70 and vinyldiazoacetate 71 undergo a combined C–H
activation/Cope rearrangement catalyzed by Rh2(R-DOSP)4 to form products 72 and 73.
Apparently, when the reaction is catalyzed by Rh2(R-DOSP)4, one enantiomer of
dihydronapthalene undergoes combined C–H activation/Cope rearrangement to provide
72, while the other enantiomer is converted by cyclopropanation to 73. Compound 72 is
obtained in 41% yield, with 92% ee. In the reaction, three chiral centers common to both
natural products are obtained. Compound 72 is then transformed in seven and eight steps
to (-)-colombiasin A 74 and (-)-elisapterosin B 75, respectively.
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Scheme 13. Combined C–H activation/Cope rearrangement applied to the synthesis of ()-colombiasin A and (-)-elisapterosin B.93

Several pharmaceutical agents have been synthesized by applying
enantioselective intermolecular C–H functionalization as a critical step in the syntheses.
(+)-Cetiedil 79,94 (S)-venlafaxine 65,89 ritalin 8295 and (+)-indatraline 8596 are some
representative examples among others. In the synthesis of (+)-cetiedil (Scheme 14),
thiophenyldiazoacetate 76 undergoes an allylic C–H insertion with 1,4 cyclohexadiene 77
catalyzed by Rh2(R-DOSP)4 to form 78 in 57% yield and 88% ee. Chloride 78 is further
converted in two steps to furnish the cholinesterase inhibitor (+)-cetiedil 79.
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Scheme 14. Intermolecular rhodium-catalyzed C–H insertion applied to the synthesis of
(+)-cetiedil.94

Ritalin, also known as (+)-methylphenidate, is used for the treatment of attention
deficit hyperactivity disorder (ADHD). Conventional synthetic approaches to this
compound involve multi-step synthesis; conversely, intermolecular rhodium-catalyzed
C–H insertion allowed a direct and rapid approach. The Rh2(S-biDOSP)4-catalyzed
reaction of the protected piperidine 80 with methyl phenyldiazoaceatate 81, followed by
removal of the protecting group, completed a rapid synthesis of (+)-methylphenidate 82
(Scheme 15).
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Scheme 15. Intermolecular rhodium-catalyzed insertion applied to the synthesis of (+)methylphenidate.95

Indatraline is a potent psychoactive compound with a strong binding and
inhibitory affinity for monoamine reuptake inhibitors such as dopamine and serotonin.
The synthesis of indatraline has been completed via Rh2(S-DOSP)4-catalyzed reaction of
(3,4 dichlorophenyl)diazoacetate 83 and 1,4-cyclohexadiene 77 to give C–H insertion
product 84 in 83% yield and 93% ee. Product 84 was then transformed in six steps to (+)indatraline 85 (Scheme 16).
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Scheme 16. Intermolecular rhodium-catalyzed insertion applied to the synthesis of (+)indatraline.96

1.5.2 Intramolecular Rhodium-Induced C–H Insertion
The majority of synthetically meaningful rhodium(II) catalyzed reactions are
intramolecular C–H insertion reactions.97-102 As mention earlier, this occurs when the
rhodium carbenoid and the target C–H bond are in the same molecule, connected by a
suitable tether. In general, rhodium-induced intramolecular C–H insertions are best
catalyzed by rhodium(II) carboxamidates103 and occur with an overwhelming preference
for the formation of five-membered carbocyles/hetereocycles, in which the order of
reactivity is tertiary > secondary >> primary.45, 104 This inherent preference can be
overridden by substrate conformation, local electronic effects and the nature of the
ligands on the rhodium catalyst to obtain four- and six-membered ring compounds on
select substrates.57, 70 However, there is no standard procedure that dictates the
application of these controlling factors. At times, competing influences may result in the
formation of mixtures of products as demonstrated by Hu and co-workers in the β- and γ26

lactam synthesis via C–H insertion of diazoacetamides (Scheme 17).105 The activating
effect of the amide nitrogen and the strong electron-withdrawing substituent attached to
the carbene favored the formation of a β-lactam. Apparently, the presence of the strong
electron-withdrawing substituent leads to the early TS 88 resulting in β-lactam 90. The
absence of a strong electron-withdrawing substituent favored a late TS 89 leading to γlactam 91.

Scheme 17. Formation of β- and γ-lactams by intramolecular rhodium-catalyzed
insertion.105

A notable feature of intramolecular C–H insertion is its inherent ability to convert
an acyclic tertiary chiral center into a cyclic quaternary chiral center with retention of
absolute configuration.74, 106 This phenomenon has been exploited by Taber and coworkers in the synthesis of (-)-hamigeran B (Scheme 18).106 A key step in the synthesis
was the Rh2(S-pttl)4-catalyzed reaction of α-aryl-α-diazoketone 92, which leads to the C–
H insertion product 93 in 83% yield with retention of configuration at the quaternary
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center. However, a mixture of diastereomers was obtained because of the sterogenic
center adjacent to the carbonyl moiety. The desired configuration was conveniently
attained by equilibrating the mixture, and subsequent steps furnished the product (-)hamigeran B 94.

Scheme 18. Intramolecular rhodium-catalyzed insertion applied to the synthesis of (-)hamigeran B.106

During intramolecular C–H insertion, EDG and heteroatoms tend to activate
adjacent C–H bonds towards insertion, while EWG deactivate adjacent C–H bonds.107, 108
This aspect of intramolecular C–H insertion has been utilized by Fukuyama and coworkers to generate benzofurans from α-aryl-α-diazoketones via intramolecular C–H
insertion en route to the synthesis of the complex macrocyclic spermine alkaloid (-)ephedradine (Scheme 19).107 In one case, reaction of α-aryl-α-diazoketone 95 catalyzed
by Rh2(S-DOSP)4 led to C–H insertion product 96 in 63% yield. A diastereomeric ratio
of 13 : 1 was obtained with the aid of a chiral auxiliary in combination with the chiral
catalyst. Benzofuran 96 was converted to the product (-)-ephedradine 97 in 14 steps.
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Scheme 19. Intramolecular rhodium-catalyzed insertion applied to the synthesis of (-)ephedraline.107

Intramolecular C–H insertion has been widely used in the synthesis of γbutyrolactones and γ-lactams (Scheme 20).108, 109 Notable examples are the
pharmaceutical agents (R)-baclofen.HCl 101 and (R)-rolipram 105, respectively. (R)Baclofen.HCl is a GABAB receptor agonist, while (R)-rolipram is a phosphodiesterase
type IV inhibitor. The synthesis of 101 begins from p-chlorophenethyl alcohol and
involves a Rh2(S-MPPIM)4-catalyzed intramolecular C–H insertion reaction of
diazoacetate 99 to afford the γ-butyrolactone 100 in 81% yield and 99% ee, which is
further converted to 101 in a 60% overall yield.110 Hu and co-workers111 have reported
the synthesis of 105 starting from isovanillin 102 and utilizing cumyl(2,2-dimethylbenzyl) as an N-protecting group for a Rh2(MEOX)4-catalyzed intramolecular C–H
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insertion of α-diazoacetamide 103 to provide the γ-lactams 104 in 64% yield and 46% ee.
Removal of the cumyl protecting group furnishes 105 in 15% overall yield.

Scheme 20. Synthesis of γ-butyrolactones and γ-lactams by intramolecular rhodiumcatalyzed insertion.110, 111

Naturally occurring lignin lactones such as (±)-enterolactone 106, (±)-hinokinin
107, (-)-arctigenin 108, (+)-isodeoxy-podophyllotoxin 109, (+)-isolauricerisinol 110, and
(+)-imperanene 111, are some representative examples of natural products that have been
synthesized by employing intramolecular C–H insertion to generate γ-butyrolactones as
crucial steps in the syntheses (Figure 4).112
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Figure 4. Natural occurring lignin lactones synthesized by using rhodium-catalyzed
intramolecular C–H insertion to generate γ-butyrolactones.112

Another important aspect of intramolecular C–H insertion is that the reaction can
break the symmetry of molecules, thereby generating complex products from relatively
simple precursors. This aspect has been put into use by Taber and co-workers in the
synthesis of the sesquiterpene antibiotic pentalenolactone E.113 In a key step of the
synthetic route (Scheme 21), the tricyclic ketone 114 is furnished by Rh2(OAc)4catalyzed intramolecular C–H insertion of α-diazo-β-ketoester 113 with a single chiral
center. The ester is converted to tricyclic ketone 114 with high asymmetric induction
resulting in three chiral centers. The tricyclic ketone is then converted in five steps to
complete the synthesis of pentalenolactone E 115.
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Scheme 21. Use of intramolecular rhodium-catalyzed insertion in the synthesis of
pentalenolactone E by Taber and co-workers.113

The effectiveness of rhodium-catalyzed intramolecular C–H insertion to form new
C–C bonds in fused-ring systems under strained conditions has also been
demonstrated.114, 115 In the synthesis of (+)-morphine by White et al. (Scheme 22),114
carboxylic acid 116 was treated with oxalyl chloride followed by diazomethane to form
α-diazoketone 117 in 63% yield. Rh2(OAc)4-catalyzed intramolecular insertion of 117
afforded the fused-cyclopentanone 118 in 50% yield, from which the piperidine ring of
(+)-morphine 119 was installed at a later stage in the synthesis.

Scheme 22. Use of intramolecular rhodium-catalyzed insertion to construct carbocycles
in strained and fused systems.114

Similarly to the synthesis of (+)-morphine, Srikrishna and Gharpure115 have
reported the synthesis of (-)-neopupukean-4,10-dione 122, (-)-neopupukean-10-one 123,
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(-)-2-pupukeanone 129 and (-)-4-thiocyanatoneopupukeanane 125. A characteristic
feature of neopupukeananes is the presence of the subtle 9-isopropyl-3,6dimethyltricyclo[4.3.1.0]decane (isotwistane) framework that constitutes two quaternary
carbon atoms in addition to the isocyano and thiocyanato moieties. In the report, the
isotwistane framework was formed via Rh2(OAc)4-catalyzed intramolecular insertion
from the corresponding diazo ketone 121. The diazo ketone is obtained from (R)-carvone
120 by employing double Michael reactions with LiHMDS and methyl methacrylate to
get bicyclic keto esters, which are further subjected to base hydrolysis to get the
corresponding keto acids. Treatment of the keto acids with oxalyl chloride followed by
diazomethane results in the formation of the desired diazo ketones. The isotwistane
framework is then converted to the various neopupukeananes by subsequent reactions.

Scheme 23. Synthesis of neopupukeananes via intramolecular rhodium-catalyzed
insertion.115
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Using similar transformations to the ones described above, the synthesis of (-)-2pupukeanone was also completed starting from 120 (Scheme 24). Rh2(tfa)4-catalyzed
intramolecular C–H insertion of the diazo ketone 127gave diketone 128 in 47% yield,
which was converted in three steps to (-)-2-pupukeanone 129.

Scheme 24. Synthesis of (-)-2-pupukeanone via intramolecular rhodium-catalyzed
insertion.115
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CHAPTER 2
RHODIUM-CATALYZED INTRAMOLECULAR C–H INSERTION ON
DIAZOSULFONES AND DIAZOSULFONATES
2.1 Introduction
The earliest studies on rhodium-catalyzed intramolecular C–H insertion on αdiazosulfones were performed by Durst and co-workers.116, 117 These studies
demonstrated the formation of five-membered γ-sulfones fused to phenyl, thiophene and
indole ring compounds (Table 2). The products are formed from the insertion of the
rhodium carbenoid carbon into an aromatic ortho C–H bond. However, the reaction
shows a preference to products arising from insertion at the carbon atom para to alkoxy
substituents in cases where competition between para- and ortho C–H bonds is possible
(substrate 133, Table 2). Also, ortho-methoxy substituted aromatic α-diazosulfones
provide no identifiable products (substrate 134, Table 2), perhaps due to competing
oxygen ylide formation, followed by decomposition. The presence of an additional
substituent adjacent to the sulfone fragment (substrate 135, Table 2) result in the
formation of diasteromers, but with no influence on the outcome of the reaction. While it
is possible to obtain products with α-diazo esters, α-diazo ketones and sulfonyl
diazomethane afford no products under the same reaction conditions. Following this
initial report by Durst and co-workers, for over two decades, there have been no other
reports on either intermolecular or intramolecular C–H insertion involving α-
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diazosulfones and α-diazosulfonates, in which the sulfone fragment is a part of the
formed ring.

Table 2. Rhodium-catalyzed intramolecular C–H insertion resulting in the formation of γsulfones fused to phenyl, thiophene and indole ring compounds reported by Durst and coworkers.116

S

Ar

P

Yield (%)

130

14-48

131

50

132

24

133

42

134

0
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Table 2. Cont.
S

Ar

P

Yield (%)

47

135

Recently, Du Bois and co-workers have demonstrated that rhodium nitrenoids
generated from the corresponding sulfamate esters undergo intramolecular nitrogen–
hydrogen insertion to form six-membered ring sulfamates.118-121 As proposed, the
difference in bond lengths and bond angles around the sulfur atom is responsible for the
change of preference. Expanding on Du Bois’ work, Novikov and co-workers previously
disclosed the preferential formation of cyclic six-membered sulfones and sulfonates via
rhodium-catalyzed intramolecular C–H insertion of aliphatic diazosulfones and
diazosulfonates (Table 3).122 As in the case of nitrene insertion, the preference for sixmembered rings has also been attributed to longer bond lengths and larger bond angles
around the sulfonyl fragment incorporated into the newly forming ring, which allows
more distant C–H bonds to be targeted for insertion resulting in favorable six-membered
ring.
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Table 3. Rhodium-catalyzed intramolecular C–H insertion of aliphatic diazosulfones and
diazosulfonates leading to the formation of six-membered rings by Novikov and coworkers.122

S

X

R

136

CH2

55a

137

CH2

56

138

O

53

139

O

55a

140

O

80b

P

Yield (%)

a

Isolated as a single isomer.
Diasteromeric ratio varied from experiment to experiment, ranging from complete to
2:1 in favor of the same diasteromer
b

A subsequent report by Wolckenhauer et al.123 has shown that in the case of
diazosulfonates, the preference for six-membered rings persists on a variety of substrates
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(Table 4). Remarkably, the preference for six-membered rings is maintained even when
formation of a strained system is required.

Table 4. Formation of six-membered sulfonates from the corresponding diazosulfonates
via intramolecular rhodium-catalyzed C–H insertion reported by Wolckenhauer and coworkers.

S

R

P

Yield (%)

141

84b

142

94a

143

85a

144

64a

145

57c
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Table 4. Cont.
S

a

R

P

Yield (%)

146

66d

147

68a

148

77a

: Rh2(OAc)4, DCM; b: Rh2(esp)2, DCM; c: Rh2(tpa)4, DCM; d: Rh2(tfa)4, CCl4

2.2 Formation of Five- versus Six-Membered Cyclic Sulfones via Rhodium-Catalyzed
Intramolecular C–H Insertion
In the initial report by Novikov and co-workers in 2007,122 sulfone 149a (Table 5)
was identified as the major product of intramolecular C–H insertion of the corresponding
diazosulfone 136. A more detailed analysis of the reaction mixture revealed the presence
of a small amount of the cis isomer as well as isomers with a five-membered ring. This
provoked follow-up studies into the contributing roles of the catalyst, structure of the
diazosulfone, and the local C–H insertion site electronic effects to the selectivity of the
reaction.124
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An effort to characterize the reaction mixture proved daunting as the separation
of the other isomers (five-membered ring isomers and the cis six-membered ring isomer)
turned out to be difficult, and was further complicated by simultaneous equilibrium
between 150a and 150b during flash chromatography. However, it was found that the
mixture of 150a and 150b isomerized with DBU (1,8-diazabicyclo[5.4.0]undec-7-ene) in
DCM (dichloromethane) for 24 h at room temperature to provide exclusively 150a. Also,
equilibrating the mixture prior to flash chromatography separation simplified the
purification of the products. Curiously, under these isomerization conditions, the sixmembered ring diastereomers 149a and 149b formed a mixture with a ratio close to 1:1.
Mindful of the fact that the electronic properties of the ligands on the rhodium
catalyst dictate the reactivity of the resultant rhodium carbenoid, the efficacy of other
catalysts in the reactions of the diazosulfone substrate 136 was investigated (Table 5).
Doyle’s Rh2(cap)4 (rhodium(II) caprolactam),125 which is known to enhance C–H
insertion selectivity, Rh2(tpa)4 ( rhodium(II) triphenyl acetate), and Du Bois’118 tethered
Rh2(esp)4 (bis[rhodium(α, α, ά, ά -tetramethyl-1,3-benzenedipropionic acid)]) catalysts
proved effective for this transformation showing results similar to Rh2(OAc)4. Rh2(cap)4
catalyst was unreactive at room temperature or at reflux in DCM, necessitating a switch
to the higher boiling solvent dichloroethane. Unexpectedly, Rh2(pfb)4 (rhodium(II)
perfluorobutyrate) catalyst led to a reversal of the usual selectivity, providing exclusively
the five-membered ring products. These results infer that rhodium(II) catalysts with
strong electron-withdrawing ligands such as Rh2(pfb)4 tend to favor the formation of five-
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membered sulfones, while those with electron-donating ligands tend to favor sixmembered sulfones.124

Table 5. Effect of catalyst on five- versus six-membered sulfone selectivity reported by
Jungong et al.124

Rh2L4, conditionsa

Yield of 149b (%)

Yield of 150b (%)

Rh2(OAc)4, rt, DCM

65

9

Rh2(esp)2, rt, DCM

70

9

Rh2(tpa)4, rt, DCM

50

20

Rh2(cap)4, 80 oC, (CH2Cl)2

60

8

Rh2(pfb)4, rt, DCM

27

49

a

All reactions were carried out by slow addition of the solution of diazosulfone to 1
mol% of the catalyst.
b
Isolated yields, combined for both diastereomers

In order to explore the effect of the structure of the diazosulfone and that of the
C–H insertion site on the selectivity of the transformation, the necessary diazosulfone
substrates were prepared using the synthetic sequence outlined in Scheme 25. The
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appropriate alkyl bromide or alkyl tosylate was subjected to a nucleophilic substitution
reaction by ethyl mercaptoacetate in the presence of potassium carbonate and catalytic
amounts of sodium iodide in refluxing acetone. For diazosulfone 153 (Scheme 25), the
solvent was switched to DMF (dimethylformamide). The resulting sulfides were oxidized
to sulfones using m-CPBA (meta-chloroperoxybenzoic acid) in DCM or oxone in a 1:1
mixture of acetone and water. The obtained sulfones were then treated with NosN3 (4nitrobenzenesulfonyl azide) in the presence of DIPEA (diisopropylethylamine) in CH3CN
(acetonitrile) or DMF to afford the desired diazosulfones. Preparation of diazosulfone
154 was achieved by acid-catalyzed SN1 substitution to make the sulfide which was
further converted to the corresponding diazosulfone as described above.

Scheme 25. Preparation of diazosulfones.124
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As mentioned in the previous chapter, intramolecular C–H insertion is favored at
sites that stabilize positive charge. Decrease in substitution at the C–H insertion site
(substrate 155, Table 6) predictably disfavored the insertion, resulting in the preferential
formation of the five-membered ring products, with only small amounts of the sixmembered ring sulfone. This stems from the fact that secondary C–H bonds stabilize
positive charge better than primary C–H bonds, and as such, insertion is favored at the
secondary C–H bond leading to the formation of the five-membered ring sulfone, while
that at the less favored primary C–H bond results in the six-membered sulfone.
Remarkably, the use of Rh2(pfb)4, which at this point in the study was known to favor
five-membered ring sulfones, made the preference for five-membered ring sulfones
complete, also greatly improving the yield of the product. No trace amounts of sixmembered sulfone were detected.

Table 6. Effects of structure of diazosulfone on selectivity of rhodium-catalyzed
intramolecular C–H insertion leading to the formation of five- and six-membered rings
reported by Jungong et al.124

S

R1

R2

R3

conditionsa

Yield of P.1b (%)

Yield of P.2b (%)

136

H

H

Me

A

65

9

155

H

H

H

A

2

25
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Table 6. Cont.
R1

R2

R3

conditionsa

Yield of P.1b (%)

Yield of P.2b (%)

155

H

H

H

B

4

45

155

H

H

H

C

Not detected

80

156

Me

H

Me

A

40

24

156

Me

H

Me

B

26

34

156

Me

H

Me

C

8

60

157

Me

Me

Me

D

5

75

157

Me

Me

Me

E

Not detected

64

a

Conditions: A: Rh2(OAc)4, DCM, rt; B: Rh2(esp)2, DCM, rt; C: Rh2(pfb)4, DCM, rt; D:
Rh2(OAc)4, (CH2Cl)2, reflux; E: Rh2(pfb)4, (CH2Cl)2, reflux.
b
Isolated yields, combined for both diastereomers

The presence of substituents adjacent to the sulfone moiety favored the formation
of five-membered ring sulfones. Monomethyl substitution (substrate 156, Table 6) led to
the formation of almost equivalent amounts of five- and six-membered sulfones. Use of
Rh2(pfb)4 enhanced the shift in selectivity; making the five-membered ring sulfone the
prevalent product. Notably, selectivity in the formation of the substitution center adjacent
to the sulfone fragment (β-position) was observed for this substrate.
The formation of small amounts (5-10% combined) of several products possibly
containing the opposite configuration at the β-position was observed. Definitive
identification of these products was not achieved due to the difficulty encountered during
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purification. The dimethyl-substituted diazosulfone 157 was stable to the rhodium
catalysts screened at rt or reflux in DCM, requiring reflux in dichloroethane to react. The
reaction resulted in the formation of a five-membered ring even with Rh2(OAc)4. Use of
Rh2(pfb)4 led to complete selectivity towards the five-membered sulfone at the expense of
decreased yield. These results can be explained by the decrease in the angle of C–C–SO2
fragment due to steric compression, favoring the five-membered ring geometry.
Having established that the structure of the diazosulfone, local insertion site
electronic effects, and rhodium catalyst used affect the selectivity of the reaction, the next
objective was to investigate the feasibility of formation of four-membered sulfones. The
necessary substrates (Table 7) were prepared as described previously.

Table 7. Preparation of diazosulfones.

S

R

S.1

S.2

Yield (%)

158

88

159

85
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Table 7. Cont.
S

R

S.1

S.2

Yield (%)
90

160

Surprisingly, Rh2(pfb)4 reacted with diazosulfone 158.S.2 to form exclusively
five-membered ring. Even though Rh2(pfb)4 is known to favor the formation of fivemembered ring, C–H insertion was expected to occur at the secondary C–H bond due to
its ability to stabilize positive charge better, which would lead to the formation of a fourmembered ring. When Rh2(OAc)4 was used, decomposition of the diazosulfone was
observed with no traces of a sulfone product. Increasing substitution at the secondary
insertion site (diazosulfone 159.S.2), Rh2(pfb)4 reacted to form a four-membered sulfone.
The obtained four-membered sulfone was stable enough to be fully characterized, but
gradually isomerized via elimination to alkenylsulfone 161 (Scheme 26).

Scheme 26. Isomerization of a four-membered ring sulfone to an alkenylsulfone.
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As expected, the insertion was favored at the tertiary C–H bond over the primary
C–H bond of diazosulfone. Again, use of Rh2(OAc)4 resulted in complete decomposition
of the diazosulfone with no isolatable products. Reaction of Rh2(pfb)4 with diazosulfone
160.S.2, which possesses primary, secondary and tertiary insertion sites, furnished a
five-membered ring sulfone.

Table 8. Studies on the formation of four-membered ring sulfones.

S

R1

R2

R3

method

Yield of P.1 (%)

Yield of P.2 (%)

158.2

H

H

H

A

Not detected

67

158.2

H

H

H

B

Not detected

Not detected

159.2

Me

H

H

A

57a

Not detected

159.2

Me

H

H

B

Not detected

Not detected

160.2

H

Me

Me

A

Not detected
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A: Rh2(pfb)4, DCM, rt; B: Rh2(OAc)4, DCM, rt
a
Reported yield is for four-membered sulfone, which isomerized over time to
alkenylsulfone 161.
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2.3 Structural and Stereochemical Assignments of the Products
The relative stereochemistry of the products was determined by employing
standard NMR techniques (1H, 13C{1H}, COSY, DEPT, and NOE). The relative
configuration of stereocenters in 149a was assigned on basis of the coupling constants
between Hb and Hc (Figure 5). Smaller coupling constant and appearance of another
coupling constant to Ha (confirmed by COSY) indicate the equatorial position of Hb.
Similarly, diaxial arrangement of Hb and Hc is established in 156.1, while indicating the
cis arrangement in 156.2. Bidirectional NOE correlation between Ha and Hb established
the configuration of the β-center. While formation of the cis isomer of 157.1 appeared to
occur in the reaction of 157 (by presence of characteristic peaks in the crude spectra), it
appeared to recede after equilibration, and only 157.1 was isolated. It has been verified
that 157.1 does not change upon treatment with DBU, unlike 149a and 156.1, which
produce mixtures of cis and trans isomers. This could be explained by unfavorable diaxial
interaction with the methyl group that would be present in the cis isomer of 157.1, but not
in 149b and 156.2.
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Figure 5. Stereochemical and structural assigments of the six-membered sulfones.124

All five-membered products were isolated as single isomers after equilibration.
They all show similar patterns of chemical shifts and NOE correlations between protons.
The five-membered ring products have been assigned trans configuration for the Me, Et,
and CO2Et substituents on the basis of NOE data and coupling constants. Observed NOEs
and their relative intensities were consistent with the proposed structures, while several
disagreements can be found with the cis isomers. Additionally, the large coupling
constant (10 Hz) between Hc and He in 150a (Hc and He in 155.2, Hd and Hh in 156.2, Hc
and Hf in 157.2) indicate a dihedral angle that is close to either 0 or 180° (Figure 6).
Weak NOE correlations between these hydrogens suggest against the small dihedral
angle that would force these hydrogens to a close proximity. For 156.2, relative
configuration of the C5 center was unambiguously confirmed by a bidirectional NOE
between Hb and Hd.
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Figure 6. NOE responses (%) observed for isomers 150a, 155.2, 156.2, and 157.2.124

2.4 Conclusion
Intramolecular rhodium-catalyzed C–H insertion on alkylsulfonyl diazoacetate
substrates initially reported to favor six-membered ring compounds is sensitive to the
structure of the substrate as well as the catalyst used. The presence of substituents
adjacent to the sulfonyl moiety was found to tilt the selectivity of the transformation
towards the formation of five-membered sulfones. Unexpectedly, the same influence was
exerted by Rh2(pfb)4 catalyst, apparently due to the presence of the strong electronwithdrawing ligands, which led to increased activity. This work has highlighted the fact
that the selectivity of intramolecular rhodium-catalyzed C–H insertion on aliphatic
alkylsulfonyl diazoacetate substrates initially reported to favor six-membered ring
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compounds can be reversed by strategically installing alkyl substitutions next to the
sulfone center. Also, carefully selecting the rhodium catalyst used allows more control
over the selectivity of the transformation. It has also been demonstrated that it is possible
to obtain four-membered ring sulfones from select diazo sulfones by intramolecular
rhodium-catalyzed C–H insertion. The obtained cyclic sulfones are potentially useful
intermediates in synthesis. These results will be crucial in expanding the scope of this
research as well as exploring the full synthetic potential of the resulting cyclic sulfones.

2.5 Experimental Section for Rhodium-Catalyzed Intramolecular C–H Insertion Studies
on Diazosulfones
All reactions were carried out under an inert nitrogen atmosphere unless
otherwise stated. All reagents were used as purchased without further purification except
otherwise stated. 1H-NMR (500 Hz) and 13C{1H} NMR (125 Hz) spectra were recorded
on an Avance 500 Bruker spectrometer and calibrated using residual undeuterated solvent
as internal references. Coupling constants are given in Hz. IR spectra were recorded on a
Perkin-Elmer Spectrum 400 Series FTIR spectrometer. Specific rotations were measured
on an AUTOPOL III automatic polarimeter in anhydrous CHCl3 using a 10 cm cell.
HRMS data were obtained on an Agilent 61969A TOF high resolution mass spectrometer
using electrospray ionization (ESI). Melting points were determined on a MEL-TEMP
melting point apparatus. Analytical TLC was performed using silica gel pre-coated TLC
plates (E. Merck no. 5715-7). Flash chromatography was performed using 40-63 μm
silica gel (Merck, Geduran, no. 11567-1) as the stationary phase. Tetrahydrofuran (THF)
was dried by distilling it from sodium and benzophenone in a continuous still under a
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nitrogen atmosphere. Chloroform, dichloromethane and triethylamine were distilled from
calcium hydride under an atmosphere of nitrogen.

Procedures for compounds and physical data from Scheme 25
Compounds 136, 151, 152, 153, 154, 155, 156, and 157 were prepared using the literature
procedure reported by John et al,122 except otherwise stated. Physical data for
compounds 136 and 151 have already been reported; however, 1H NMR and 13C{1H}
NMR are provided.

Ethyl (butylsulfonyl)acetate (151): colorless oil, 1H NMR (500 MHz, CDCl3): δ 4.26 (q,
J = 7, 2H), 3.94 (s, 2H), 3.22–3.26 (m, 2H), 1.81–1.88 (m, 2H), 1.49 (q, J = 7.5, 2H),
1.31 (t, J = 7, 3H), 0.97 (t, J = 7.5, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 163.3, 62.8,
57.5, 53.5, 24.0, 21.8, 14.1, 13.6.

Ethyl (hexan-2-ylsulfonyl)acetate (153): pale yellow oil, 1H NMR (500 MHz, CDCl3): δ
4.27 (q, J = 7, 2H), 3.99 (d, J = 14.5, 1H), 3.94 (d, J = 14.5, 1H), 3.35–3.43 (m, 1H),
1.99–2.07 (m, 1H), 1.52–1.66 (m, 2H), 1.47 (d, J = 6.5, 3H), 1.30–1.45 (m, 6H), 1.42 (t, J
= 6.5), 1.33 (t, J = 7), 0.94 (t, J = 7, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 163.3,
62.8, 58.2, 55.2, 28.8, 28.3, 22.6, 14.2, 14.0, 12.9. HRMS (ESI) calcd for C10H24NO4S
[M+NH4]+ 254.1420, found 254.1404.
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Ethyl (2-methylhexan-2-ylsulfonyl)acetate (154): pale yellow oil, 1H NMR (500 MHz,
CDCl3): δ 4.28 (q, J = 7, 2H), 3.94 (s, 2H), 1.76–1.81 (m, 2H), 1.30–1.46 (m, 13H), 1.40
(s), 1.33 (t, J = 7), 0.93 (t, J = 7, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 162.9, 65.3,
62.8, 53.3, 35.0, 26.1, 23.3, 20.7, 14.2, 14.1. HRMS (ESI) calcd for C11H26NO4S
[M+NH4]+ 254.1577, found 254.1609.

Ethyl (propylsulfonyl)acetate (158.1): colorless oil, 1H NMR (500 MHz, CDCl3): δ 4.26
(q, J = 7.2, 2H), 3.92 (s, 2H), 3.20–3.25 (m, 2H), 1.9 (q, J = 7.5, 2H), 1.32 (t, J = 7.2,
3H), 1.09 (t, J = 7.5, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 163.2 (C) , 62.9 (CH2),
57.8 (CH2), 55.4 (CH2), 16.3 (CH2), 14.4 (CH3), 13.5 (CH3). HRMS (ESI) calcd for
C7H15O4S [M+H]+ 195.0671, found 195.0691.

Ethyl (2-methylpropylsulfonyl)acetate (159.1): colorless oil, 1H NMR (500 MHz,
CDCl3): δ 4.28 (q, J = 7.2, 2H), 3.94 (s, 2H), 3.17–3.20 (m, 2H), 2.41 (m, 1H), 1.33 (t, J
= 7.2, 3H), 1.15 (d, J = 6.6, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 163.6, 63.1, 57.9,
52.3, 30.9, 27.9, 22.5, 14.5. HRMS (ESI) calcd for C8H17O4S [M+H]+ 209.0832, found
209.0847.

Ethyl (3-methylbutylsulfonyl)acetate (160.1): colorless oil, 1H NMR (500 MHz,
CDCl3): δ 4.28 (q, J = 7, 2H), 3.94 (s, 2H), 3.20–3.30 (m, 2H), 1.70-1.80 (m, 4H), 1.32 (t,
J = 7, 3H), 0.96 (d, J = 6.6, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 163.6 (C), 63.0
(CH2), 61.4 (CH2), 59.0 (CH2), 24.3(CH), 23.1 (CH3), 14.1 (CH3).
54

Note: The signal for the diazo carbon was not observed in 13C{1H} NMR for any of the
diazo compounds, possibly due to quadrupole broadening. IR spectra showing the diazo
stretch (2130 cm-1) are provided for diazo compounds.

Ethyl (butylsulfonyl)diazoacetate (155): yellow oil, 1H NMR (500 MHz, CDCl3): δ
4.33 (q, J = 7, 2H), 3.35–3.43 (m, 2H), 1.77–1.86 (m, 2H), 1.48 (q, J = 7.5, 2H), 1.33 (t, J
= 7, 3H), 0.96 (t, J = 7.5, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 160.3, 62.7, 56.6,
24.8, 21.5, 14.5, 13.7. IR (neat, cm-1): 2129, 1714, 1467.

Ethyl (2-hexylsulfonyl)diazoacetate (156): yellow oil, 1H NMR (500 MHz, CDCl3): δ
4.33 (q, J = 7, 2H), 3.44–3.51 (m, 1H), 1.98–2.06 (m, 1H), 1.56–1.65 (m, 1H), 1.44–1.52
(m, 1H), 1.42 (d, J = 7, 3H), 1.31–1.40 (m, 6H), 1.34 (t, J = 7), 0.94 (t, J = 7, 3H).
13

C{1H} NMR (CDCl3, 125 MHz)): δ 160.4, 62.7, 61.7, 28.8, 28.7, 22.6, 14.5, 14.0, 13.2.

IR (neat, cm-1): 2127, 1714, 1463.

Ethyl (propylsulfonyl)diazoacetate (158.2): yellow oil, 1H NMR (500 MHz, CDCl3): δ
4.26 (q, J = 7, 2H), 3.24–3.30(m, 2H), 1.70–1.83 (m, 2H), 1.217 (t, J = 7.2, 3H), 1.02 (t, J
= 7.2, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 160.4 (C), 62.9(CH2), 58.6 (CH2), 24.8
(CH2), 17.1(CH2), 14.9 (CH3), 13.3 (CH3). IR (neat, cm-1): 2120.
Ethyl (2-methylpropylsulfonyl)diazoacetate (159.2): yellow oil, 1H NMR (500 MHz,
CDCl3): δ 4.34 (q, J = 7.2, 2H), 3.28–3.34 (m, 2H), 2.28–2.39 (m, 1H), 1.39 (t, J = 7.2,
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3H), 1.1 (d, J = 7.2, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 160.1 (C), 64.6 (CH2),
62.8(CH2), 24.7 (CH), 22.9 (CH3), 14.7 (CH3). IR (neat, cm-1): 2123.

Ethyl (3-methylbutylsulfonyl)diazoacetate (160.2): yellow oil, 1H NMR (500 MHz,
CDCl3): δ 4.33 (q, J = 7.2, 2H), 3.37–3.41 (m, 2H), 1.68–1.72 (m,1H), 1.34 (t, J = 7.2),
0.96 (d, J = 7.2, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 160.5 (C), 62.8 (CH2), 55.4
(CH2), 31.4 (CH), 27.7 (CH3), 22.57(CH3), 14.6 (CH3). IR (neat, cm-1): 2125.

General procedure for C–H insertion
To the suspension of the catalyst (1 mol%) in CH2Cl2 (or ClCH2CH2Cl, 4
mL/mmol), a solution of the corresponding diazo compound (1 equiv., 0.1–1 mmol) in
CH2Cl2 (or ClCH2CH2Cl, 2 mL/mmol) was added at rt (or reflux) over a period of 1 h
using a syringe pump. Upon completion of the addition, the reaction mixture was stirred
at rt for additional 8 h. The volatiles were removed under reduced pressure. The crude
reaction mixture was separated on silica column (ethyl acetate–hexanes, 0–40%).
Typically, it was possible to divide the mixture into three parts—the unpolar
decomposition products, mixture or various cyclization products, and the more polar sixmembered trans isomer. In some cases, isolation of the cis six-membered product was
also possible. The incompletely separated mixture of the cyclization products was
dissolved in CH2Cl2 and treated with 1 equiv. of DBU for 24 h. 1 M HCl solution was
added, and the reaction mixture was stirred for 15 min. The layers were separated,
aqueous layer was washed with CH2Cl2, and the combined organic layers were dried and
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concentrated. The chromatography on silica column (ethyl acetate–hexanes, 0–40%)
provided the trans five-membered ring product, cis six-membered ring product, and
additional amount of the trans six-membered product, formed by equilibration from the
cis isomer.

cis-Ethyl tetrahydro-3-methyl-2H-thiopyran-1,1-dioxide-2-carboxylate (149b): white
flaky solid, mp 36–37 oC, 1H NMR (500 MHz, CDCl3): δ 4.27 (qd, J = 7, 1, 2H), 3.77
(dd, J = 4.5, 3, 1H), 3.56 (td, J = 13, 5, 1H), 2.93 (dq, J = 14, 3, 1H), 2.50–2.59 (m, 1H),
2.04–2.16 (m, 2H), 1.84 (qd, J = 13, 5, 1H), 1.55–1.65 (m, 1H; overlapped with water
peak), 1.33 (t, J = 7, 3H), 1.06 (d, J = 7, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 166.3
(C), 70.1 (CH), 62.4 (CH2), 48.0 (CH2), 34.4 (CH), 26.7 (CH2), 23.3 (CH2), 19.8 (CH3),
14.3 (CH3). HRMS (ESI) calcd for C9H20NO4S [M+NH4]+ 238.1107, found 238.1095.

trans-Ethyl tetrahydro-3-ethylthiophene-1,1-dioxide-2-carboxylate (150a): pale
yellow oil, 1H NMR (500 MHz, CDCl3): δ 4.25–4.48 (m, 2H), 3.58 (d, J = 10, 1H), 3.28
(ddd, J = 13, 7, 2, 1H), 3.10 (td, J = 13, 7, 1H), 2.68–2.77 (m, 1H), 2.35–2.42 (m, 1H),
1.76–1.86 (m, 1H), 1.60–1.69 (m, 1H), 1.49–1.56 (m, 1H), 1.34 (t, J = 7, 3H), 0.97 (t, J =
7.5, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 165.8 (C), 70.9 (CH), 62.9 (CH2), 52.9
(CH2), 41.7 (CH), 27.4 (CH2), 26.3 (CH2), 14.3 (CH3), 11.5 (CH3). HRMS (ESI) calcd
for C9H17O4S [M+H] 221.0842, found 221.0854, C9H20NO4S [M+NH4] 238.1107, found
238.1121.
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Ethyl tetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (155.1): pale yellow oil, 1H
NMR (500 MHz, CDCl3): δ 4.24–4.34 (m, 2H), 3.85 (ddd, J = 6.5, 4.5, 2, 1H), 3.45 (ddd,
J = 14, 9, 4.5, 1H), 2.95–3.02 (m, 1H), 2.26–2.39 (m, 2H), 2.07–2.17 (m, 2H), 1.89–1.98
(m, 1H), 1.57–1.65 (m, 1H), 1.33 (t, J = 7, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ
166.1 (C), 65.2 (CH), 62.6 (CH2), 51.1 (CH2), 28.1 (CH2), 24.3 (CH2), 20.1 (CH2), 14.2
(CH3). HRMS (ESI) calcd for C8H18NO4S [M+NH4]+ 224.0951, found 224.0951.

trans-Ethyl tetrahydro-3-methylthiophene-1,1-dioxide-2-carboxylate (155.2): white
flaky solid, mp 42–44 oC, 1H NMR (500 MHz, CDCl3): δ 4.25–4.39 (m, 2H), 3.52 (d, J =
10.5, 1H), 3.31 (ddd, J = 13, 7, 1.5, 1H), 3.13 (td, J = 13, 7, 1H), 2.76–2.87 (m, 1H),
2.30–2.36 (m, 1H), 1.82 (qd, J = 13, 7, 1H), 1.34 (t, J = 7, 3H), 1.22 (d, J = 6.5, 3H).
13

C{1H} NMR (CDCl3, 125 MHz): δ 165.1 (C), 72.3 (CH), 62.9 (CH2), 53.4 (CH2), 35.2

(CH), 28.7 (CH2), 19.2 (CH3), 14.3 (CH3). HRMS (ESI) calcd for C8H15NO4S [M+H]
207.0686, found 207.0695; C8H14NO4NaS [M+Na]+ 229.0505, found 207.0515.

(2R,3R,6R)-Ethyl tetrahydro-3,6-dimethyl-2H-thiopyran-1,1-dioxide-2-carboxylate
(156.1): white solid, mp 102–103 oC, 1H NMR (500 MHz, CDCl3): δ 4.33 (qd, J = 7, 4,
2H), 3.51 (d, J = 12, 1H), 2.87–2.96 (m, 1H), 2.52–2.60 (m, 1H), 1.88–1.99 (m, 3H), 1.38
(d, J = 6.5, 3H), 1.27–1.36 (m, 4H), 1.34 (t, J = 7), 1.03 (d, J = 6.5, 3H). 13C{1H} NMR
(CDCl3, 125 MHz): δ 163.8 (C), 73.0 (CH), 62.6 (CH2), 57.6 (CH), 34.8 (CH), 33.1
(CH2), 31.4 (CH2), 19.9 (CH3), 14.4 (CH3), 10.9 (CH3). HRMS (ESI) calcd for
C10H22NO4S [M+NH4]+ 252.1264, found 252.1255.
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(2S,3R,6R)-Ethyl tetrahydro-3,6-dimethyl-2H-thiopyran-1,1-dioxide-2-carboxylate
(156.2): white solid, mp 77–78 oC, 1H NMR (500 MHz, CDCl3): δ 4.27 (q, J = 7, 2H),
3.83 (d, J = 4.5, 1H), 3.60–3.68 (m, 1H), 2.51–2.59 (m, 1H), 1.81–2.02 (m, 3H), 1.55–
1.61 (m, 1H; overlapped with water peak), 1.35 (δ, J = 7, 3H), 1.33 (t, J = 7, 3H), 1.06 (d,
J = 7, 3H). 13C{1H} NMR (CDCl3, 125 MHz): d 166.4 (C), 70.0 (CH), 62.3 (CH2), 52.7
(CH), 34.7 (CH), 31.6 (CH2), 27.7 (CH2), 19.7 (CH3), 14.3 (CH3), 10.7 (CH3). HRMS
(ESI) calcd for C10H19NO4S [M+H]+ 235.0999, found 235.1014.

(2S,3S,5R)-Ethyl tetrahydro-3-ethyl-5-methylthiophene-1,1-dioxide-2-carboxylate
(153.2): pale yellow oil, 1H NMR (500 MHz, CDCl3): δ 4.25–4.37 (m, 2H), 3.57 (d, J =
10, 1H), 3.14–3.24 (m, 1H), 2.60–2.70 (m, 1H), 2.37 (dt, J = 13, 6.5, 1H), 1.55–1.64 (m,
1H; overlapped with the water peak at δ 1.60), 1.42–1.52 (m, 2H), 1.39 (d, J = 6.5, 3H),
1.34 (t, J = 7, 3H), 0.94 (t, J = 7, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 166.1 (C),
70.7 (CH), 62.9 (CH2), 58.6 (CH), 39.2 (CH), 34.5 (CH2), 27.6 (CH2), 14.3 (CH3), 11.4
(CH3), 11.1 (CH3). HRMS (ESI) calcd for C10H22NO4S [M+NH4]+ 252.1264, found
252.1250.

trans-Ethyl tetrahydro-3,6,6-trimethyl-2H-thiopyran-1,1-dioxide-2-carboxylate
(157.1): pale yellow oil, 1H NMR (500 MHz, CDCl3): δ 4.30–4.37 (m, 2H), 3.73 (d, J =
12, 1H), 2.52–2.61 (m, 1H), 2.16–2.23 (m, 1H), 1.71–1.77 (m, 2H), 1.44–1.51 (m, 4H),
1.47 (s), 1.40 (s, 3H), 1.34 (t, J = 7, 3H), 1.03 (d, J = 6.5, 3H). 13C{1H} NMR (CDCl3,
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125 MHz): δ 164.1 (C), 67.8 (CH), 62.6 (CH2), 59.0 (C), 36.5 (CH2), 34.8 (CH), 28.7
(CH2), 21.5 (CH3), 21.1 (CH3), 20.0 (CH3), 14.4 (CH3). HRMS (ESI) calcd for
C11H24NO4S [M+NH4]+ 266.1421, found 266.1411.

trans-Ethyl tetrahydro-3-ethyl-5,5-dimethylthiophene-1,1-dioxide-2-carboxylate
(157.2): pale yellow oil, 1H NMR (500 MHz, CDCl3): δ 4.26–4.37 (m, 2H), 3.61 (d, J =
9.5, 1H), 2.73–2.82 (m, 1H), 2.10 (dd, J = 13, 6.5, 1H), 1.73 (t, J = 13, 1H), 1.48–1.55
(m, 2H; overlapped with the water peak at δ 1.60), 1.42 (s, 3H), 1.44 (s, 3H), 1.34 (t, J =
7, 3H), 0.92 (t, J = 7.5, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 166.4 (C), 71.3 (CH3),
62.8 (CH2), 62.3 (C), 41.5 (CH2), 37.2 (CH), 28.1 (CH2), 22.1 (CH3), 21.5 (CH3), 14.3
(CH3), 11.6 (CH3). HRMS (ESI) calcd for C11H21NO4S [M+H] 249.1155, found
249.1176; C11H24NO4S [M+NH4]+ 266.1421, found 266.1441.

Ethyl 3,3-dimethylthiotane-1,1-dioxide-2-carboxylate (159.2.2): pale yellow oil, 1H
NMR (500 MHz, CDCl3): δ 2.64 (s, 1H), 4.20-4.25 (m, 2H), 3.7-3.8 (dd, J = 12.9, 12.6,
2H), 1.47-1.49 (s, 6H; overlapped with the water peak at δ 1.60), 1.20 (t, J = 7.2, 3H).
13

C{1H} NMR (CDCl3, 125 MHz): δ 163.3 (C), 84.5 (CH), 74.9 (CH2), 62.4 (CH2), 29.4

(C), 28.5 (CH3), 24.0 (CH3), 14.5 (CH3).
Ethyl (2-methyl-2-propenylsulfonyl)acetate (161): pale yellow oil, 1H NMR (500
MHz, CDCl3): δ 5.29-5.27 (δ, J = 11.3), 4.30 (q, J = 7.2, 2H), 3.9-4.10 (d, J = 23.3, 2H),
2.0 (s, 3H), 1.34 (t, J = 7.2, 3H), 13C{1H} NMR (CDCl3, 125 MHz): δ 163.5 (C), 134.1
(CH), 121.5 (C), 63.0 (CH2), 61.4 (CH2), 55.0 (CH2), 22.9 (CH3), 14.3 (CH3).
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Ethyl tetrahydro-2-ethyl-3,3-dimethylthiophene-1,1-dioxide-2-carboxylate (160.2.2):
pale yellow oil, 1H NMR (500 MHz, CDCl3): δ 4.22-4.38 (m, 2H), 3.65 (s, 1H), 3.243.40 (m, 2H), 2.26-2.40 (m, 1H), 1.85-2.10 (m, 1H), 1.36 (s, 3H), 1.34 (t, J = 7.2, 3H),
1.33 (s, 3H).

13

C{1H} NMR (CDCl3, 125 MHz): δ 165.1 (C), 75.0 (CH2), 62.5 (CH),

52.6 (CH2), 40.9 (CH2), 36.2 (CH), 29.3 (CH3), 24.5 (CH3), 14.7 (CH3). HRMS (ESI)
calcd for C9H17O4S [M+H] 221.0862, found 221.0847.
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CHAPTER 3
ENANTIOSELECTIVE RHODIUM-CATALYZED INTRAMOLECULAR C–H
INSERTION ON DIAZOSULFONES
3.1 Introduction
The factors, which determine the regioselectivity of rhodium-catalyzed
intramolecular C–H insertion reactions on diazosulfones, have been disclosed by Jungong
and co-workers124 and are discussed in the previous chapter. However, the
enantioselective version of these transformations remains largely unexplored. To date,
there is only a single report on enantioselective intramolecular C–H insertion on
diazosulfones published in 2009 by Maguire and co-workers.126 In this report, chiral
copper bis-oxazoline catalysts have been employed for C–H insertion reactions on
diazosulfones to afford cis-thiopyrans in moderate yields (21-68%) but excellent
enantioselectivities (85-98%) (Table 9)
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Table 9. Enantioselective intramolecular copper-catalyzed C–H insertion reactions of
diazosulfones reported by Maguire and co-workers.126

S

R

R1

Yield (%)

ee (%)

163

OMe

Ph

47

98

164

OMe

4-tolyl

64

96

165

OMe

4-anisole

56

91

166

OMe

4-nitrophenyl

-

-

167

OMe

benzyl

42

96

168

OMe

ethyl

68

97

169

OBn

octyl

66

90

170

OBn

octyl

21

70

171

Me

Ph

30

85

172

Ph

Ph

49

97

Enantioselective rhodium-catalyzed intramolecular C–H insertion reactions have
been performed on diazocarbonyl substrates using chiral rhodium catalysts.51, 98, 127, 128
Most of these catalysts are derived by simple ligand displacement reactions from
rhodium(II) tetraacetate. Prior to the advent of chiral rhodium catalysts, control of
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diasrereoselectivity in intramolecular C–H insertion reactions had been attained by using
chiral diazocarbonyl compounds, which favored 1,2- and 1,3-asymmetric inductions.129,
130

For fused ring systems, asymmetric induction has been observed by exploiting the

preferential insertion into equatorial over axial C–H bonds.131 The groups of Taber128 and
Wee132 have also demonstrated the use of chiral auxiliaries to control diastereoselectivity
in rhodium-catalyzed intramolecular C–H insertion reactions.
Enantioselective rhodium-catalyzed intramolecular C–H insertion on
diazosulfones has not yet been reported. This prompted further investigation into the
feasibility of controlling diastereoselectivity during the rhodium-catalyzed intramolecular
C–H insertion event on diazosulfones. For this study, diazosulfone 136 was used as the
model substrate for C–H insertion. Several chiral rhodium catalysts were screened,
aiming to optimize the yield and enantioselectivity of the transformation.

3.2 Results and Discussion
Jungong and co-workers124 have demonstrated that intramolecular C–H insertion
on diazosulfone 136 using achiral dirhodium catalyst Rh2(OAc)4 14 would result to the
formation of eight possible diastereomers: four six-membered ring sulfones and four fivemembered ring sulfones (Scheme 27). The four diasteromers for each class of sulfones
(six- or five-membered) comprise of two trans enantiomers (R,R and S,S) and two cis
enantiomers (R,S and S,R), and the trans enantiomers were isolated as major products
over the cis enantiomers.

64

Scheme 27. Formation of six- and five-membered sulfones by intramolecular C–H
insertion reported by Jungong and co-wokers.124

The formation of eight possible diastereomers greatly limits the synthetic utility
of this transformation, mandating the need to establish reaction conditions that would
favor the formation of a single diastereomer. To this end, the primary objective was to
originate reaction conditions, which would allow the formation of just one six-membered
enantiomer. The work reported by Jungong and co-workers identified diazosulfone 136 to
preferentially favor the formation of six- over five-membered sulfones, which favored the
decision to use it as the model substrate for these studies.
Efforts to effectively isolate and characterize the cis isomers turned out to be
unexpectedly difficult, so the enantioselectivity was determined as an enantiomeric ratio
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(er) between the trans enantiomers (R,R and S,S). The er for each reaction was deduced
by subjecting the obtained six-membered sulfone trans isomers to a DIBALH reduction,
followed by Steglich esterification of the resulting alcohol with (S)-acetylmandelic acid
in the presence of DCC (N,N'-dicyclohexylcarbodiimide) and DMAP (4dimethylaminopyridine) (Scheme 28).

Scheme 28. Synthesis of sulfonyl acetylmandalates for determination of enantiomeric
ratio.

The crude reaction mixture was analyzed by 1H NMR without prior purification to
guarantee that the enantiomeric ratio remained undistorted. Two sets of peaks were used
to assign enantiomeric ratios; the doublet peaks between 0.5-1 ppm corresponding to the
methyl group next to the C–H insertion center, and the singlets between 5.8-6.5 ppm
corresponding to the proton adjacent to the acetate moiety (Figure 7). The observed
enantiomeric ratios were consistent for both peaks.
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Figure 7. 1H NMR spectrum of sulfonyl acetylmandalate showing peaks used for
enantiomeric ratio determination.

The study was initiated by screening various chiral rhodium catalysts for this
transformation (Figure 9). Rh2(S-MEPY)4 17 and Rh2(S-DOSP)4 15, which have been
very effective in other cases, showed poor results, providing moderate yields (45-55%),
and poor enantioselectivity (1:1 to 1.2 :1 er) (Table 10).65, 133 Use of non-polar solvent
(2,2-dimethylbutane) with 15 provided the first glimpse of selectivity (1.2 :1 er) (Table
10), although complications arose due to poor solubility of the diazo compound in this
solvent. Rh2(S-MEPY)4 was unreactive in DCM at room temperature, requiring reflux in
the higher boiling solvent dichloroethane. Next, the class of catalysts derived from
phthalimide-protected amino acids was explored, starting with Rh2(S-pttl)4, derived from
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tert-leucine. This provided the first encouraging result (2.5: 1 er). The additional bonus
was the increased yield of the product (85%).

Figure 8. Chiral rhodium(II) carboxylate catalysts screened for enantioselective
intamolecular C–H insertion.

Following this lead, it was logical to modify the backbone of Rh2(S-pttl)4 catalyst
to ascertain what effect that would have on the outcome of the transfromation. Increasing
and decreasing the size of the substituents at the amino acid center would alter its
catalytic pocket, which in turn will have an effect on the yield and the selectivity.
Substituting tert-butyl group with a benzyl moiety (Rh2(S-ptpa)4) 177 decreased the yield
and selectivity to 70% and 2:1, respectively. However, introduction of the bulky
adamantyl group (Rh2(S-ptad)4) 176 at the same position improved the yield to 90% but
at the detriment of the enantioselectivity which dropped to 2:1 er. Surprisingly,
increasing the size of the phthaloyl group by introducing a tert-butyl group at the 4position (Rh2(S-tpttl)4) 178, slightly raised the yield to 88% but reversed the
enantioselectivity to 1:2 er. When the phthaloyl substituent was replaced by the bulkier
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N-naphthaloyl group (Rh2(S-nttl)4) 179, the yield was maintained at 88%, while the
enantioselectivity remained unreversed, but dropped slightly to 2.3:1 er. Maintaining the
N-naphthtaloyl group and replacing the tert-butyl group with a benzyl group Rh2(S-ntpa)4
181, held the yield at 87% but further dropped the enantioselectivity to 2:1 er. On the
other hand, the use of Rh2(S-nta)4 180, where the N-naphthtaloyl group is maintained, but
the size of the tert-butyl group is decreased to a methyl group, dropped the
enantioselectivity even further to 1.8:1 er, even though the yield remained at 87%.
Because all modifications failed to increase the enantioselectivity compared to Rh2(Spttl)4, it was used as the model catalyst for investigating optimal reaction conditions.

Table 10. Effect of chiral rhodium(II) carboxylate catalyst on the enantioselectivity of
intramolecular C–H insertion on diazosulfones.

Entry

Rh2L4, conditions

Yield (%)

er

1

Rh2(S-MEPY)4, 80 oC, (CH2Cl)2

55

1:1

2

Rh2(S-DOSP)4, rt, DCM

50

1.05:1

3

Rh2(S-DOSP)4, rt, 2,2-dimethylbutane

45

1.2:1

4

Rh2(S-pttl)4, rt, DCM

85

2.5:1

5

Rh2(S-ptad)4, rt, DCM

90

2:1

6

Rh2(S-ptpa)4, rt, DCM

70

2:1

69

Table 10. Cont.
Rh2L4, conditions

Yield (%)

er

7

Rh2(S-nttl)4, rt, DCM

88

2.3:1

8

Rh2(S-ntpa)4, rt, DCM

86

2:1

9

Rh2(S-nta)4, rt, DCM

87

1.8:1

Enantioselective rhodium-catalyzed intramolecular C–H insertion reactions on
diazocarbonyl compounds have been shown to afford better selectivities when carried out
at lower temperatures.51, 134 In this light, the reaction temperature was decreased to 0 oC,
then to -20 oC, maintaining DCM as the solvent. In both cases, the enantioselectivity was
increased to 3:1 er but at the detriment to the yield which dropped to 65% and 61%,
respectively. The reason appears to be the lack of decomposition of the diazosulfone at
temperatures significantly below 0 oC. Switching the solvent to toluene at room
temperature also raised the enantioselectivity to 3:1 er but reduced the yield to 78%.
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Table 11. Effect of temperature and solvent on the enantioselectivity of rhodiumcatalyzed intramolecular C–H insertion of diazosulfones.

Entry

Conditions

Yield (%)

er

1

Rh2(S-pttl)4, 0 oC, DCM

65

3:1

2

Rh2(S-pttl)4, -20 oC, DCM

61

3:1

3

Rh2(S-pttl)4, rt, toluene

78

3:1

The next phase of the study was to investigate the effect of the structure of
diazosulfone 136 on the enantioselectivity and yield (Table 12). This entailed maintaining
the catalyst as Rh2(S-pttl)4, while modifying the ester substituent. The necessary diazo
substrates were prepared as previously described. Several transesterification conditions
were tested to transform sulfone 151 to the desired sulfone esters, but were not effective.
However, base-catalyzed hydrolysis of 151 using potassium hydroxide in methanol
furnished sulfone acid 182. The resulting acid 182 was then coupled to various alcohols
by employing Yamaguchi esterification conditions in the presence of DMAP, benzoyl
chloride and TEA (triethylamine). The obtained sulfone esters were subjected to diazo
transfer conditions (NosN3, DIPEA, DMF) to provide the desired diazosulfones, which
were treated with Rh2(S-pttl)4 in DCM at rt.
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Table 12. Preparation of diazosulfonyl acetates.

R

Sulfone

Me

183

i-Pr

diazosulfone
189

Yield of sulfone
(%)
90

Yield of diazosulfone
(%)
91

184

190

85

88

t-Bu

185

191

87

90

(+)-menthyl

186

192

90

92

(-)-menthyl

187

193

87

80

CH(i-Pr)2

188

194

86

94

Decreasing (methyl) or increasing (isopropyl, tert-butyl, and diisopropyl) the size
of the ester substituent had no significant effect on the yield and selectivity. Notably, the
selectivity dropped to 2:1 er when the ester substituent become even bulkier
(diisopropyl).
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Table 13. Effect of diazosulfone substrates on the enantioselectivity of rhodium-catalyzed
intramolecular C–H insertion.

Entry

R

Product

Rh2L4

Yield (%)

er

1

Me

195

Rh2(S-pttl)4, rt, DCM

85

2.5:1

2

i-Pr

196

Rh2(S-pttl)4, rt, DCM

81

2.2:1

3

t-Bu

197

Rh2(S-pttl)4, rt, DCM

32 (82)*

2.5:1

4

(+)-menthyl

198

Rh2(S-pttl)4, rt, DCM

82

1:2

5

(-)-menthyl

199

Rh2(S-pttl)4, rt, DCM

94

20:1

6

(-)-menthyl

199

Rh2(OAc)4, rt, DCM

70

1:1

7

CH(i-Pr)2

200

Rh2(S-pttl)4, rt, DCM

83

2:1

*Partial de-tert-butylation appeared to happen during the reaction.

The introduction of a chiral ester substituent, (-)-menthyl, amplified both the yield
and enantioselectivity to 94% and 20:1 er, respectively. Unexpectedly, the use of
Rh2(OAc)4 with the chiral menthyl diazosulfone decreased the yield to 60%, with no
selectivity (1:1 er). The use of (+)-menthyl reversed the enantioselectivity towards the
other enantiomer, but decreased the ratio to 1:2 er. This confirms that the (-)-menthyl
group acts as a directing chiral auxiliary and not a bulky group, and the observed
selectivity of 20:1 is a synergic cooperative effect.
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To ascertain the absolute configuration of the obtained C–H insertion products,
sulfone 149 was synthesized in enantiopure fashion by an independent method (Scheme
29). Enatiopure (R)-pentane-1,4-diol 201 was obtained as described from L-glutamic
acid135 and converted to ditosylate. Selective substitution of the primary tosylate with
ethyl thioglycolate followed by oxidation yielded sulfone. Its treatment with a base in
DMSO gave 149 via intramolecular SN2 substitution, along with a cis isomer. The
configuration of the product was assigned to be 2S,3S, assuming inversion in the course
of substitution. The optical rotation of the alcohol, obtained upon reduction of this
product, along with NMR analysis of its acetylmandalate indicated that it is the
enantiomer of the material obtained by reduction of 199.

Scheme 29. Synthesis of enantiopure sulfone 149.
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3.3 Experimental Section for Enantioselective Rhodium-Catalyzed Intramolecular C–H
Insertion on Diazosulfones
All reactions were carried out under an inert nitrogen atmosphere unless otherwise stated.
All reagents were used as purchased without further purification unless otherwise stated.
1

H-NMR (500 Hz) and 13C{1H} NMR (125 Hz) spectra were recorded on an Avance 500

Bruker spectrometer and calibrated using residual undeuterated solvent as internal
references. Coupling constants are given in Hz. IR spectra were recorded on a PerkinElmer Spectrum 400 Series FTIR spectrometer. Specific rotations were measured on an
AUTOPOL III automatic polarimeter in anhydrous CHCl3 using a 10 cm cell. HRMS
data were obtained on an Agilent 61969A TOF high resolution mass spectrometer using
electrospray ionization (ESI). Melting points were determined on a MEL-TEMP melting
point apparatus. Analytical TLC was performed using silica gel pre-coated TLC plates
(E. Merck no. 5715-7). Flash chromatography was performed using 40-63 μm silica gel
(Merck, Geduran, no. 11567-1) as the stationary phase. Tetrahydrofuran (THF) was dried
by distilling it from sodium and benzophenone in a continuous still under a nitrogen
atmosphere. Chloroform, dichloromethane and triethylamine were distilled from calcium
hydride under an atmosphere of nitrogen.

Preparation of (pentylsulfonyl)acetic acid (182)
To a solution of ethyl (pentylsulfonyl)acetate (720 mg, 3.24 mmol), dissolved in
MeOH (8 mL), was added KOH (85%, 250 mg, 3.80 mmol), dissolved in MeOH (8 mL),
at rt. The resulting solution was then stirred for 3 h, after which the reaction was
complete as indicated by TLC analysis. The reaction mixture was concentrated under
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reduced pressure, diluted with water (20 mL), washed with dichloromethane (3 × 10 mL),
diluted with 20 mL of 1N HCl solution, and extracted with ethyl acetate (3 × 20 mL). The
ethyl acetate extract was washed with brine, dried over anhydrous Na2SO4 and
evaporated under reduced pressure to afford 178 (570 mg, 91%) as a white crystalline
powder that was used without further purification.

(Pentylsulfonyl)acetic acid (182): m.p. 78-79 oC. 1H NMR (CDCl3, 500 MHz): δ 9.20
(br s, 1H), 4.04 (s, 2H), 3.26-3.31 (m, 2H), 1.85-1.93 (m, 2H), 1.35-1.50 (m, 4H), 0.94 (t,
J = 7.3, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 170.0 (C), 57.3 (CH2), 54.0 (CH2),
30.6 (CH2), 22.3 (CH2), 21.7 (CH2), 13.9 (CH3). HRMS (ESI) calcd for C17H18O4NS
[M+NH4]+ 212.0956, found
212.0983.

General procedure for preparation of sulfonylacetates (183-188)
(Pentylsulfonyl)acetic acid (182, 1 equiv.), benzoyl chloride (1 equiv.) and THF
(2.5 mL/mmol) were charged to a round bottom flask, equipped with a magnetic stirrer.
To the resulting solution Et3N (2 equiv.) was added slowly, followed by the
corresponding alcohol (1 equiv.), and DMAP (0.25 equiv.). The obtained mixture was
stirred at rt for 6 h (TLC analysis revealed the reaction was complete). The reaction
mixture was diluted with EtOAc (40 mL) and washed with water (3 × 30 mL). The
organic phase was further washed with brine, dried over anhydrous Na2SO4 and
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evaporated under reduced pressure to afford the crude product that was purified by flash
chromatography on a silica gel column using EtOAc-hexanes (0:1 to 1:9).

Methyl (pentylsulfonyl)acetate (183): 1H NMR (CDCl3, 500 MHz): δ 3.96 (s, 2H), 3.83
(s, 3H), 3.22-3.27 (m, 2H), 1.83-1.91 (m, 2H), 1.34-1.48 (m, 4H), 0.93 (t, J = 7, 3H).
13

C{1H} NMR (CDCl3, 125 MHz): δ 163.8 (C), 57.4 (CH2), 53.7 (CH2), 53.5 (CH3), 30.6

(CH2), 22.3 (CH2), 21.7 (CH2), 13.9 (CH3). HRMS (ESI) calcd for C8H17O4S [M+H]+
209.0842, found 209.0848.

Isopropyl (pentylsulfonyl)acetate (184): 1H NMR (CDCl3, 500 MHz): δ 5.11 (septet, J
= 6.5, 1H), 3.91 (s, 2H), 3.22-3.27 (m, 2H), 1.84-1.92 (m, 2H), 1.34-1.48 (m, 4H), 1.31
(d, J= 6.5, 6H), 0.93 (t, J = 7, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 162.8 (C), 70.9
(CH), 57.8 (CH2), 53.7 (CH2), 30.6 (CH2), 22.3 (CH2), 21.7 (CH2), 21.8 (CH3), 13.9
(CH3). HRMS (ESI) calcd for C10H21O4S [M+H]+ 237.1160, found 237.1158.

t-Butyl (pentylsulfonyl)acetate (185): 1H NMR (CDCl3, 500 MHz): δ 3.86 (s, 2H),
3.21-3.25 (m, 2H), 1.83-1.90 (m, 2H), 1.51 (s, 9H), 1.33-1.48 (m, 4H), 0.92 (t, J = 7, 3H).
13

C{1H} NMR (CDCl3, 125 MHz): δ 162.3 (C), 84.3 (C), 58.6 (CH2), 53.6 (CH2), 30.6

(CH2), 28.0 (CH3), 22.3 (CH2), 21.8 (CH2), 13.9 (CH3). HRMS (ESI) calcd for
C11H26O4NS [M+NH4]+ 268.1582, found 268.1588.
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2,4-Dimethyl-3-pentyl (pentylsulfonyl)acetate (186): 1H NMR (CDCl3, 500 MHz): δ
4.69 (t, J = 6, 1H), 3.97 (s, 2H), 3.24-3.28 (m, 2H), 1.84-2.00 (m, 4H), 1.33-1.48 (m,
4H),0.92 (t, J = 7.5, 3H), 0.91 (t, J = 6, 12H). 13C{1H} NMR (CDCl3, 125 MHz): δ 163.4
(C), 86.2 (CH), 57.5 (CH2), 53.7 (CH2), 30.6 (CH2), 29.6 (CH), 22.3 (CH2), 21.9 (CH2),
19.6 (CH3), 17.3 (CH3), 13.9 (CH3). HRMS (ESI) calcd for C14H32NO4S [M+NH4]+
310.2052, found 310.2054.

(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl (pentylsulfonyl)acetate (187): [α]D20 = 45.9o (c 3.5, CHCl3). 1H NMR (CDCl3, 500 MHz): δ 4.79 (td, J = 11, 4.5, 1H), 3.93 (s,
2H),3.20-3.29 (m, 2H), 2.01-2.07 (m, 1H), 1.84-1.96 (m, 3H), 1.68-1.74 (m, 2H), 1.341.55 (m, 6H), 1.02-1.12 (m, 2H), 0.85-0.96 (m, 10H), 0.77 (d, J = 7, 3H). 13C{1H} NMR
(CDCl3, 125 MHz): δ 163.0 (C), 77.4 (CH), 57.9 (CH2), 53.8 (CH2), 47.0 (CH), 40.7
(CH2), 34.3 (CH2), 31.7 (CH), 30.7 (CH2), 26.3 (CH), 23.4 (CH2), 22.3 (CH3), 22.1
(CH2), 21.8 (CH3), 20.9 (CH3), 16.2 (CH3), 13.9 (CH3). HRMS (ESI) calcd for
C17H36NO4S [M+NH4]+ 350.2365, found 350.2350.

(1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl (pentylsulfonyl)acetate (188) (enantiomer
of 187, from (+)-menthol): Spectral data were identical to 187. [α]D20 = +45.7o (c 3.1,
CHCl3).
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General procedure for preparation of sulfonyldiazoacetates (189-194)
The corresponding alkyl (pentylsulfonyl)acetate (1 equiv.) was dissolved in THF
(2.5 mL/mmol) and cooled to -45 oC. Mesyl azide (2.5 equiv.) was added, followed by
dropwise addition of 1.5 equiv. of DBU. The reaction mixture was stirred for 1 h,
maintaining the temperature at -45 oC, after which it was warmed up to rt over a 15-20
min interval. The obtained mixture was poured over 20 mL of a half-saturated (NH4)2SO4
solution, extracted with DCM (3 × 20 mL), dried over anhydrous Na2SO4 and
concentrated under reduced pressure to afford the crude product that was purified by
flash chromatography on a silica gel column using EtOAc-hexanes (0:1 to 1:9).
Note: The diazo carbon does not appear in the 13C{1H} NMR spectra of all diazo
compounds. IR spectra show a strong diazo stretch at ~ 2130 cm-1.

Methyl (pentylsulfonyl)diazoacetate (189): 1H NMR (CDCl3, 500 MHz): δ 3.87 (s, 3H),
3.35-3.40 (m, 2H), 1.80-1.87 (m, 2H), 1.32-1.46 (m, 4H), 0.92 (t, J = 7, 3H). 13C{1H}
NMR (CDCl3, 125 MHz): δ 160.7 (C), 56.8 (CH2), 53.3 (CH3), 30.3 (CH2), 22.5 (CH2),
22.3 (CH2), 13.9 (CH3). IR (CH2Cl2, cm-1): 2132, 1719, 1338, 1147.

Isopropyl (pentylsulfonyl)diazoacetate (190): 1H NMR (CDCl3, 500 MHz): δ 5.18
(septet, J = 6.5, 1H), 3.35-3.41 (m, 2H), 1.80-1.87 (m, 2H), 1.32-1.46 (m, 4H), 1.32 (d, J
= 6.5, 6H), 0.91 (t, J = 7, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 159.9 (C), 71.0
(CH), 56.7 (CH2), 30.3 (CH2), 22.5 (CH2), 22.3 (CH2), 22.0 (CH3), 13.9 (CH3). IR
(CH2Cl2, cm-1): 2131, 1710, 1341, 1147.
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t-Butyl (pentylsulfonyl)diazoacetate (191): 1H NMR (CDCl3, 500 MHz): δ 3.34-3.39
(m, 2H), 1.80-1.87 (m, 2H), 1.54 (s, 9H), 1.33-1.47 (m, 4H), 0.93 (t, J = 7, 3H). 13C{1H}
NMR (CDCl3, 125 MHz): δ 159.4 (C), 85.1 (C), 56.6 (CH2), 30.3 (CH2), 28.5 (CH3), 22.6
(CH2), 22.3 (CH2), 13.9 (CH3). IR (CH2Cl2, cm-1): 2128, 1708, 1338, 1146.

2,4-Dimethyl-3-pentyl (pentylsulfonyl)diazoacetate (192): 1H NMR (CDCl3, 500
MHz): δ 4.75 (t, J = 6, 1H), 3.35-3.40 (m, 2H), 1.93-2.01 (m, 2H), 1.79-1.87 (m, 2H),
1.32-1.46 (m, 4H), 0.89-0.94 (m, 15H). 13C{1H} NMR (CDCl3, 125 MHz): δ 160.6 (C),
86.2 (CH), 56.7 (CH2), 30.3 (CH2), 29.7 (CH), 22.8 (CH2), 22.3 (CH2), 19.7 (CH3), 17.4
(CH3), 13.9 (CH3). IR (CH2Cl2, cm-1): 2130, 1709, 1338, 1147.

(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl (pentylsulfonyl)diazoacetate (193): [α]D20
= -56.5o (c 2.1, CHCl3).1H NMR (CDCl3, 500 MHz): δ 4.86 (td, J = 11, 4.5, 1H), 3.313.42 (m, 2H), 2.02-2.08 (m, 1H), 1.78-1.89 (m, 3H), 1.66-1.74 (m, 2H), 1.31-1.56 (m,
6H), 1.02-1.12 (m, 2H), 0.83-0.94 (m, 10H), 0.78 (d, J = 7, 3H). 13C{1H} NMR (CDCl3,
125 MHz): δ 160.0 (C), 77.3 (CH), 56.7 (CH2), 47.2 (CH), 41.1 (CH2), 34.2 (CH2), 31.6
(CH), 30.3 (CH2), 26.6 (CH), 23.6 (CH2), 22.6 (CH2), 22.3 (CH2), 22.1 (CH3), 20.9
(CH3), 16.5 (CH3), 13.9 (CH3). IR (CH2Cl2, cm-1): 2131, 1705, 1336, 1146.

(1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl (pentylsulfonyl)diazoacetate (194)
(enantiomer of 193, from (+)-menthol): Spectral data were identical to 193. [α]D20 =
+54.7o (c 3.5, CHCl3).
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General procedure for C-H insertion (195-200)
To the solution of Rh(II) catalyst (1 mol%) in CH2Cl2 (2.5 mL/mmol) was added
the corresponding alkyl(pentylsulfonyl)diazoacetate (1 equiv.) dissolved in DCM (2.5
mL/mmol) over 2 h via a syringe pump. The resulting mixture was stirred at rt for 12 h
after which the reaction was complete as indicated by TLC analysis. The reaction mixture
was then evaporated under reduced pressure to afford the crude product that was purified
by flash chromatography using EtOAc-hexanes.

trans-Ethyl 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (149): The
data matched previously reported.

trans-Methyl 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (195): 1H
NMR (CDCl3,500 MHz): δ 3.86 (s, 3H), 3.58 (d, J = 11, 1H), 3.18 (dt, J = 14, 4, 1H),
2.88-2.96 (m, 1H), 2.52-2.62 (m, 1H), 2.09-2.23 (m, 2H), 1.94-2.01 (m, 1H), 1.23-1.33
(m, 1H), 1.07 (d, J = 7, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 164.5 (C), 72.7 (CH),
53.4 (CH3), 52.0 (CH2), 34.5 (CH), 32.0 (CH2), 22.9 (CH2), 20.0 (CH3). HRMS (ESI)
calcd for C8H15O4S [M+H]+ 207.0691, found 207.0668.

trans-Isopropyl 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (196):
1

H NMR (CDCl3, 500 MHz): δ 5.18 (septet, J = 6.5, 1H), 3.52 (d, J = 11, 1H), 3.16 (dt, J

= 14, 4, 1H), 2.86-2.94 (m, 1H), 2.51-2.61 (m, 1H), 2.08-2.23 (m, 2H), 1.93-1.99 (m,
1H), 1.33 (d, J = 6.5, 3H), 1.32 (d, J = 6.5, 3H), 1.23-1.30 (m, 1H), 1.08 (d, J = 6.5, 3H).
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13

C{1H} NMR (CDCl3, 125 MHz): δ 163.5 (C), 72.9 (CH), 70.6 (CH), 52.0 (CH2), 34.5

(CH), 32.0 (CH2), 22.8 (CH2), 21.9 (CH3), 21.8 (CH3), 19.8 (CH3). HRMS (ESI) calcd
for C10H22O4NS [M+NH4]+ 252.1269, found 252.1390.

trans-t-Butyl 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (197): 1H
NMR (CDCl3,500 MHz): δ 3.44 (d, J = 11, 1H), 3.14 (dt, J = 14, 4, 1H), 2.84-2.92 (m,
1H), 2.46-2.56 (m, 1H), 2.06-2.21 (m, 2H), 1.90-1.97 (m, 1H), 1.53 (s, 9H), 1.20-1.30
(m, 1H), 1.08 (d, J = 6, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 163.0 (C), 83.9 (C),
73.4 (CH), 52.0 (CH2), 34.5 (CH), 32.0 (CH2), 28.1 (CH3), 22.9 (CH2), 19.8 (CH3).
HRMS (ESI) calcd for C11H24O4NS [M+NH4]+ 266.1426, found 266.1383.

trans-2,4-Dimethyl-3-pentyl 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2carboxylate (200): 1H NMR (CDCl3, 500 MHz): δ 4.75 (t, J = 6, 1H), 3.60 (d, J = 11,
1H), 3.16 (dt, J = 14, 4, 1H), 2.92 (td, J = 13, 4, 1H), 2.51-2.61 (m, 1H), 2.07- 2.23 (m,
2H), 1.91-2.01 (m, 3H), 1.23-1.33 (m, 1H), 1.10 (d, J = 6, 3H), 0.96 (d, J = 7, 3H), 0.96
(d, J = 7, 3H), 0.91 (t, J = 7, 6H). 13C{1H} NMR (CDCl3, 125 MHz): δ 164.1 (C), 86.1
(CH), 72.9 (CH), 52.1 (CH2), 34.3 (CH), 32.1 (CH2), 29.7 (CH), 29.5 (CH), 22.8 (CH2),
20.3 (CH3), 19.8 (CH3), 17.7 (CH3), 17.2 (CH3). HRMS (ESI) calcd for C14H30NO4S
[M+NH4]+ 308.1895, found 308.1877. Note: accidental equivalence of two methyls at
19.8.
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(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl (2R,3R)-3-methyltetrahydro-2Hthiopyran-1,1-dioxide-2-carboxylate (199): [α]D20 = -28.7o (c 1.3, CHCl3). 1H NMR
(CDCl3, 500 MHz): δ 4.84 (td, J = 11, 4.5, 1H), 3.54 (d, J = 11, 1H), 3.15 (dt, J = 14, 4,
1H),2.90 (td, J = 14, 4, 1H), 2.50-2.60 (m, 1H), 2.08-2.23 (m, 3H), 1.92-2.01 (m, 2H),
1.66-1.74 (m, 2H), 1.44-1.54 (m, 2H), 1.21-1.31 (m, 1H), 1.02-1.14 (m, 5H), 1.07 (d, J =
6.5), 0.84-0.95 (m, 7H), 0.92 (d, J = 6.5), 0.91 (d, J = 6.5), 0.77 (d, J = 7, 3H). 13C{1H}
NMR (CDCl3, 125 MHz): δ 163.5 (C), 77.4 (CH), 73.1 (CH), 52.1 (CH2), 46.9 (CH),
40.6 (CH2), 34.4 (CH), 34.4 (CH2), 32.1 (CH2), 31.7 (CH), 26.2 (CH), 23.3 (CH2), 22.9
(CH2), 22.1 (CH3), 21.0 (CH3), 19.8 (CH3), 16.1 (CH3). HRMS (ESI) calcd for
C17H34NO4S [M+NH4]+ 348.2208, found 348.2206.

For entries 4 and 6 in Table 13, inseparable mixtures of 199 and its diastereomer were
obtained. They were directly reduced to alcohol 173 for determination of the ratio.

General procedure for the reduction of cyclized sulfonylacetates
To the corresponding thiopyran-1,1-dioxide carboxylate (1 equiv.) in DCM (2.5
mL/mmol) was added DIBALH (2.2 equiv.) and the resulting mixture stirred at rt for 12
h. The reaction was quenched with MeOH (0.7 mL). 10%-Solution of Rochelle salt (5
mL) was added and vigorously stirred for several hours, until solids disappeared. The
water layer was extracted with DCM (3 × 5mL) and then EtOAc (5 mL). The combined
organic extracts were washed with brine, dried over anhydrous Na2SO4 and concentrated

83

to afford a crude product that was purified by flash chromatography using EtOAchexanes (1:4 to 1:1).

trans-(3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-yl)methanol (173): m.p. 94-95
o

C. 1H NMR (CDCl3, 500 MHz): δ 4.45 (dd, J =13, 3.5, 1H), 4.00 (ddd, J = 5.5, 9, 14,

1H), 3.11 (dt, J = 14, 3.5, 1H), 2.90-2.98 (m, 1H), 2.60 (dd, J = 11.5, 5.5, 1H), 2.50 (dd, J
= 9, 4.5, 1H), 2.34-2.44 (m, 1H), 2.06-2.19 (m, 2H), 1.92 (dd, J = 14.5, 3, 1H), 1.28-1.37
(m, 1H), 1.14 (d, J = 6.5, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 68.4 (CH), 56.2
(CH2), 52.2 (CH2), 33.3 (CH2), 31.8 (CH), 23.1 (CH2), 19.1 (CH3). HRMS (ESI) calcd
for C7H15O3S [M+H]+ 179.0741, found 179.0746.

(2R,3R)-(3-Methyltetrahydro-2H-thiopyran-1,1-dioxide-2-yl)methanol (R,R-173),
obtained by reduction of 199: [α]D20 = -16.7o (c 0.5, CHCl3)

(2S,3S)-(3-Methyltetrahydro-2H-thiopyran-1,1-dioxide-2-yl)methanol (S,S-173),
obtained by reduction of S,S-194: [α]D20 = +14.1o (c 0.4, CHCl3)

Determination of enantiomeric ratio
An oven-dried round bottom flask, equipped with a magnetic stirrer, was charged
with DCC (1.5 equiv.), (S)-acetylmandelic acid (1.5 equiv.), and DCM (2.5 mL/mmol).
The resulting solution was stirred at rt for 30 min, after which alcohol 173 (1 equiv.)
dissolved in DCM (2.5 mL/mmol) was added, followed by DMAP (0.5 equiv.). The
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reaction mixture was stirred at rt for 8 h. The reaction mixture was taken up in EtOAc (50
mL), washed with 1N HCl solution (2 ×10 mL) and then with saturated NaHCO3. The
organic phase was further washed with brine, dried over anhydrous Na2SO4, and
evaporated under reduced pressure to afford the crude product, which was used for 1H
NMR analysis without further purification to determine the diastereomeric ratio. The
enantioselectivity or diastereoselectivity was measured by integration of the
diastereomeric signals (CHCH2-O-CO, CH3-CH, Ph-CH(OAc)-CO) in 1H NMR spectra
of the acetylmandalates. It was shown that chromatographic purification of the product
can be performed without affecting the ratio determined by NMR spectroscopy.

Preparation of (R)-1,4-bis(4-toluenesulfonyloxy)pentane (202)
To the solution of (R)-pentane-1,4-diol (197, 75 mg, 0.72 mmol), prepared as
described from L-glutamic acid, in pyridine (1.8 mL) at 0 oC was added ptoluenesulfonyl chloride (345 mg, 1.80 mmol). The mixture was kept at 0 oC for 5 h, then
warmed up to rt allowed to stand at this temperature for 20 h. The mixture was diluted
with ethyl acetate, washed with 1N HCl solution, saturated aq. NaHCO3 solution, brine,
dried over MgSO4 and concentrated under reduced pressure. The crude product was
purified using flash chromatography to provide the pure ditosylate 198 (223 mg, 75%).

(R)-1,4-Bis(4-toluenesulfonyloxy)pentane (202): [α]D20 = +15.1o (c 2.3, CHCl3). 1H
NMR (CDCl3, 500 MHz): δ 7.76 (d, J = 8.5, 2H), 7.755 (d, J = 8, 2H), 7.35 (d, J = 8.5,
2H), 7.33 (d, J = 8.5, 2H), 4.57 (sextet, J = 6, 1H), 3.90-4.00 (m, 2H), 2.45 (s, 3H), 2.44
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(s, 3H), 1.55-1.71 (m, 4H), 1.19 (d, J = 6, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ
145.1 (C), 144.9 (C), 134.4 (C), 133.1 (C), 130.1 (CH), 130.0 (CH), 128.0 (CH), 127.8
(CH), 79.3 (CH), 69.3 (CH2), 32.6 (CH2), 24.6 (CH2), 21.8 (CH3), 20.9 (CH3). HRMS
(ESI) calcd for C19H28NO6S2 [M+NH4]+ 430.1352, found 430.1301. Note: accidental
equivalence of two methyls at 21.8 ppm.

Preparation of (R)-ethyl [4-(4-toluenesulfonyloxy)pentylsulfonyl]acetate (203)
Ditosylate 202 (18 mg, 0.040 mmol) and ethylthioglycolate (8 mg, 0.07 mmol)
under nitrogen were dissolved in acetone (0.1 mL), and K2CO3 (10 mg, 0.07 mmol) was
added. The reaction mixture was stirred at rt for 18 h, the solvent was removed under
reduced pressure, and the residue was treated with water (5 mL) and ethyl acetate (10
mL). The layers were separated, the organic layer washed with brine, dried and
concentrated. The crude was dissolved in CH2Cl2 (0.2 mL) and treated with m-CPBA
(70%, 27 mg, 0.22 mmol), and left at rt for 20 h. After that time, the mixture was diluted
with ethyl acetate, washed with NaHSO3, saturated aq. NaHCO3 solution, brine, dried
and concentrated. Chromatography provided 199 as a yellow oil (14 mg, 82%)

(R)-Ethyl [4-(4-toluenesulfonyloxy)pentylsulfonyl]acetate (203): [α]D20 = +14.1o (c
1.7, CHCl3). 1H NMR (CDCl3, 500 MHz): δ 7.80 (d, J = 8.5, 2H), 7.35 (d, J = 8.5, 2H),
4.62-4.70 (m, 1H), 4.27 (q, J = 7, 2H), 3.92 (s, 2H), 3.19-3.26 (m, 2H), 2.45 (s, 3H),
1.70-1.96 (m, 4H), 1.33 (t, J = 7, 3H), 1.26 (d, J = 6.5, 3H). 13C{1H} NMR (CDCl3, 125
MHz): δ 163.2 (C), 145.1 (C), 134.3 (C), 130.1 (CH), 127.9 (CH), 79.0 (CH), 63.0 (CH2),
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57.7 (CH2), 53.0 (CH2), 35.1 (CH2), 21.9 (CH3), 20.9 (CH3), 17.9 (CH2), 14.2 (CH3).
HRMS (ESI) calcd for C16H28NO7S2 [M+NH4]+ 410.1301, found 410.1315.

Preparation of (2S,3S)-ethyl 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2carboxylate (149)
Sulfone 203 (35 mg, 0.089 mmol) was dissolved in DMSO (0.5 mL) under
nitrogen atmosphere, and K2CO3 (18.5 mg, 0.134 mmol) was added. The mixture was
vigorously stirred at rt for 24 h, then diluted with water (10 mL), and extracted with ethyl
acetate (2 × 10 mL). The organic layer was washed with brine, dried over MgSO4 and
concentrated. Chromatography provided 149a (12.7 g, 65%), along with the cis isomer,
149b (5 mg, 25%). The spectral data for the compounds match previously reported.122

(2S,3S)-Ethyl 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (S,S149a): [α]D20 = +32.5o (c 0.5, CHCl3).

(2R,3S)-Ethyl 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (149b):
[α]D20 = -36.8o (c 0.3, CHCl3
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CHAPTER 4
SYNTHETICALLY USEFUL TRANSFORMATIONS OF CYCLIC SIXMEMBERED SULFONES AND SULFONATES OBTAINED BY RHODIUMCATALYZED INTRAMOLECULAR C–H INSERTION
4.1 Introduction
Rhodium-catalyzed intramolecular C–H insertion on diazo carbonyl compounds
has emerged as a powerful synthetic tool in the last three decades.14, 63 The potential of
this reaction as a new C–C bond forming procedure, as well as its ability to streamline
complex molecule synthesis are well documented.42, 82, 88, 136 As mentioned earlier,
rhodium-catalyzed intramolecular C–H insertion on diazo carbonyl compounds occurs
with overwhelming preference for five-membered carbocycles/heterocycles. This
inherent preference can be overridden by factors such as substrate conformation, insertion
site electronic effects and the reactivity of the rhodium catalyst. However, there is no
standard procedure as to how these controlling factors can be fully explored. The
extension of rhodium-catalyzed intramolecular C–H insertion to diazosulfones and
diazosulfonates implicitly creates new avenues to employ C–H insertion in ways
unattainable with diazo carbonyl compounds.
Jungong and co-workers124 have elaborated on the formation of cyclic sixmembered sulfones and sulfonates by means of rhodium-catalyzed intramolecular C–H
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insertion. However, the chemistry of these novel cyclic six-membered compounds as
synthetic precursors or intermediates remains largely unexplored. There is a small
number of reports in the literature where cyclic six-membered sulfones and sulfonates
have been converted into synthetically more relevant intermediates.123 Notably, Du Bois
and co-workers123 have illustrated that the carbon–oxygen bond of cyclic six-membered
ring sulfonates can be displaced with nucleophiles such as NaCN, NaN3, NaOAc, and
thiolates to form the corresponding sulfonate salts. Even though direct extrusion of SO3
from the resulting salts under a variety of conditions proved futile, the salts were
successfully transformed to acyclic esters in two steps (Scheme 30).

Scheme 30. Nucleophilic substitution reactions of δ-sultones reported by Du Bois and coworkers.123

Desulfonation of cyclic six-membered sulfonates under oxidative conditions to
furnish five-membered lactols has also been observed by Du Bois and co-workers
(Scheme 31).123 The transformation is reported to involve an oxygen transfer followed by
a (C–S) bond cleavage to generate an α-keto ester, which is trapped internally by the
pending hydroxyl group.
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Scheme 31. Desulfonation of δ-sultones to form substituted lactols reported by Du Bois
and co-workers.123

The above examples depict six-membered cyclic sulfones and sulfonates as
promising synthetic intermediates well-suited for complex molecule synthesis. This has
provoked studies to explore synthetically meaningful transformations for these substrates,
which would lead to precursors and intermediates of added value.

4.2 Results and Discussion
4.2.1 Direct Desulfonation of Cyclic Six-Membered Sulfonates (δSultones) to δ-Valerolactones via Samarium Iodide Reduction
For δ-sultones, it was envisioned that direct desulfonation could be achieved by
reductive cleavage of the C–S bond which would allow a “remote alkylation” at a γposition relative to the hydroxyl group (Scheme 32).

Scheme 32. Remote alkylation of alcohols leading to the formation of 5-hydroxyesters.
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Many examples of desulfonation have been demonstrated with α-arylsulfonyl
esters.137-139 However, there is no such example for α-alkoxysulfonyl substituted esters.
Seemingly, the aryl group on the sulfur atom is essential for this reaction, as δ-sultones
did not react in the presence of known regents for the reduction, such as Al/Hg,140
Na/Hg,141 Mg-MeOH,138 and SmI2-MeOH.137 Desulfonation of fluoroalkylsulfonyl
oxindoles has been attained by using SmI2 at prolonged reaction times.139 In this light,
Jungong and co-workers have uncovered that SmI2 in combination with DMPU would
react with δ-sultones to afford δ-valerolactones within three hours (Table 14).142

Table 14. SmI2 reduction of δ-sultones to form δ-valerolactones reported by Jungong and
coworkers.142

S

time

P

Yield (%)

45 min

47

3h

45
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Table 14. Cont.
S

time

P

3h

Yield (%)
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The replacement of DMPU with the relatively more toxic HMPA yielded similar
results. The obtained δ-valerolactones are a consequence of the cyclization of the initially
formed 5-hydroxyesters (Scheme 33). The 5-hydroxyesters are formed from the reduction
of δ-sultones catalyzed by SmI2/DMPU. The extrusion of SO2 from these esters followed
by cyclization furnishes the desired lactones. Apparently, the yields for lactones 215 and
216 are low because of the volatility of the products and a small scale of reaction. The
reaction was found to be sensitive to the source of SmI2, as mixed success was observed
with commercially available SmI2. However, the reaction was high yielding and worked
reliably with SmI2 prepared by the reaction of samarium metal with mercury iodide
following a modification of the literature procedure for the preparation of SmCl3.143
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Scheme 33. Mechanism for SmI2/DMPU reduction of δ-sultones to form δvalerolactones.

4.2.2 Direct Desulfonation of Cyclic Six-Membered Sulfonates (δSultones) to γ-Butyrolactones via t-Butyl Hydroxyperoxide (TBHP)
Oxidation
According to literature reports,123 the desulfonation of sulfonates has been
examined under oxidative conditions to form lactols. It was reasoned that αhydroxylation of δ-sultones would lead to the scission of the C–S bond, thereby
permitting desulfonation and subsequent internal cyclization to 5-hydroxy-2-oxoester
(Scheme 34).

Scheme 34. Oxidative desulfonation of δ-sultones to 5-hydroxy-2-oxoesters.

The α-hydroxylation was attained by oxidizing the corresponding enolates with
TBHP (t-butyl hydroperoxide). While numerous bases (NaH, DBU, K2CO3, KOH, t93

BuOLi, TEA, and NaHMDS) effect the formation of the enolates, subsequent oxidation
and cyclization steps were unproductive. Eventually, TBHP in combination with t-BuOK
or KHMDS allowed the formation of γ-butyrolactones (Table 15).

Table 15. TBHP oxidative desulfonation of δ-sultones to γ-butyrolactones.

S

conditions

P

Yield (%)

TBHP, t-BuOK, rt

93

TBHP, t-BuOK, rt

85

TBHP, KHMDS, rt

70

94

Table 15. Cont.
S

conditions

P

Yield (%)

TBHP, KHMDS, rt

74

Even though δ-sultone esters in the presence of t-BuOK and KHMDS both form
enolates, the transformations were found to be high yielding when t-BuOK was used to
deprotonate δ-sultones derived from secondary alcohols and KHMDS for those derived
from primary alcohols. Presumably, the reported γ-butyrolactones are obtained from the
cyclization of the trapped 5-hydroxy-2-oxoesters (Scheme 35). Deprotonation of TBHP
forms a t-butyl hydroperoxyl nucleophile, which reacts with the potassium enolate to
form an alkoxide, which is eventually ring-opened, forcing the cleavage of the C–S bond
to provide the 5-hydroxy-2-oxoester 227 that is further oxidized, presumably via a
Baeyer-Villiger type of process, to form the mixed anhydride 233. Anhydride 233
undegoes SO2 extrusion followed by cyclization to yield the final lactone 234.
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Scheme 35. Mechanism of TBHP oxidative desulfonation of δ-sultones to γbutyrolactones.

4.2.3 Alkylation of δ-Sultones and Carbethoxythiane-1,1-Dioxides
In general, δ-sultones and carbethoxythiane-1,1-dioxides are fairly strong C–H
acids, which are configurationally stable in the absence of a base. Focusing on the C–H
center adjacent to the SO2 moiety, the alkylation of these compounds with active
electrophiles under relatively mild conditions (NaH, alkylating agent, THF, rt, 16 h) was
observed (Table 16). Interestingly, under these conditions, it was possible to selectively
alkylate sultone 234, although Du Bois and co-workers have demonstrated that δ-sultones
can themselves act as electrophiles in nucleophilic substitutions. Also, high
diastereoselectivity was witnessed in the alkylation of substrates 149a and 155.2.
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Table 16. Alkylation of δ-sultones and carbethoxythiane-1,1-dioxides.142

S

X

alkylating agent

CH2

allyl bromide

95

CH2

ethyl iodide

80

CH2

tosyl azide

90

CH2

hexachloroethane

80

81

CH2

p-chlorobenzyl
bromide

97

P

Yield (%)

Table 16. Cont.
S

X

alkylating agent

CH2

diiodomethane

86

O

allyl bromide

85

CH2

allyl bromide

95

p-chlorobenzyl
bromide

95

CH2

90

CH2

p-chlorobenzyl
bromide

98

P

The stereochemistry of alkylation products 244, 245 and 246 was deduced from
NOE correlations (Figure 9). In the case of 246, the alcohol 246b, obtained after
DIBALH reduction was used.

Figure 9. Stereochemical assignment of alkylated products.142

It was found that the ester functionality of the δ-sultones can be selectively
reduced by DIBALH without affecting the sultone moiety, although care must be taken as
prolonged reaction times degrade the yield. While borane-dimethyl sulfide also proved
effective, LAH was ineffective with both sulfones and sulfonates resulting in complete
hydrogenolysis of the ester functionality to the methyl group.
Most notably, it has been uncovered that alkylated products, upon treatment with
NaHMDS, could be rearranged by migration of the carbethoxy group in a manner similar
to that of β-ketoesters (Scheme 36).
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Scheme 36. Rearrangement of alkylated sulfones.142

4.2.4 Formation of Cyclic α-Sulfonyl Oximes
Sulfonyl oximes constitute an important group of organic intermediates capable of
undergoing nucleophilic substitution reactions to provide oxime ethers, which in turn lead
to amines and carbonyl compounds.144-146 The synthetic potential of α-sulfonyl oximes is
well known, however that of cyclic α-sulfonyl oximes remains limited, perhaps due to a
little diversion within this group of compounds. A novel transformation of
carbethoxythiane-1,1-dioxides to the corresponding cyclic α-sulfonyl oximes under
relatively mild conditions (isoamyl nitrite, NaH, THF) is herein reported (Table 17). For
δ-sultones, under the same conditions, the reaction was met with complications resulting
in a mixture of undesirable products.
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Table 17. Formation of α-sulfonyl oximes from carbethoxythiane-1,1-dioxides.

Substrate

X

Product

Yield (%)

CH2

87

CH2

82

CH2

85

CH2

90

The obtained cyclic α-sulfonyl oximes are formed as depicted on Scheme 37.
Alkylation of carbethoxythiane-1,1-dioxide using NaH and isoamyl nitrite 260 results in
the formation of sulfonyl nitrite 261. The nitite reacts with isoamyloxyl nuclophile
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generated from the alkylation step to form 262, which undergoes rearrangement,
followed by protonation to furnish the desired the cyclic α-sulfonyl oxime 264.

Scheme 37. Mechanism of formation of cyclic α-sulfonyl oximes.

4.3 Conclusion
The conversion of δ-sultones to δ-valerolactones and γ-butyrolactones has been
demonstrated. This outlines a protocol to substituted lactones, which are common
intermediates in the synthesis of several natural products. The stereoselective alkylation
of δ-sultones and thiane-1,1-dioxides has also been attained. This opens possibilities for
simple differential alkylation of thiane-1,1-dioxides, as well as construction of bicyclic
sulfur-containing heterocyles, which could be converted to medium-sized carbocycles by
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desulfonation. Lastly, novel cyclic α-sulfonyl oximes have been obtained from thiane1,1-dioxides under relatively mild conditions. The availability of these compounds would
facilitate studies on cyclic sulfonyl oximes. In a nut shell, these findings will be
beneficial for further studies directed at exploring the full potential of δ-sultones and
thiane-1,1-dioxides in synthesis.

4.4 Experimental Section on Synthetic Utility of Cyclic Six-Membered Sulfones and
Sulfonates obtained by Rhodium-Catalyzed Intramolecular C–H Insertion
All reactions were carried out under an inert nitrogen atmosphere unless
otherwise stated. All reagents were used as purchased without further purification except
otherwise stated. 1H-NMR (500 Hz) and 13C{1H} NMR (125 Hz) spectra were recorded
on an Avance 500 Bruker spectrometer and calibrated using residual undeuterated solvent
as internal references. Coupling constants are given in Hz. IR spectra were recorded on a
Perkin-Elmer Spectrum 400 Series FTIR spectrometer. Specific rotations were measured
on an AUTOPOL III automatic polarimeter in anhydrous CHCl3 using a 10 cm cell.
HRMS data were obtained on an Agilent 61969A TOF high resolution mass spectrometer
using electrospray ionization (ESI). Melting points were determined on a MEL-TEMP
melting point apparatus. Analytical TLC was performed using silica gel pre-coated TLC
plates (E. Merck no. 5715-7). Flash chromatography was performed using 40-63 μm
silica gel (Merck, Geduran, no. 11567-1) as the stationary phase. Tetrahydrofuran (THF)
was dried by distilling it from sodium and benzophenone in a continuous still under a
nitrogen atmosphere. Chloroform, dichloromethane and triethylamine were distilled from
calcium hydride under an atmosphere of nitrogen.
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General procedure for reduction of δ-sultones with SmI2/DMPU
To the solution of sultone (0.1 mmol) in dry THF (0.5 mL) containing DMPU (50
mg, 0.40 mmol) was added 0.1 M solution of SmI2 (commercially available, or prepared
by dissolving solid SmI2, obtained by reaction of samarium metal with HgI2, in dry THF)
until the blue color persisted, and 2 mL after that (typically around 5 mL). The reaction
mixture was stirred at rt for the specified time, after which 1N HCl solution was added (5
mL). Hexane (30 mL) was added, and the reaction mixture was stirred for 15 min at rt.
The layers were separated; the aqueous layer was washed with hexane (10 mL). The
combined organic layers were washed with water (10 mL), dried over Na2SO4, and
carefully concentrated. Flash chromatography (hexane-Et2O) provided the product. The
obtained lactones have been previously reported. The spectral data for the obtained
compounds match those reported in the literature, as that of the independently prepared
authentic samples.

General procedure for oxidation of δ-sultones with TBHP/t-BuOK
To a solution of δ-sultone in THF (2.5 mL/mmol) was added t-BuOK (10 equiv.)
or KHMDS (10 equiv.) followed by TBHP (4 equiv.). After stirring at rt for 16 h,
Na2SO3 was added and the resulting suspension stirred for 15 min to destroy excess
TBHP. This was followed by the addition of 20 mL of 1N HCl solution and the resulting
mixture taken up in Et2O, washed with brine, dried over MgSO4 and evaporated to afford
a crude product, which was purified by flash chromatography.
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Spectra data for 3,3,6-trimethylhexahydrobenzofuran-2-one (224) matched that in
literature.

7,8,8-Trimethyl-4-oxatricyclo[4.2.1.03,7]nonan-5-one (225): colorless oil. 1H NMR
(CDCl3, 500 MHz): δ 4.35 (d, 1H), 2.12-2.30 (m, 3H), 1.87 (m, 1H), 1.5 (d, J = 12.6,
1H), 1.39 (d, J = 14.2, 1H), 1.05 (s, 3H), 0.88 (s, 3H), 0.86 (s, 3H). 13C{1H} NMR
(CDCl3, 125 MHz): δ 181.5 (C), 87.1 (CH), 58.8 (C), 49.2 (C), 46.6 (CH), 46.3 (CH),
36.8 (CH2), 33.4 (CH2), 20.5 (CH3), 19.4 (CH3), 11.6 (CH3).

3-Methyl-3-(4-methyl-3-pentenyl)dihydrofuran-2-one (226): Pale yellow oil. 1H NMR
(CDCl3, 500 MHz): δ 4.35 (d, 1H), 2.12-2.30 (m, 3H), 1.87 (m, 1H), 1.5 (d, J = 12.6,
1H), 1.39 (d, J = 14.2, 1H), 1.05 (s, 3H), 0.88 (s, 3H), 0.86 (s, 3H). 13C{1H} NMR
(CDCl3, 125 MHz): δ 181.5 (C), 87.1 (CH), 58.8 (C), 49.2 (C), 46.6 (CH), 46.3 (CH),
36.8 (CH2), 33.4 (CH2), 20.5 (CH3), 19.4 (CH3), 11.6 (CH3).

3-(3-Benzyloxypropyl)-3-ethyldihydrofuran-2-one (227): 1H NMR (CDCl3, 500 MHz):
δ 7.27 (m, 5H), 4.44 (s, 2H), 3.60 (t, J = 7, 2H), 3.40 (t, J = 6.6, 2H), 1.50-1.60 (m, 2H),
1.40-1.48 (m, 2H), 1.31-1.38 (m, 1H), 1.22-1.29 (m, 1H), 0.79 (t, J = 7, 3H). 13C{1H}
NMR (CDCl3, 125 MHz): δ 139.0 (C), 128.7 (CH), 128.0 (CH), 127.9 (CH), 73.3 (CH2),
71.1 (CH2), 61.6 (CH2), 36.8 (CH2), 35.3 (C), 30.1 (CH2), 29.9 (CH2), 27.2 (CH2), 26.3
(CH2), 11.1 (CH3).
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General procedure for alkylation of δ-sultones and thiane-1,1-dioxides
Sodium hydride (20 mg, 60% dispersion in mineral oil, 0.5 mmol) was washed
with THF (3 × 10 mL), and a solution of thiane-1,1-dioxide (0.2 mmol) in THF (1 mL)
was added to it. After stirring for 15 min (when gas evolution subsided), the
corresponding alkyl halide (allyl bromide, ethyl iodide or p-chlorobenzyl chloride, 0.4
mmol) was added, and the reaction mixture was allowed to stir at rt for 16 h. 1N HCl
solution (5 mL) was added, and the mixture was extracted with EtOAc (2 × 20 mL). The
organic layer was dried with Na2SO4, and concentrated under reduced pressure. The
product was purified by flash chromatography (hexane-EtOAc).

2-Allyl-2-carbethoxy-3,3-dimethylthiane-1,1-dioxide ( 237): Pale yellow oil. 1H NMR
(CDCl3, 500 MHz): δ 6.08-6.17 (m, 1H), 5.23 (dd, J = 17, 1.5, 1H), 5.14 (dd, J = 10, 1.5,
1H), 4.25-4.36 (m, 2H), 3.81 (td, J = 13.5, 4, 1H), 2.97-3.04 (m, 2H), 2.82 (dd, J = 15, 7,
1H), 2.12-2.29 (m, 2H), 1.92-1.99 (m, 1H), 1.33-1.39 (m, 4H), 1.36 (t, J = 7), 1.31 (s,
3H), 1.00 (s, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 168.3 (C), 134.2 (CH), 118.6
(CH2), 78.0 (C), 62.2 (CH2), 51.2 (CH2), 40.1 (C), 36.4 (CH2), 31.8 (CH2), 28.8 (CH3),
23.0 (CH3), 19.4 (CH2), 14.2 (CH3). HRMS (ESI) calcd for C13H26NO4S (M+NH4)+
292.1577, found 292.1559.

2-Ethyl-2-carbethoxy-3,3-dimethylthiane-1,1-dioxide ( 238): Pale yellow oil. 1H NMR
(CDCl3, 500 MHz):δ 4.33-4.39 (m, 1H), 4.24-4.32 (m, 1H), 3.84 (td, J = 13.5, 4, 1H),
3.00 (dt, J = 13.5, 3.5, 1H), 2.24-3.31 (m, 1H), 2.20 (ddd, J = 14, 3.5, 3, 1H), 2.03-2.11
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(m, 2H), 1.90-1.96 (m, 1H), 1.36 (t, J = 7.3, 3H), 1.29-1.35 (m, 1H), 1.27 (s, 3H), 1.26 (t,
J = 7.3, 3H), 0.96 (s, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 168.4 (C), 78.7 (C), 62.0
(CH2), 52.0 (CH2), 40.2 (C), 36.3 (CH2), 28.7 (CH3), 23.3 (CH3), 20.9 (CH2), 19.4 (CH2),
14.3 (CH3), 11.1 (CH3). HRMS (ESI) calcd for C12H26NO4S (M+NH4)+ 280.1577, found
280.1577.

2-Azido-2-carbethoxy-3,3-dimethylthiane-1,1-dioxide (239): Pale yellow oil. 1H NMR
(CDCl3, 500 MHz): δ 4.37-4.51 (m, 2H), 3.51 (td, J = 13.5, 4, 1H), 3.26-3.31 (m, 1H),
2.08-2.21 (m, 2H), 1.9 (td, J = 15, 4, 1H), 1.52-1.62 (m, 1H), 1.40 (t, J = 7.2), 1.20 (s,
3H), 1.08 (s, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 165.3 (C), 101.0 (C), 83.9 (CH2),
64.0 (CH2), 50.4 (CH2), 41.5 (C), 34.7 (CH3), 19.7 (CH3), 14.4 (CH3). HRMS (ESI) calcd
for C10H25N2O4S (M+NH4)+ 269.1283, found 293.1273.

2-Chloro-2-carbethoxy-3,3-dimethylthiane-1,1-dioxide (240): Pale yellow oil. 1H
NMR (CDCl3, 500 MHz): 4.35 (q, 2H), 3.85 (td, J = 16.4, 3.4, 1H), 3.23 (dt, J = 13.5,
3.1, 1H), 2.24-3.31 (m, 1H), 2.24-2.34 (m, 1H), 2.04-2.11 (m, 1H), 1.6 (dd, J = 12.2, 5.6,
1H), 1.40 (s, 3H), 1.39 (t, J = 7.3, 3H), 1.10 (s, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ
165.4 (C), 92.1 (C), 64.3 (CH2), 50.3 (CH2), 43.4 (CH2), 35.4 (CH2), 27.5 (C), 24.2
(CH3), 19.6 (CH3), 14.2 (CH3).

2-(4-Chlorobenzyl)-2-carbethoxy-3,3-dimethylthiane-1,1-dioxide (241): Pale yellow
oil. 1H NMR (CDCl3, 500 MHz): 7.44 (d, J = 8.1), 7.20 (d, J = 8.5), 4.28 (q, J = 7.2,
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2H), 3.81 (td, J = 13.5, 4, 1H), 3.55 (t, J = 14.5, 2H), 3.28 (d, J = 14.5, 1H), 3.02 (dt, J =
13, 3.2, 1H), 2.25 (qt, J = 13.8, 3.1, 1H), 2.05 (td, J = 14.1, 2.8, 1H), 1.92-1.98 (m, 1H),
1.42 (s, 3H), 1.34 (t, J = 7.3, 3H), 1.04 (s, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ
167.6 (C), 134.4 (C), 134.2 (CH), 127.7 (CH), 79.5 (CH2), 62.2 (C), 52.3 (CH2), 40.8
(CH3), 36.5 (CH3), 32.1 (CH2), 29.0 (CH2), 23.2 (CH3), 19.4 (CH3), 14.2 (CH3). HRMS
(ESI) calcd for C17H24NO4SCl (M+NH4)+ 376.1442, found 359.1083.

2-Methyl-2-carbethoxy-3,3-dimethylthiane-1,1-dioxide (242): Pale yellow oil. 1H
NMR (CDCl3, 500 MHz): 4.18-4.25 (m, 2H), 3.72 (td, J = 13.2, 4.7, 1H), 2.92 (dt, J =
13.5, 3.1, 1H), 1.98-2.12 (m, 1H), 1.82 (qd, J = 12.9, 4, 1H), 1.6 (s, 3H), 1.3 (t, J = 7.3,
3H), 0.88 (d, J = 6.6, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 168.4 (C), 72.4 (C), 62.6
(CH2), 49.2 (CH2), 40.9 (CH2), 29.2 (CH2), 23.3 (C), 17.5 (CH3), 14.6 (CH3), 14.5 (CH3).

3-Allyl-3-carbethoxy-4,4-dimethyl-1,2-oxathiane-2,2-dioxide ( 243): Pale yellow oil.
1

H NMR (CDCl3, 500 MHz): δ 6.05 (ddt, J = 14, 10, 7, 1H), 5.27 (dd, J = 17, 1.5, 1H),

5.18 (dd, J = 10, 1.5, 1H), 4.72 (td, J = 12, 2, 1H), 4.44 (ddd, J = 11.5, 4.5, 2.5, 1H),
4.29-4.38 (m, 2H), 2.86-2.96 (m, 2H), 2.61 (td, J = 13.5, 4, 1H), 1.43 (s, 3H), 1.33-1.39
(m, 4H), 1.36 (t, J = 7), 0.99 (s, 3H). 13C{1H} NMR (CDCl3 125 MHz): δ 166.5 (C),
133.4 (CH), 119.5 (CH2), 76.8 (C), 69.3 (CH2), 62.6 (CH2), 39.6 (CH2), 36.7 (CH2), 34.3
(CH2), 27.8 (CH3), 23.6 (CH3), 14.2 (CH3). HRMS (ESI) calcd for C12H24NO5S
(M+NH4)+ 294.1369, found 294.1388.
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(2R,3S)-2-Allyl-2-carbethoxy-3-methylthiane-1,1-dioxide (244 ): Pale yellow oil. 1H
NMR (CDCl3, 500 MHz): δ 6.10-6.19 (m, 1H), 5.20 (dq, J = 17, 1, 1H), 5.14 (d, J = 10,
1H), 4.26-4.37 (m, 2H), 3.79 (td, J = 13.5, 4.5, 1H), 3.11 (dd, J = 15, 5.5, 1H), 2.98 (dt, J
= 13.5, 3.5, 1H), 2.82 (dd, J = 15.5, 8.5, 1H), 2.24-2.31 (m, 1H), 2.03-2.17 (m, 2H), 1.80
(qd, J=13, 3.5, 1H), 1.60 (dq, J = 14.5, 3.5, 1H, overlapped with water peak at 1.60 ppm),
1.36 (t, J = 7.5, 3H), 0.99 (d, J = 6.5, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 167.5
(C), 133.3 (CH), 119.0 (CH2), 75.5 (C), 62.4 (CH2), 50.7 (CH2), 39.1 (CH), 34.8 (CH2),
29.1 (CH2), 23.0 (CH2), 17.4 (CH3), 14.3 (CH3). HRMS (ESI) calcd for C12H21O4S
(M+H)+ 261.1155, found 261.1171.

(2R,3S)-2-Carbethoxy-2-(4-chlorobenzyl)-3-methylthiane-1,1-dioxide ( 245): Pale
yellow oil. 1H NMR (CDCl3, 500 MHz): δ 7.42 (d, J = 8, 2H), 7.22 (d, J = 8, 2H), 4.304.40 (m, 2H), 3.76 (td, J = 13.5, 4, 1H), 3.66 (d, J = 14.5, 1H), 3.34 (d, J = 14.5, 1H),
2.96 (dt, J = 14, 3.5, 1H), 2.33-2.41 (m, 1H), 2.08-2.19 (m, 1H), 2.00-2.07 (m, 1H), 1.631.72 (m, 2H), 1.37 (t, J = 7, 3H), 1.07 (d, J = 7, 3H). 13C{1H} NMR (CDCl3, 125 MHz):
δ 167.1 (C), 134.1 (C), 133.2 (CH), 133.1 (C), 128.0 (CH), 77.2 (C), 62.6 (CH2), 51.5
(CH2), 40.4 (CH), 35.6 (CH2), 29.6 (CH2), 22.9 (CH2), 18.1 (CH3), 14.4 (CH3). HRMS
(ESI) calcd for C16H25NO4SCl (M+NH4)+ 362.1187, found 362.1172.

(2R,3S)-2-Carbethoxy-2-(4-chlorobenzyl)-3-methylthiolane-1,1-dioxide (246 ): Pale
yellow oil. 1H NMR (CDCl3, 500 MHz): δ 7.39 (d, J = 8.5, 2H), 7.25 (d, J = 8.5, 2H),
4.30 (qd, J = 7, 1.5, 2H), 3.44-3.52 (m, 2H), 3.27 (d, J = 14.5, 1H), 3.14-3.21 (m, 1H),
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2.47-2.55 (m, 1H), 2.21-2.29 (m, 1H), 1.96-2.05 (m, 1H), 1.33 (t, J = 7.3, 3H), 0.90 (d, J
= 7, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 166.6 (C), 133.6 (C), 133.3 (C), 132.6
(CH), 128.5 (CH), 74.5 (C), 62.5 (CH2), 50.7 (CH2), 40.1 (CH), 35.2 (CH2), 27.0 (CH2),
17.0 (CH3), 14.3 (CH3). HRMS (ESI) calcd for C15H23NO4SCl (M+NH4)+ 348.1031,
found 348.1035.

DIBALH reduction of 236 and 246
To the solution of 236 or 246 (0.1 mmol) in CH2Cl2 (0.5 mL), solution of
DIBALH (0.5 mL, 1M in hexane, 0.5 mmol) was added at 0 oC. The reaction mixture
was kept at 0 oC for 1h (236), or 10 h at rt (246). Concentrated aqueous solution of
sodium potassium tartrate was added (10 mL), and the reaction mixture was stirred for
1h. The layers were separated; the aqueous layer was washed with EtOAc (20 mL). The
combined organic layers were washed with brine, dried over Na2SO4, and concentrated.
Flash chromatography (hexane-EtOAc) provided the product.

3-Hydroxymethyl-4,4-dimethyl-1,2-oxathiane-2,2-dioxide (236b): Obtained in 90%
yield. Clear oil, solidified on standing. mp 62-63 oC. 1H NMR (CDCl3, 500 MHz): δ 4.66
(td, J = 11.5, 2.5, 1H), 4.46 (dt, J = 11.5, 4, 1H), 4.20 (ddd, J = 12.5, 8, 3, 1H), 4.02-4.09
(ddd, J = 12.5, 8, 3, 1H), 3.11 (dd, J = 8, 3, 1H), 2.41 (dd, J = 8, 3, 1H), 1.92 (ddd, J =
14.5, 11.5 , 4, 1H), 1.61 (ddd, J = 14.5, 4, 2.5, 1H), 1.27 (s, 3H), 1.22 (s, 3H). 13C{1H}
NMR (CDCl3, 125 MHz): δ 69.9 (CH), 69.7 (CH2), 58.3 (CH2), 38.9 (CH2), 35.8 (C),
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29.9 (CH3), 22.1 (CH3). HRMS (ESI) calcd for C7H18NO4S (M+NH4)+ 212.0951, found
212.0950.

(2R,3S)-4-Chlorobenzyl-2-hydroxymethyl-3-methylthiolane-1,1-dioxide (246b):
Obtained in 94% yield. Pale yellow oil. 1H NMR (CDCl3, 500 MHz): δ 7.28-7.31 (m,
4H), 3.94 (dd, J = 13, 6, 1H), 3.75 (dd, J = 13, 8, 1H), 3.42 (d, J = 14, 1H), 3.29 (ddd, J =
13, 8.5, 3, 1H), 3.07 (ddd, J = 13, 10.5, 8.5,1H), 2.82 (d, J = 14, 1H), 2.59 (dd, J = 8, 6,
1H), 2.31-2.39 (m, 1H), 2.13-2.21 (m, 1H), 1.90-2.00 (m, 1H), 0.85 (d, J = 7, 3H).
13

C{1H} NMR (CDCl3, 125 MHz): δ 133.8 (C), 133.5 (C), 132.2 (CH), 128.9 (CH), 68.1

(C), 61.3 (CH2), 51.4 (CH2), 39.5 (CH), 36.5 (CH2), 27.7 (CH2), 15.8 (CH3). HRMS
(ESI) calcd for C13H21NO3SCl (M+NH4)+ 306.0925, found 306.0941.

Rearrangement of 237
Compound 237 (25 mg, 0.091 mmol) was dissolved in dry THF (0.2 mL), and
solution of NaHMDS in THF (2M in THF, 90 µL, 0.18 mmol) was added. After stirring
at rt for 1.5 h, the reaction was quenched with 1N HCl solution (5 mL), and extracted
with EtOAc (2 × 20 mL). The organic layer was washed with brine, dried and
concentrated. The products were isolated using flash chromatography (EtOAc-hexane).
The products isomerise during chromatography (verified by resubjecting pure 250a to
chromatography). Typically, small amounts of pure 250a and 250b were isolated, along
with a mixture of the two. 250b (the more polar isomer) was determined to be the cis
isomer by diaxial NOE correlation between H2 and H6. Combined yield 20 mg (84%).
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trans-2-Allyl-6-carbethoxy-3,3-dimethylthiane-1,1-dioxide (250a): Pale yellow oil. 1H
NMR (CDCl3, 500 MHz): δ 5.94-6.03 (m, 1H), 5.16 (dd, J = 17, 1.5, 1H), 5.07 (dd, J =
10, 1.5, 1H), 4.21-4.32 (m, 2H), 3.88 (dd, J = 5, 3, 1H), 3.43 (dd, J = 7, 4, 1H), 2.78-2.87
(m, 1H), 2.50 (ddd, J = 14, 5, 3, 1H), 2.38-2.45 (m, 1H), 2.13 (dq, J = 15, 3, 1H), 2.04
(td, J = 14, 3, 1H), 1.39 (dt, J = 14.5, 3.5, 1H), 1.32 (t, J = 7, 3H), 1.15 (s, 3H), 1.11 (s,
3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 167.2 (C), 136.8 (CH), 116.8 (CH2), 66.8
(CH), 63.9 (CH), 62.4 (CH2), 37.4 (C), 34.8 (CH2), 31.0 (CH3), 26.3 (CH2), 23.4 (CH2),
19.9 (CH3), 14.2 (CH3). HRMS (ESI) calcd for C13H23O4S (M+H)+ 275.1311, found
275.1320.

cis-2-Allyl-6-carbethoxy-3,3-dimethylthiane-1,1-dioxide ( 250b): Pale yellow oil. 1H
NMR (CDCl3, 500 MHz): δ 5.94-6.03 (m, 1H), 5.14 (dd, J = 17, 1.5, 1H), 5.07 (dd, J =
10, 1.5, 1H), 4.25-4.37 (m, 2H), 3.81 (dd, J = 13, 3.5, 1H), 2.83-2.91 (m, 1H), 2.82 (dd, J
= 7, 3, 1H), 2.37-2.51 (m, 2H), 2.14 (dq, J = 15, 3, 1H), 1.68 (ddd, J = 14.5, 4.5, 3, 1H),
1.52 (td, J = 14, 3, 1H), 1.33 (t, J = 7, 3H), 1.16 (s, 3H), 1.09 (s, 3H). 13C{1H} NMR
(CDCl3, 125 MHz): δ 164.2 (C), 136.7 (CH), 117.1 (CH2), 71.6 (CH), 66.1 (CH), 62.8
(CH2), 39.6 (CH2), 37.7 (C), 30.9 (CH3), 26.7 (CH2), 23.5 (CH2), 19.5 (CH3), 14.3 (CH3).
HRMS (ESI) calcd for C13H23O4S (M+H)+ 275.1311, found 275.1319.

General Procedure for the preparation of α-sulfonyl oximes (254-257)
To a stirred solution of carbethoxythiane-1,1-dioxide (30-50 mg) in 2 mL of THF
was added NaH (2 equiv.). After stirring at rt for 15 min, isoamyl nirite (2 equiv.) is
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added and the combined mixture further stirred at room for 16 h. Upon completion as
indicated by TLC analysis, the reaction is acidified with 1N HCl solution, extracted with
Et2O or EtOAc, washed with brine, dried over MgSO4, filtered and the excess solvent
removed under reduced pressure to afford a crude product that was purified by flash
chromatography (35% EtOAc/Hexanes).

2-Hydroxyimino-3-methylthiane-1,1-dioxide (254) : Pale yellow oil. 1H NMR (CDCl3,
500 MHz):

-3.97 (m, 1H), 3.30-3.33 (m, 1H), 3.09-3.15 (m, 1H), 2.49-

2.53 (m, 1H), 2.05-2.10 (m, 2H), 1.80-1.94 (m, 2H), 1.47 (d, J = 6.6, 3H), 13C{1H} NMR
(CDCl3, 125 MHz): δ 160.9 (C), 54.8 (CH2), 31.1 (CH), 30.8 (CH2), 19.8 (CH2), 16.68
(CH3).

2-Hydroxyiminothiane-1,1-dioxide (255): Pale yellow oil. 1H NMR (CDCl3, 500 MHz):
δ 9.37 (s, 1H), 3.14 (t, J = 6, 2H), 2.97 (t, J = 6, 2H), 2.14-2.18 (m, 2H), 1.73-1.77 (m,
2H). 13C{1H} NMR (CDCl3, 125 MHz): δ 158.1 (C), 55.23 (CH2), 25.6 (CH2), 25.0
(CH2), 24.4 (CH2).

2-Hydroxyimino-3-ethylthiane-1,1-dioxide (256): Pale yellow oil. 1H NMR (CDCl3,
500 MHz):

s, 1H), 3.72-3.73 (m, 1H), 3.41 (q, J = 7, 1H), 3.20-3.30 (m, 1H),

3.00-3.10 (m, 1H), 2.30-2.42 (m, 1H), 1.96-2.10 (m, 2H), 1.80-1.90 (m, 1H), 1.70-1.80
(m, 1H), 1.60 (ddd, J = 20, 14, 7, 1H), 1.18 (t, J = 7, 3H), 0.89 (t, J = 7.2, 3H). 13C{1H}
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NMR (CDCl3, 125 MHz): δ 160.0 (C), 66.2 (CH2), 55.1 (CH2), 38.2 (CH), 29.0 (CH2),
24.3 (CH2), 20.0 (CH2), 15.6 (CH), 12.4 (CH3).

2-Hydroxyimino-3-butylthiane-1,1-dioxide (257): Pale yellow oil. 1H NMR (CDCl3,
500 MHz):

32 (s, 1H), 3.84-3.85 (m, 1H), 3.20-3.33 (m, 1H), 3.10-3.14 (m, 1H),

2.454-2.48 (m, 1H), 2.02-2.09 (m, 2H), 1.89-1.91 (m, 1H), 1.77-1.81 (m, 1H), 1.60-1.65
(m, 5H), 0.92 (t, J = 7, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 160.2 (C), 55.2 (CH2),
36.5 (CH), 30.7 (CH2), 30.0 (CH2), 29.2 (CH2), 22.8 (CH2), 20.0 (CH2), 14.3 (CH3).
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CHAPTER 5
APPLICATION OF RHODIUM-CATALYZED INTRAMOLECULAR C–H
INSERTION ON DIAZO SULFONES AND SULFONATES TOWARDS THE
SYNTHESIS OF NATURAL PRODUCTS
5.1 Synthesis of (+)-Bakuchiol
5.1.1 Isolation and Biological Activity of (+)-Bakuchiol
(+)-Bakuchiol is a meroterpenoid that can be found naturally in the leaves of
Psoralea glandulosa as well as the seeds of Psoralea corylifolia.147, 148 Both plants
belong to the Fabaceae family. Psoralea glandulosa is a perennial plant common along
the west coast of South America, especially in Peru and Chile, while Psoralea corylifolia
is widely distributed around India and Southeastern Asia, and has been routinely used for
Chinese and Indian medicine.

Figure 10. Structure of (+)-bakuchiol.

The urge to synthesize (+)-bakuchiol was heightened by its broad spectrum of
applications, ranging from treating neurodegenerative diseases, breast cancer, oral
hygiene, plant diseases, antibacterial agent, bone strength-enhancing agent and skin care
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agent.149 There have also been several reports describing the use of (+)-bakuchiol as an
anti-inflammatory,150 antioxidant,151 antitumor,152 and immunosuppressive agents.153

5.1.2 Previous Syntheses of (+)-Bakuchiol
The first enantioselective total synthesis of (+)-bakuchiol was reported by Takano
and co-workers in 1990.154 Since then, other syntheses have been elaborated by the
groups of Sakakiyama,155 Esumi,156 and Du.157 To date, the most efficient synthesis is
that developed by Du and co-workers, which resulted in a 51% overall yield (Scheme
38). The synthesis was attained in 10 steps starting from geraniol. Geraniol was
converted to epoxy silyl ether via enantioselective Sharpless epoxidation, followed by
protection of the hydroxyl functionality with TBSCl. The Yamamoto epoxide
rearrangement induced by methylaluminum bis[4-bromo-2,6-di(t-butyl)phenoxide]
(MABR) provided key intermediate 269 with the desired configuration of the quaternary
chiral center.

Scheme 38. Construction of the quaternary chiral center by Sharpless epoxidation and
Yamamoto rearrangement reported by Du and co-workers.157
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5.1.3 Application of Intramolecular C–H Insertion on Diazosulfonates in
the Synthesis of (+)-Bakuchiol
The structure of (+)-bakuchiol is similar to that of citronellol, which is abundantly
present in nature. Guided by earlier studies on the formation of δ-sultones from the
corresponding alcohols, as well as the conversion of the obtained δ-sultones into δvalerolactones,122, 142 it was envisioned that (+)-bakuchiol could be synthesized from
commercially available citronellol by employing rhodium-catalyzed intramolecular C–H
insertion to install the quaternary center in the structure (Scheme 39).

Scheme 39. Retrosynthetic disconnection for (+)-bakuchiol.

The exposure of sultone ester 207 to the SmI2/DMPU reduction conditions was
expected to form δ-valerolactone 271. Its reduction to a diol, followed by protection of
the hydroxyl groups and subsequent elimination would complete the synthesis of the key
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intermediate 272, that would then be modified to the final product (+)-bakuchiol.
Unexpectedly, the conversion of the sultone ester to the δ-valerolactone proved futile as it
afforded a mixture of inseparable products. Even so, the peaks corresponding to the more
substituted double bond could not be identified by 1H NMR – an indication that the
double was sensitive to the reaction conditions and interfered in the reduction.
The enantioselective synthesis of (+)-bakuchiol was then achieved by employing
the synthetic route outlined below (Scheme 40).136 Rhodium-catalyzed intramolecular
C–H insertion was used in the synthesis of sultone ester 207. Basically, (S)-(-)-βcitronellol was treated with ethyl (chlorosulfonyl)acetate in the presence of imidazole in
THF. The resulting sulfonate ester was exposed to diazotransfer conditions (MsN3, DBU,
THF, 1 h, -45 oC) to afford the diazosulfonate ester 141. Rhodium-catalyzed
intramolecular C–H insertion of 141 provided 207.

Scheme 40. Synthesis of δ-sultone 207 via rhodium-catalyzed intramolecular C–H
insertion following procedure by Wolckenhauer and co-workers.123
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Reduction of sultone ester 207 in the presence of DIBAL followed by mesylation
of the resulting alcohol provided mesylates 274. Subsequent elimination followed by
desulfonation in the presence of excess tributyltin lithium in THF resulted in alcohol 277.
Swern oxidation of 277 completed the synthesis of key aldehyde 272.

Scheme 41. Synthesis of aldehyde 272.136

To complete the synthesis, the procedure reported by Du and co-workers was
used. Treatment of aldehyde 272 with (4-methoxybenzyl)magnesium bromide gave
alcohol 279, which upon exposure to phosphoryl chloride in pyridine led to (+)-bakuchiol
methyl ether 280. Conversion of 280 to (+)-bakuchiol was achieved with methyl
magnesium iodide at elevated temperatures.
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Scheme 42. Synthesis of (+)-bakuchiol from an aldehyde following the procedure by Du
and co-workers.157

5.2 Studies towards Synthesis of (+)-Quebrachamine
5.2.1 Isolation and Biological Activity of (+)-Quebrachamine
(+)-Quebrachamine is an aspidosperma alkaloid, isolated from Aspidosperma
quebracho tree back.158 The Aspidosperma quebracho tree, also known as white
quebracho is common in South American countries. In general, Aspidosperma quebracho
alkaloids (aspidospermine,159 yohimbine,160 quebrachamine,158 and akuammidine161) have
been reported to possess diverse pharmacological properties such as hypertensive,
spasmolytic, diuretic, peripheral vasoconstrictor, arterial hypertensive, respiratory
stimulant, uterine sedative, and local anesthetic.158, 162, 163
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Figure 11. Aspidosperma alkaloids isolated from the white quebracho.

5.2.2 Previous Syntheses of Quebrachamine
The molecular architecture of quebrachamine encompasses a synthetically
challenging nine-membered ring. This, alongside its attractive pharmacological potential
has attracted considerable and sustainable interest from researchers. The first total
synthesis for quebrachamine was reported in 1963 by Stork and co-workers.159 Since
then, there have been 20 other reported syntheses for quebrachamine. To date, the most
efficient synthesis for quebrachamine, elaborated by Bajtos and co-workers,164 was
achieved in 13 linear steps and 17.8% overall yield. The synthesis entailed forming the
indole core via a formal [3+2] dipolar cycloaddition between a functionalized nitrile and
donor-acceptor cyclopropane, and the synthetically challenging nine-membered ring was
prepared by an efficient chloroacetamide photocyclization (Scheme 43).
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Scheme 43. Total synthesis of (±)-quebrachamine via [3+2] cycloaddition and efficient
chloroacetamide photocyclization reported by Bajtos and co-workers.164

5.2.3 Application of Rhodium-Catalyzed Intramolecular C–H Insertion on
Diazosulfonates towards the Synthesis of (+)-Quebrachamine
Inspired by the findings on oxidative desulfonation of δ-sultones to γbutyrolactone using TBHP, it was envisioned that quebrachamine could be synthesized
starting from commercially available 1,4-butanediol by employing the retrosynthetic
disconnection shown on Scheme 44. Rhodium-catalyzed intramolecular C–H insertion
will be used to implant the quaternary chiral center in the structure, followed by
subsequent desulfonation to afford the key substituted γ-butyrolactone 227.
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Scheme 44. Retrosynthetic analysis for the synthesis of (+)-quebrachamine.

The synthesis began with the preparation of alcohol 289, which was completed in
five steps from commercially available 1,4-butanediol 288 (Scheme 45). Monoprotection of the diol using silver oxide and benzyl chloride, followed by Swern
oxidation of the resulting mono-protected alcohol led to aldehyde 292. The HornerWadworth-Emmons (HWE) reaction of 292 with triethyl phosphonoacetate provided α,βunsaturated ester 293. Conjugate 1,4-addition of ethylmagnesium bromide to 293
followed by LAH reduction completed the synthesis of alcohol 289.
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Scheme 45. Preparation of alcohol 289.

The coupling of alcohol 289 with ethyl (chlorosulfonyl)acetate in the presence of
ImH in THF afforded sulfonate ester 295, which was subjected to diazotransfer
conditions (nosyl azide, DIPEA, DMF, 0 oC). Rhodium-catalyzed intramolecular C–H
insertion of the obtained diazosulfonate 296 gave δ-sultone ester 223. Oxidative
desulfonation of 223 with TBHP/KHMDS resulted in the key substituted γ-butyrolactone
227, which we intent in the future to couple with commercially available tryptamine 290.
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Scheme 46. Preparation of substituted γ-butyrolactone 223.

5.3 Studies towards Synthesis of (-)-Mesembrine
5.3.1 Isolation and Biological Activity of (-)-Mesembrine
(-)-Mesembrine is the major alkaloid in Sceletium tortuosum, a groundcover plant
native to Southern Africa.165 Recent studies confirm that mesembrine is an effective
serotonin re-uptake inhibitor as well as a potent inhibitor of the enzyme
phosphodiesterase 4 (PDE4).166 Mesembrine permits the brain to function with reduced
levels of serotonin, allowing time for natural levels to build up.

Figure 12. Structure of (-)-mesembrine.
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5.3.2 Application of Rhodium-Catalyzed Intramolecular C–H Insertion on
Diazosulfonates towards the Synthesis of (-)-Mesembrine
The molecular structure of (-)-mesembrine and its attractive biological properties
have made it one of the most interesting molecules in organic synthesis. To date, there
are over 40 total and formal syntheses of this compound. Inspite of the numerous
syntheses of (-)-mesembrine, rhodium-catalysed intramolecular C–H insertion on
diazosulfonates appeared to be a promising strategy that could be explored to install the
quaternary chiral center in the structure, which upon desulfonation to a γ-butyrolactone
would be critical to the completion of the synthesis (Scheme 47).

Scheme 47. Retrosynthetic disconnection for (-)-mesembrine.
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The synthesis began with the preparation of alcohol 300, which was obtained
from commercially available 3,4-dimethoxybenzaldehyde 301 in three linear steps. HWE
reaction of 301 afforded α,β-unsaturated ester 302. Conjugate 1,4-addition of but-1enylmagnesium bromide to 302, followed by LAH reduction of the ester functionality
completed the preparation of 300.

Scheme 48. Preparation of alcohol 300.

Treatment of alcohol 300 with ethyl (chlorosulfonyl)acetate in the presence of
ImH in THF afforded sulfonate ester 304, which upon exposure to diazotransfer
condition (nosyl azide, DIPEA, DMF, 0 oC) led to diazosulfonate ester 305.
Unanticipatedly, several rhodium-catalyzed C–H insertion conditions proved futile and
the insertion is still under investigation.
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Scheme 49. Preparation of substituted δ-sultone 299.

5.4 Experimental Section on Application of Rhodium-Catalyzed Intramolecular C–H
Insertion on Diazo Sulfones and Sulfonates towards the Synthesis of Natural Products
All reactions were carried out under an inert nitrogen atmosphere unless otherwise stated.
All reagents were used as purchased without further purification unless otherwise stated.
1

H-NMR (500 Hz) and 13C{1H} NMR (125 Hz) spectra were recorded on an Avance 500

Bruker spectrometer and calibrated using residual undeuterated solvent as internal
references. Coupling constants are given in Hz. IR spectra were recorded on a PerkinElmer Spectrum 400 Series FTIR spectrometer. Specific rotations were measured on an
AUTOPOL III automatic polarimeter in anhydrous CHCl3 using a 10 cm cell. HRMS
data were obtained on an Agilent 61969A TOF high resolution mass spectrometer using
electrospray ionization (ESI). Melting points were determined on a MEL-TEMP melting
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point apparatus. Analytical TLC was performed using silica gel pre-coated TLC plates
(E. Merck no. 5715-7). Flash chromatography was performed using 40-63 μm silica gel
(Merck, Geduran, no. 11567-1) as the stationary phase. Tetrahydrofuran (THF) was dried
by distilling it from sodium and benzophenone in a continuous still under a nitrogen
atmosphere. Chloroform, dichloromethane and triethylamine were distilled from calcium
hydride under an atmosphere of nitrogen.

Preparation of 4-(benzyloxy)butan-1-ol 291
To a stirred solution of 1,4-butanediol (1 equiv.) in DCM was added freshly
prepared Ag2O (1.5 equiv.) and benzyl bromide (1.1equiv.). The reaction was stirred for
3 h and filtered through a silica gel pad. Evaporation of the solvent, followed by flash
chromatography afforded 291. Ag2O was prepared by stirring equimolar solutions of
AgNO3 and NaOH in water for 5 min. The resulting brown precipitate was filtered and
dried in for 20 min in an oven. The obtained solid was cooled to room temperature,
crushed to a fine powder and used as described.

Preparation of 4-(benzyloxy)butanal 292
DMSO (1.19 g, 15.2 mmol) was added dropwise to a solution of (COCl)2 (0.968
g, 7.60 mmol) in CH2Cl2 (20 mL) at -78 °C. After 15 min, a solution of alcohol 291
(0.688 g, 3.81 mmol) in CH2Cl2 (5 mL) was added dropwise to the reaction mixture at 78 °C. After an additional 45 min, Et3N (1.53 g, 15.2 mmol) was added dropwise to the
reaction mixture. After stirring for an additional 1 h, the reaction mixture was quenched
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with water, extracted with CH2Cl2, washed with brine, and dried with Na2SO4. The
solvent was removed under reduced pressure to afford crude 292. The crude product was
purified by flash chromatography on silica gel using 3% ethyl acetate in hexanes as an
eluent to afford 292 as colorless oil in 90% yield.

Preparation of (E)-ethyl 6-(benzyloxy)hex-2-enoate 293 and (E)-ethyl [3-(3,4dimethoxy)phenyl]acrylate 302
To a stirred solution of 292or 301 (1.04 g, 9.36 mmol) in DCM ( 20 mL, 2.5
mL/mmol) was added (carbethoxymethylene)triphenylphosphorane (3.54 g, 1.1 equiv)
and the combined reaction mixture further stirred vigorously at room temperature for 16
h. After, the reaction mixture was evaporated to afford a crude product, which was
purified by flash chromatography.

Procedure for preparation of but-1-enylmagnesium bromide
An oven dried 100 mL round bottom flask equipped with a magnetic stirring bar
and a septum was charged with LiCl (1.57 g, 37.0 mmol) and heated with a heat gun
under high vacuum for 30 min. Magnesium turning (1.80 g, 74.0 mmol) and THF were
added and the magnesium activated with DIBALH (70.0 µL, 0.400 mmol). After stirring
for 5 min, the suspension was cooled to -20 oC and 4-bromo-1-butene (4.00 g, 29.6mol)
added slowly, after which it was further stirred at -20 oC for 1h. The obtained solution
was used for subsequent steps without purification.
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Procedure for preparation of ethyl 6-benzyloxy-3-ethylhexanoate 294 and ethyl 3[(3,4-dimethoxy)phenyl]-6-heptenoate 303
A 50 mL round bottom flask was charged with LiCl (29 mg, 0.68 mmol), CuI (65
mg, 0.34 mmol) and THF (5.0 mL, 2.5 mL/mol), and stirred at rt for 10 min until a pale
yellow solution formed. The solution was cooled to 0 oC, 292 or 301 (850 mg, 3.41
mmol) was added followed by TMSCl (409 mg, 3.76 mmol) and the obtained mixture
further stirred for 15 min. A solution of EtMgBr (5.0 mL, 2.1 mmol) was added dropwise
until the color of the solution turned violet. After stirring for 3 h, the reaction misture was
poured onto 20 mL of saturated aqueous NH4Cl solution, extracted with ether and dried
over MgSO4. The solvent was removed under reduced pressure and the crude product
purified by flash chromatography.

Ethyl 6-benzyloxy-3-ethylhexanoate (294): Pale yellow oil. 1H NMR (CDCl3, 500
MHz): 7.3 (m, 5H), 4.40 (s, 2H), 4.02 (q, J = 7.2, 2H), 3.40 (t, J = 6.6, 2H), 2.17 (dd, J
= 7.0, 2.2, 1H), 1.78 (q, J = 6.6, 1H), 1.58 (q, J = 6.6, 1H), 1.22-1.40 (m, 4H), 1.19 (t, J =
7.2, 3H), 0.82 (t, J = 7.5, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 173.9 (C), 139.1 (C),
129.0 (CH), 128.0 (CH), 73.3 (CH2), 71.0 (CH2), 60.6 (CH2), 39.1 (CH2), 36.7 (CH), 30.3
(CH2), 27.3 (CH2), 26.6 (CH2), 14.8 (CH3), 11.1 (CH3).

Ethyl 3-[(3,4-dimethoxy)phenyl]-6-heptenoate (303): Pale yellow oil. 1H NMR
(CDCl3, 500 MHz): 6.76 (d, J = 8.1, 1H), 6.68 (ddd, J = 15.4, 8.1, 2.0, 2H), 5.68-5.76
(m, 1H), 4.88-4.93 (m, 2H), 4.00 (q, J = 7.0, 2H), 3.89 (s, 3H), 3.87(s, 3H), 3.01-3.06 (m,
1H), 2.54 (dddd, J = 14.8, 7.8, 7.2, 7.0, 2H), 1.86-1.90 (m, 2H), 1.62-1.74 (m, 2H), 1.11
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(t, J = 7.0, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 172.6 (C), 149.2 (CH), 147.9 (C),
138.5 (CH), 136.6 (C), 119.7 (CH), 115.1 (CH2), 111.5 (CH3), 111.2 (CH3), 60.5 (CH2),
56.2 (CH), 42.3 (CH2), 41.6 (CH), 35.7 (CH2), 31.8 (CH2), 14.5 (CH3).

Procedure for preparation of 6-benzyloxy-3-ethyl-1-hexanol 289 and 3-[(3,4dimethoxy)phenyl]-hept-6-en-1-ol 300
A 50 mL round bottom flask charged with 294 or 303 (608 mg, 2.18 mmol) was
stirred at 0 oC for 5 min followed by the addition of LAH (112 mg, 2.60 mmol). After
stirring for 4 h, the reaction mixture was cooled to 0 oC and Na2SO4.10H20 (5 g) added to
it. The resulting suspension was further stirred for 15 min, after which it was filtered and
the residue washed several times with hot EtOAc. The combined organic extract was
evaporated under reduced pressure to afford a crude product which was purified by flash
chromatography.

6-Benzyloxy-3-ethyl-1-hexanol (289): Pale yellow oil. 1H NMR (CDCl3, 500 MHz):
7.4 (m, 5H), 4.53 (s, 2H), 3.68-3.72 (m, 2H), 3.50 (t, J = 6.6, 2H), 1.60-1.70 (m, 2H),
1.58 (q, J = 6.6, 2H), 1.28-1.48 (m, 6H), 0.84 (t, J = 7.5, 3H). 13C{1H} NMR (CDCl3, 125
MHz): δ 139.1 (C), 129.0 (C), 128.1 (CH), 127.9 (CH), 73.4 (CH2), 71.3 (CH2), 61.8
(CH2), 36.9 (CH2), 36.0 (CH), 30.1 (CH2), 27.3 (CH2), 26.4 (CH2), 11.1 (CH3).

3-[(3,4-Dimethoxy)phenyl]-hept-6-en-1-ol (300): Pale yellow oil. 1H NMR (CDCl3, 500
MHz): 6.79 (d, J = 8.1, 1H), 6.69 (ddd, J = 16, 7.8, 1.8, 2H), 5.73-5.78 (m, 1H), 4.91132

4.95 (m, 2H), 3.88 (s, 3H), 3.86 (s, 3H), 3.44-3.54 (m, 2H), 2.66 (m, 1H), 1.62-1.80 (m,
3H), 1.90-1.93 (m, 3H), 1.42 (s, 1H). 13C{1H} NMR (CDCl3, 125 MHz): δ 149.3 (CH),
147.8 (C), 139.0 (CH), 137.7 (C), 120.0 (CH), 114.9 (CH2), 111.6 (CH3), 111.0 (CH3),
61.5 (CH2), 56.2 (CH), 41.9 (CH2), 40.0 (CH), 36.5 (CH2), 32.0 (CH2).

Preparation of ethyl [(6-benzyloxy-3-ethyl)hexyloxysulfonyl]acetate 295 and ethyl
[3-(3,4-dimethoxy)phenyl-6-heptenyloxysulfonyl]acetate 304
The necessary sulfonate esters were prepared following the procedure reported by
Wolckenhauer and co-workers.123

Ethyl [(6-benzyloxy-3-ethyl)hexyloxysulfonyl]acetate (295): Pale yellow oil. 1H NMR
(CDCl3, 500 MHz): 7.50 (m, 5H), 4.52 (s, 2H), 4.49 (t, J = 7.0, 2H), 4.40 (q, J = 7.0,
2H), 4.15 (s, 2H), 3.47 (t, J = 6.6, 2H), 1.74 (q, J = 7.0, 2H), 1.61 (q, J = 6.6, 2H), 1.48
(q, J = 6.3, 2H), 1.45-1.51 (m, 6H), 1.32-1.41 (m, 3H; overlapped with triplet), 1.31 (t, J
= 7, 3), 0.88 (t, J = 7). 13C{1H} NMR (CDCl3, 125 MHz): δ 162.4 (C), 139.4 (C), 129.0
(C), 128.1 (CH), 127.9 (CH), 73.4 (CH2), 71.3 (CH2), 70.9 (CH2), 63.2 (CH2), 55.5
(CH2), 36.0 (CH2), 33.2 (CH), 29.7 (CH2), 27.3 (CH2), 25.9 (CH2), 14.4 (CH3), 11.1
(CH3).

Ethyl [3-(3,4-dimethoxy)phenyl-6-heptenyloxysulfonyl]acetate (304): Pale yellow oil.
1

H NMR (CDCl3, 500 MHz): 6.80 (d, J = 8.1, 1H), 6.68 (ddd, J = 13, 8.1, 2.2, 2H),

5.72-5.78 (m, 1H), 4.94-4.96 (m, 2H), 4.26 (q, J = 7.2, 1H), 4.25 (ddd, J = 14, 8.5, 6.3,
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1H), 4.00 (s, 2H), 3.91 (s, 3H), 3.88 (s, 3H), 2.68 (n, J = 5), 2H), 2.13-2.14 (m, 1H), 1.891.95 (m, 3H), 1.63-1.73 (m, 2H), 1.29 (t, J = 7.2, 3H). 13C{1H} NMR (CDCl3, 125 MHz):
δ 162.3 (C), 149.5 (CH), 148.1 (C), 138.6 (CH), 136.0 (C), 119.9 (CH), 115.2 (CH2),
111.8 (CH3), 111.2 (CH3), 71.1 (CH2), 63.0 (CH2), 56.2 (CH), 55.1 (CH2), 41.2 (CH2),
36.5 (CH2), 36.3 (CH2), 31.8 (CH2), 14.3 (CH3).

Procedure for preparation of ethyl [(6-benzyloxy-3ethyl)hexyloxysulfonyl]diazoacetate 296 and ethyl [3-(3,4-dimethoxy)phenyl-6heptenyloxysulfonyl]diazoacetate 305
To a solution of sulfonate 295 or 304 in DMF (2.5 mL/mmol) at 0 oC was added
nosyl azide (1.1 equiv.) followed by DIPEA (2 equiv.). The temperature was maintained
at 0 oC and the reaction mixture stirred for 7 h after which the reaction was complete as
indicated by TLC analysis. The reaction mixture was then taken up in EtOAc, washed
thrice with brine. The organic phase was dried over Na2SO4 and evaporated to give a
crude product which was purified by flash chromatography.

Ethyl [(6-benzyloxy-3-ethyl)hexyloxysulfonyl]diazoacetate (296): Pale yellow oil. 1H
NMR (CDCl3, 500 MHz): 7.30 (m, 5H), 4.44 (s, 2H), 4.32 (t, J = 7.0, 2H), 4.25 (q, J =
7.0, 2H), 3.40 (t, J = 6.6, 2H), 1.66 (q, J = 7, 2H), 1.53 (q, J = 6.6, 2H), 1.40 (q, J = 6.3,
2H), 1.20-1.32 (m, 7H; overlapped with triplet), 0.80 (t, J = 7). 13C{1H} NMR (CDCl3,
125 MHz): δ 160.0 (C), 139.1 (C), 129.0 (C), 128.1 (CH), 73.4 (CH2), 72.7 (CH2), 71.2
(CH2), 63.2 (CH2), 35.8 (CH2), 32.9 (CH), 29.7 (CH2), 27.3 (CH2), 25.9 (CH2), 14.9
(CH3), 11.1 (CH3).
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Ethyl [3-(3,4-dimethoxy)phenyl-6-heptenyloxysulfonyl]diazoacetate (305): Pale
yellow oil. 1H NMR (CDCl3, 500 MHz): 6.81 (d, J = 8.1, 1H), 6.70 (ddd, J = 13, 8.1,
1.8, 2H), 5.73-5.78 (m, 1H), 4.93-4.97 (m, 2H), 4.32 (q, J = 7.2), 4.25 (ddd, J = 15, 8.8,
5.6), 3.91 (s, 3H), 3.87 (s, 3H), 2.70 (n, J = 5.0), 2H), 2.12-2.17 (m, 1H), 1.88-1.94 (m,
3H), 1.66-1.74 (m, 2H), 1.30 (t, J = 7.2), 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 159.7
(C), 149.5 (CH), 148.1 (C), 138.6 (CH), 135.9 (C), 119.9 (CH), 115.2 (CH2), 111.7
(CH3), 111.1 (CH3), 72.1 (CH2), 63.0 (CH2), 56.3 (CH), 56.2 (CH), 55.1 (CH2), 41.2
(CH2), 36.3 (CH2), 31.8 (CH2), 14.6 (CH3).

Preparation of 3-carbethoxy-4-(3-benzyloxy)propyl-4-ethyl-1,2-oxathiane-2,2dioxide 223
To a suspension of Rh2esp2 catalyst (1 mol%) in CH2Cl2 (4 mL/mmol), a solution
of 296 (1 equiv.) in CH2Cl2 (2 mL/mmol) was added at rt over a period of 1 h using a
syringe pump. Upon completion of the addition, the reaction mixture was stirred at rt for
additional 8 h. All volatiles were removed under reduced pressure. The crude reaction
mixture was separated on silica column (ethyl acetate–hexanes, 30%).

3-Carbethoxy-4-(3-benzyloxy)propyl-4-ethyl-1,2-oxathiane-2,2-dioxide (223): Pale
yellow oil. 1H NMR (CDCl3, 500 MHz): 7.30-7.40 (m, 5H), 4.64-4.67 (m, 2H), 4.494.55 (m, 2H), 4.52 (s, 2H; overlapped with multiplet), 4.48 (s, 2H), 3.93 (d, J = 4.7, 2H),
3.41 (t, J = 6.6, 2H), 3.43-3.58 (m, 2H), 3.28-3.42 (m, 2H), 1.88-1.20 (q, J = 6.6, 2H),
1.40-1.64 (q, J = 6.3, 2H), 1.22-1.38 (m, 7H; overlapped with triplet), 0.84-0.94 (t, J =
7.0, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 160.0 (C), 139.1 (C), 129.0 (C), 128.1
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(CH), 73.4 (CH2), 72.7 (CH2), 71.2 (CH2), 63.2 (CH2), 35.8 (CH2), 32.9 (CH), 29.7
(CH2), 27.3 (CH2), 25.9 (CH2), 14.9 (CH3), 11.1 (CH3).
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APENDIX I: LIST OF ABBREVIATIONS AND ACRONYMS
1,2-DCE

1,2-dichloroethane

acam

acetamide

Ac

acetate

B3LYP

Becke, 3-parameter, Lee-Yang-Parr

BARF

tetra-aryl borate

Bn

benzyl

Bu

butyl

cap

caprolactam

DBU

1,8-diazabicyclo[5.4.0]undec-7-ene

DCC

N,N'-dicyclohexylcarbodiimide

DCM

dichloromethane

DEPT

distortionless enhancement by polarization transfer

DIBAL-H

diisobutylaluminum hydride

DIPEA

N,N-diisopropylethylamine

DMAP

dimethylaminopyridine

DMPU

N,N'-dimethylpropyleneurea

DMF

N,N-dimethylformamide

DMSO

dimethyl sulfoxide

DOSP

N-(p-dodecylphenylsulfonyl)prolinate

DPT

diisopropyltartrate

EDG

electron-donating group

EWG

electron-withdrawing group

er

enantiomeric ratio
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Et

ethyl

esp

α, α, ά, ά-tetramethyl-1,3-benzenedipropionate

FDA

food and drug administration

HMPA

hexamethylphosphoramide

HRMS

high resolution mass spectrometry

HWE

Horner-Wadsworth-Emmons

Hz

hertz

ImH

imidazole

HMDS

hexamethyldisilazane

LAH

lithium aluminum hydride

LDA

lithium diisopropylamide

MABR

methylaluminum bis[4-bromo-2,6-di(tert-butyl)phenoxide]

m-CPBA

meta-chloroperoxybenzoic acid

MEPY

methyl 2-pyrrolidone-5-carboxylate

MEOX

methyl 2-oxazolidone-4-carboxylate

MPPIM

methyl (3-phenylpropanoyl) imidazolidin-2-one-4
carboxylate

Ms

mesyl

NMR

nuclear magnetic resonance

NOE

nuclear overhauser effect

Nos

nosyl

nta

N-naphthaloyl alanate

ntpa

N-naphthaloyl phenylalanate

nttl

N-naphthaloyl tert-butylalanate

oct

octaoate

139

OTF

trifluoromethanesulfonate

pfb

perfluorobutyrate

ptad

N-phthaloyl adamantyl leucinate

ptpa

N-phthaloyl phenyl leucinate

pttl

N-phthaloyl-tert-leucinate

Py

pyridine

rt

room temperature

SN1

unimolecular nucleophilic substitution

SN2

bimolecular nucleophilic substitution

TBHP

tert-butyl hydroxyperoxide

TBDPS

tert-butyldiphenylsilyl

TBDPS

tert-butyldiphenylsilyl

TBS

tert-butyldimethylsilyl

TEA

triethylamine

tfa

trifluoroacetate

THF

tetrahydrofuran

TIPS

triisopropylsilyl

TLC

thin layer chromatography

TMS

tetramethylsilane

TMS

trimethylsilyl

tpa

triphenyl acetate

TPAP

tetrapropylammonium perruthenate

Tol

tolyl

Ts

p-toluenesulfonyl

TS

transition state
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APENDIX II: SELECTED SPECTRA, FIGURES 13–150

Figure 13. 1H NMR (500 MHz) spectrum of ethyl (propylsulfonyl)acetate (155.1) in
CDCl3.
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Figure 14. 13C{1H} NMR (125 MHz) spectrum of ethyl (propylsulfonyl)acetate (155.1) in
CDCl3.
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Figure 15. 1H NMR (500 MHz) spectrum of ethyl (2-methylpropylsulfonyl)acetate
(156.1) in CDCl3.
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Figure 16. 13C{1H} NMR (125 MHz) spectrum of ethyl (2-methylpropylsulfonyl)acetate
(156.1) in CDCl3.
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Figure 17. DEPT 135 NMR (125 MHz) spectrum of ethyl (2methylpropylsulfonyl)acetate (156.1) in CDCl3.
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Figure 18. 1H NMR (500 MHz) spectrum of ethyl (3-methylbutylsulfonyl)acetate (160.1)
in CDCl3.
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Figure 19. 13C{1H} NMR (125 MHz) spectrum of ethyl (3-methylbutylsulfonyl)acetate
(160.1) in CDCl3.
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Figure 20. 1H NMR (500 MHz) spectrum of ethyl (propylsulfonyl)diazoacetate (158.2) in
CDCl3.
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Figure 21. 13C{1H} NMR (125 MHz) spectrum of ethyl (propylsulfonyl)diazoacetate
(158.2) in CDCl3.
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Figure 22. DEPT 135 NMR (125 MHz) spectrum of ethyl (propylsulfonyl)diazoacetate
(158.2) in CDCl3.
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Figure 23. 1H NMR (500 MHz) spectrum of ethyl (2-methylpropylsulfonyl)diazoacetate
(159.2) in CDCl3.
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Figure 24. 13C{1H} NMR (125 MHz) spectrum of ethyl (2methylpropylsulfonyl)diazoacetate (159.2) in CDCl3.
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Figure 25. DEPT 135 NMR (125 MHz) spectrum of ethyl (2methylpropylsulfonyl)diazoacetate (159.2) in CDCl3.
153

Figure 26. 1H NMR (500 MHz) spectrum of ethyl (3-methylbutylsulfonyl)diazoacetate
(160.2) in CDCl3.
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Figure 27. 13C{1H} NMR (500 MHz) spectrum of ethyl (3methylbutylsulfonyl)diazoacetate (160.2) in CDCl3.
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Figure 28. DEPT 135 NMR (500 MHz) spectrum of ethyl (3methylbutylsulfonyl)diazoacetate (160.2) in CDCl3.
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Figure 29. 1H NMR (500 MHz) spectrum of ethyl (2-methyl-2-propenylsulfonyl)acetate
(161) in CDCl3.
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Figure 30. 13C{1H} NMR (125 MHz) spectrum of ethyl (2-methyl-2propenylsulfonyl)acetate (161) in CDCl3.
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Figure 31. DEPT 135 NMR (125 MHz) spectrum of ethyl (2-methyl-2propenylsulfonyl)acetate (161) in CDCl3.
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Figure 32. 1H NMR (500 MHz) spectrum of ethyl (3,3-dimethylthiotane-1,1-dioxide-2carboxylate (159.2.2) in CDCl3.
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Figure 33. 13C{1H} NMR (125 MHz) spectrum of ethyl (3,3-dimethylthiotane-1,1dioxide-2-carboxylate (159.2.2) in CDCl3.
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Figure 34. DEPT 135 NMR (125 MHz) spectrum of ethyl 3,3-dimethylthiotane-1,1dioxide-2-carboxylate (159.2.2) in CDCl3.
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Figure 35. 1H NMR (500 MHz) spectrum of ethyl tetrahydro-2-ethyl-3,3dimethylthiophene-1,1-dioxide-2-carboxylate (160.2.2) in CDCl3.
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Figure 36. 13C{1H} NMR (500 MHz) spectrum of ethyl tetrahydro-2-ethyl-3,3dimethylthiophene-1,1-dioxide-2-carboxylate (160.2.2) in CDCl3.
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Figure 37. DEPT 135 NMR (500 MHz) spectrum of ethyl tetrahydro-2-ethyl-3,3dimethylthiophene-1,1-dioxide-2-carboxylate (160.2.2) in CDCl3.
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Figure 38. 1H NMR (500 MHz) spectrum of (pentylsulfonyl)acetic acid (182) in CDCl3.
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Figure 39. 13C{1H} NMR spectrum of (pentylsulfonyl)acetic acid (182) in CDCl3.
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Figure 40. DEPT-135 NMR spectrum of (pentylsulfonyl)acetic acid (182) in CDCl3.
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Figure 41. 1H NMR (500 MHz) spectrum of methyl (pentylsulfonyl)acetate (183) in
CDCl3.
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Figure 42. 13C{1H} NMR (125 MHz) spectrum of methyl (pentylsulfonyl)acetate (183) in
CDCl3.
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Figure 43. DEPT 135 NMR (125 MHz) spectrum of methyl (pentylsulfonyl)acetate (183)
in CDCl3.
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Figure 44. 1H NMR (500 MHz) spectrum of isopropyl (pentylsulfonyl)acetate (184) in
CDCl3.
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Figure 45. 13C{1H} NMR (125MHz) spectrum of isopropyl (pentylsulfonyl)acetate (184)
in CDCl3.

173

Figure 46. DEPT 135 NMR (125MHz) spectrum of isopropyl (pentylsulfonyl)acetate
(184) in CDCl3.
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Figure 47. 1H NMR (500 MHz) spectrum of t-butyl (pentylsulfonyl)acetate (185) in
CDCl3.
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Figure 48. 13C{1H} NMR (125 MHz) spectrum of t-butyl (pentylsulfonyl)acetate (185) in
CDCl3.
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Figure 49. DEPT 135 NMR (125 MHz) spectrum of t-butyl (pentylsulfonyl)acetate (185)
in CDCl3.
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Figure 50. 1H NMR (500 MHz) spectrum of (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl
(pentylsulfonyl)acetate (187) in CDCl3.
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Figure 51. 13C{1H} NMR (500 MHz) spectrum of (1R,2S,5R)-2-isopropyl-5methylcyclohexyl (pentylsulfonyl)acetate (187) in CDCl3.
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Figure 52. DEPT 135 NMR (500 MHz) spectrum of (1R,2S,5R)-2-Isopropyl-5methylcyclohexyl (pentylsulfonyl)acetate (187) in CDCl3.
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Figure 53. 1H NMR (500 MHz) spectrum of 2,4-dimethyl-3-pentyl
(pentylsulfonyl)acetate (188) in CDCl3.

181

Figure 54. 13C{1H} NMR (125 MHz) spectrum of 2,4-dimethyl-3-pentyl
(pentylsulfonyl)acetate (188) in CDCl3.
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Figure 55. DEPT 135 NMR (125 MHz) spectrum of 2,4-dimethyl-3-pentyl
(pentylsulfonyl)acetate (188) in CDCl3.
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Figure 56. 1H NMR (500 MHz) spectrum of methyl (pentylsulfonyl)diazoacetate (189) in
CDCl3.

184

Figure 57. 13C{1H} NMR (125 MHz) spectrum of methyl (pentylsulfonyl)diazoacetate
(189) in CDCl3.
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Figure 58. DEPT 135 NMR (125 MHz) spectrum of methyl (pentylsulfonyl)diazoacetate
(189) in CDCl3.
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Figure 59. 1H NMR (500 MHz) spectrum of isopropyl (pentylsulfonyl)diazoacetate (190)
in CDCl3.
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Figure 60. 13C{1H} NMR (125 MHz) spectrum of isopropyl (pentylsulfonyl)diazoacetate
(190) in CDCl3.
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Figure 61. DEPT 135 NMR (125 MHz) spectrum of isopropyl
(pentylsulfonyl)diazoacetate (190) in CDCl3.
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Figure 62. 1H NMR (500 MHz) spectrum of t-butyl (pentylsulfonyl)diazoacetate (191) in
CDCl3.
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Figure 63. 13C{1H} NMR (125 MHz) spectrum of t-butyl (pentylsulfonyl)diazoacetate
(191) in CDCl3.
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Figure 64. DEPT 135 NMR (125 MHz) spectrum of t-butyl (pentylsulfonyl)diazoacetate
(191) in CDCl3.
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Figure 65. 1H NMR (500 MHz) spectrum of (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl
(pentylsulfonyl)diazoacetate (193) in CDCl3.
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Figure 66. 13C{1H} NMR (500 MHz) spectrum of (1R,2S,5R)-2-isopropyl-5methylcyclohexyl (pentylsulfonyl)diazoacetate (193) in CDCl3.
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Figure 67. DEPT 135 NMR (500 MHz) spectrum of (1R,2S,5R)-2-isopropyl-5methylcyclohexyl (pentylsulfonyl)diazoacetate (193) in CDCl3.
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Figure 68. 1H NMR (500 MHz) spectrum of 2,4-dimethyl-3-pentyl
(pentylsulfonyl)diazoacetate (194) in CDCl3.
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Figure 69. 13C{1H} NMR (500 MHz) spectrum of 2,4-dimethyl-3-pentyl
(pentylsulfonyl)diazoacetate (194) in CDCl3.
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Figure 70. DEPT 135 NMR (500 MHz) spectrum of 2,4-dimethyl-3-pentyl
(pentylsulfonyl)diazoacetate (194) in CDCl3.
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Figure 71. 1H NMR (500 MHz) spectrum of trans-methyl 3-methyltetrahydro-2Hthiopyran-1,1-dioxide-2-carboxylate (195) in CDCl3.
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Figure 72. 13C{1H} NMR (125 MHz) spectrum of trans-methyl 3-methyltetrahydro-2Hthiopyran-1,1-dioxide-2-carboxylate (195) in CDCl3.
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Figure 73. DEPT 135 NMR (125 MHz) spectrum of trans-methyl 3-methyltetrahydro2H-thiopyran-1,1-dioxide-2-carboxylate (195) in CDCl3.
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Figure 74. 1H NMR (500 MHz) spectrum of trans-isopropyl 3-methyltetrahydro-2Hthiopyran-1,1-dioxide-2-carboxylate (196) in CDCl3.
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Figure 75. 13C{1H} NMR (125MHz) spectrum of trans-isopropyl 3-methyltetrahydro-2Hthiopyran-1,1-dioxide-2-carboxylate (196) in CDCl3.
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Figure 76. DEPT 135 NMR (125MHz) spectrum of trans-isopropyl 3-methyltetrahydro2H-thiopyran-1,1-dioxide-2-carboxylate (196) in CDCl3.
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Figure 77. 1H NMR (500 MHz) spectrum of trans-t-butyl 3-methyltetrahydro-2Hthiopyran-1,1-dioxide-2-carboxylate (197) in CDCl3.
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Figure 78. 13C{1H} NMR (125 MHz) spectrum of trans-t-butyl 3-methyltetrahydro-2Hthiopyran-1,1-dioxide-2-carboxylate (197) in CDCl3.
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Figure 79. DEPT 135 NMR (125 MHz) spectrum of trans-t-butyl 3-methyltetrahydro2H-thiopyran-1,1-dioxide-2-carboxylate (197) in CDCl3.
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Figure 80. 1H NMR (500 MHz) spectrum of (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl
(2R,3R) 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (199) in CDCl3
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Figure 81. 13C{1H} NMR (125 MHz) spectrum of (1R,2S,5R)-2-isopropyl-5methylcyclohexyl (2R,3R) 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate
(199) in CDCl3.
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Figure 82. DEPT 135 NMR (125 MHz) spectrum of (1R,2S,5R)-2-isopropyl-5methylcyclohexyl (2R,3R) 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate
(199) in CDCl3.
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Figure 83. 1H NMR (500 MHz) spectrum of trans-2,4-dimethyl-3-pentyl 3methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (200) in CDCl3.
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Figure 84. 13C{1H} NMR (125 MHz) spectrum of trans-2,4-dimethyl-3-pentyl 3methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (200) in CDCl3.
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Figure 85. DEPT 135 NMR (125 MHz) spectrum of trans-2,4-dimethyl-3-pentyl 3methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (200) in CDCl3.
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Figure 86. 1H NMR (500 MHz) spectrum of (R)-1,4-bis(4-toluenesulfonyloxy)pentane
(202) in CDCl3.
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Figure 87. 13C{1H} NMR (125 MHz) spectrum of (R)-1,4-bis(4toluenesulfonyloxy)pentane (202) in CDCl3.
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Figure 88. DEPT 135 NMR (125 MHz) spectrum of (R)-1,4-bis(4toluenesulfonyloxy)pentane (202) in CDCl3.
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Figure 89. 1H NMR (500 MHz) spectrum of (R)-ethyl [4-(4toluenesulfonyloxy)pentylsulfonyl]acetate (203) in CDCl3.
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Figure 90. 13C{1H} NMR (125 MHz) spectrum of (R)-ethyl [4-(4toluenesulfonyloxy)pentylsulfonyl]acetate (203) in CDCl3.
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Figure 91. DEPT 135 NMR (125 MHz) spectrum of (R)-ethyl [4-(4toluenesulfonyloxy)pentylsulfonyl]acetate (203) in CDCl3.
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Figure 92. 1H NMR (500 MHz) spectrum of 7,8,8-trimethyl-4oxatricyclo[4.2.1.03,7]nonan-5-one (225) in CDCl3.
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Figure 93. 13C{1H} NMR (125 MHz) spectrum of 7,8,8-trimethyl-4oxatricyclo[4.2.1.03,7]nonan-5-one (225) in CDCl3.
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Figure 94. DEPT-135 NMR (125 MHz) spectrum of 7,8,8-trimethyl-4oxatricyclo[4.2.1.03,7]nonan-5-one (225) in CDCl3
222

Figure 95. 1H NMR (500 MHz) spectrum of 3-methyl-3-(4-methyl-3pentenyl)dihydrofuran-2-one (226) in CDCl3.
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Figure 96. 13C{1H} NMR (125 MHz) spectrum of 3-methyl-3-(4-methyl-3pentenyl)dihydrofuran-2-one (226) in CDCl3.
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Figure 97. 1H NMR (500 MHz) spectrum of 3-(3-benzyloxypropyl)-3-ethyldihydrofuran2-one (227) in CDCl3.
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Figure 98. 13C{1H} NMR (125 MHz) spectrum of 3-(3-benzyloxypropyl)-3ethyldihydrofuran-2-one (227) in CDCl3.
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Figure 99. DEPT 135 NMR (125 MHz) spectrum of 3-(3-benzyloxypropyl)-3ethyldihydrofuran-2-one (227) in CDCl3.
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Figure 100. 1H NMR (500 MHz) spectrum of 2-azido-2-carbethoxy-3,3-dimethylthiane1,1-dioxide (239) in CDCl3.
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Figure 101. 13C{1H} NMR (125 MHz) spectrum of 2-azido-2-carbethoxy-3,3dimethylthiane-1,1-dioxide (239) in CDCl3.
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Figure 102. DEPT 135 NMR (125 MHz) spectrum of 2-azido-2-carbethoxy-3,3dimethylthiane-1,1-dioxide (239) in CDCl3.
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Figure 103. 1H NMR (500 MHz) spectrum of 2-chloro-2-carbethoxy-3,3-dimethylthiane1,1-dioxide (240) in CDCl3.
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Figure 104. 13C{1H} NMR (125 MHz) spectrum of 2-chloro-2-carbethoxy-3,3dimethylthiane-1,1-dioxide (240) in CDCl3.
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Figure 105. DEPT 135 NMR (125 MHz) spectrum of 2-chloro-2-carbethoxy-3,3dimethylthiane-1,1-dioxide (240) in CDCl3.
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Figure 106. 1H NMR (500 MHz) spectrum of 2-(4-chlorobenzyl)-2-carbethoxy-3,3dimethylthiane-1,1-dioxide (241) in CDCl3.
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Figure 107. 13C{1H} NMR (125 MHz) spectrum of 2-(4-chlorobenzyl)-2-carbethoxy-3,3dimethylthiane-1,1-dioxide (241) in CDCl3.
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Figure 108. DEPT 135 NMR (125 MHz) spectrum of 2-(4-chlorobenzyl)-2-carbethoxy3,3-dimethylthiane-1,1-dioxide (241) in CDCl3.
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Figure 109. 1H NMR (500 MHz) spectrum of 2-methyl-2-carbethoxy-3,3-dimethylthiane1,1-dioxide (242) in CDCl3.
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Figure 110. 13C{1H} NMR (125 MHz) spectrum of 2-methyl-2-carbethoxy-3,3dimethylthiane-1,1-dioxide (242) in CDCl3.
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Figure 111. DEPT 135 NMR (125 MHz) spectrum of 2-methyl-2-carbethoxy-3,3dimethylthiane-1,1-dioxide (242) in CDCl3.

239

Figure 112. 1H NMR (500 MHz) spectrum of 2-hydroxyimino-3-methylthiane-1,1dioxide (254) in CDCl3.
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Figure 113. 13C{1H} NMR (125 MHz) spectrum of 2-hydroxyimino-3-methylthiane-1,1dioxide (254) in CDCl3.
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Figure 114. DEPT 135 NMR (125 MHz) spectrum of 2-hydroxyimino-3-methylthiane1,1-dioxide (254) in CDCl3.
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Figure 115. 1H NMR (500 MHz) spectrum of 2-hydroxyiminothiane-1,1- dioxide (255) in
CDCl3.
243

Figure 116. 13C{1H} NMR (500 MHz) spectrum of 2-hydroxyiminothiane-1,1- dioxide
(255) in CDCl3.
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Figure 117. DEPT 135 NMR (500 MHz) spectrum of 2-hydroxyiminothiane-1,1- dioxide
(255) in CDCl3.
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Figure 118. 1H NMR (500 MHz) spectrum of 2-hydroxyimino-3-ethylthiane-1,1-dioxide
(256) in CDCl3.
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Figure 119. 13C{1H} NMR (125 MHz) spectrum of 2-hydroxyimino-3-ethylthiane-1,1dioxide (256) in CDCl3.
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Figure 120. DEPT 135 NMR (125 MHz) spectrum of 2-hydroxyimino-3-ethylthiane-1,1dioxide (256) in CDCl3.
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Figure 121. 1H NMR (500 MHz) spectrum of 2-hydroxyimino-3-butylthiane-1,1-dioxide
(257) in CDCl3.
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Figure 122. 13C{1H} NMR (125 MHz) spectrum of 2-hydroxyimino-3-butylthiane-1,1dioxide (257) in CDCl3.
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Figure 123. DEPT 135 NMR (125 MHz) spectrum of 2-hydroxyimino-3-butylthiane-1,1dioxide (257) in CDCl3.
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Figure 124. 1H NMR (500 MHz) spectrum of ethyl 6-benzyloxy-3-ethylhexanoate (294)
in CDCl3.
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Figure 125. 13C{1H} NMR (125 MHz) spectrum of ethyl 6-benzyloxy-3-ethylhexanoate
(294) in CDCl3.
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Figure 126. DEPT 135 NMR (125 MHz) spectrum of ethyl 6-benzyloxy-3ethylhexanoate (294) in CDCl3.
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Figure 127. 1H NMR (500 MHz) spectrum of 6-benzyloxy-3-ethyl-1-hexanol (289) in
CDCl3.
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Figure 128. 13C{1H} NMR (500 MHz) spectrum of 6-benzyloxy-3-ethyl-1-hexanol (589)
in CDCl3.
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Figure 129. DEPT 135 NMR (500 MHz) spectrum of 6-benzyloxy-3-ethyl-1-hexanol
(289) in CDCl3.
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Figure 130. 1H NMR (500 MHz) spectrum of ethyl [(6-benzyloxy-3ethyl)hexyloxysulfonyl]acetate (295) in CDCl3.
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Figure 131. 13C{1H} NMR (125 MHz) spectrum of ethyl [(6-benzyloxy-3ethyl)hexyloxysulfonyl]acetate (295) in CDCl3.
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Figure 132. DEPT 135 NMR (125 MHz) spectrum of ethyl [(6-benzyloxy-3ethyl)hexyloxysulfonyl]acetate (295) in CDCl3.
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Figure 133. 1H NMR (500 MHz) spectrum of ethyl [(6-benzyloxy-3ethyl)hexyloxysulfonyl]diazoacetate (296) in CDCl3.
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Figure 134. 13C{1H} NMR (125 MHz) spectrum of ethyl [(6-benzyloxy-3ethyl)hexyloxysulfonyl]diazoacetate (296) in CDCl3.
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Figure 135. DEPT 135 NMR (125 MHz) spectrum of ethyl [(6-benzyloxy-3ethyl)hexyloxysulfonyl]diazoacetate (296) in CDCl3.
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Figure 136. 1H NMR (500 MHz) spectrum of 3-carbethoxy-4-(3-benzyloxy)propyl-4ethyl-1,2- oxathiane-2,2-dioxide (223) in CDCl3.
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Figure 137. 13C{1H} NMR (500 MHz) spectrum of 3-carbethoxy-4-(3-benzyloxy)propyl4-ethyl-1,2- oxathiane-2,2-dioxide (223) in CDCl3.
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Figure 138. DEPT 135 NMR (500 MHz) spectrum of 3-carbethoxy-4-(3benzyloxy)propyl-4-ethyl-1,2- oxathiane-2,2-dioxide (223) in CDCl3.
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Figure 139. 1H NMR (500 MHz) spectrum of ethyl 3-(3,4-dimethoxy)phenyl-6heptenoate (303) in CDCl3.
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Figure 140. 13C{1H} NMR (125 MHz) spectrum of ethyl 3-(3,4-dimethoxy)phenyl-6heptenoate (303) in CDCl3.
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Figure 141. DEPT 135 NMR (125 MHz) spectrum of ethyl 3-(3,4-dimethoxy)phenyl-6heptenoate (303) in CDCl3.

269

Figure 142. 1H NMR (500 MHz) spectrum of 3-(3,4-dimethoxy)phenyl-hept-6-en-1-ol
(300) in CDCl3.
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Figure 143. 13C{1H} NMR (125 MHz) spectrum of 3-(3,4-dimethoxy)phenylhept-6-en-1ol (300) in CDCl3.
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Figure 144. DEPT 135 NMR (125 MHz) spectrum of 3-(3,4-dimethoxy)phenylhept-6-en1-ol (300) in CDCl3.

272

Figure 145. 1H NMR (500 MHz) spectrum of ethyl [3-(3,4-dimethoxy)phenyl-6heptenyloxysulfonyl]acetate (304) in CDCl3.

273

Figure 146. 13C{1H} NMR (125 MHz) spectrum of ethyl [3-(3,4-dimethoxy)phenyl-6heptenyloxysulfonyl]acetate (304) in CDCl3.
274

Figure 147. DEPT 135 NMR (125 MHz) spectrum of ethyl [3-(3,4-dimethoxy)phenyl-6heptenyloxysulfonyl]acetate (304) in CDCl3.

275

Figure 148. 1H NMR (500 MHz) spectrum of ethyl [3-(3,4-dimethoxy)phenyl-6heptenyloxysulfonyl]diazoacetate (305) in CDCl3.

276

Figure 149. 13C{1H} NMR (125 MHz) spectrum of ethyl [3-(3,4-dimethoxy)phenyl-6heptenyloxysulfonyl]diazoacetate (305) in CDCl3.

277

Figure 150. DEPT 135 NMR (125 MHz) spectrum of ethyl [3-(3,4-dimethoxy)phenyl-6heptenyloxysulfonyl]diazoacetate (305) in CDCl3.
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